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Abstract 
Neurodegenerative diseases are prolonged and progressive. In general, 
they affect individuals in the latter stages of their lives. The pathology of 
neural cell degeneration is widely researched, and most current 
therapeutic strategies aim to delay its progression by either promoting 
neuronal regeneration, resurrecting the lost brain function with 
stimulation electrodes or by cell replacement therapies.  Neuronal and 
glial cells are researched to better understand the physiological condition 
and to find a cure for degenerative diseases. In current in vitro techniques, 
cells dissociated from their natural three-dimensional (3D) tissue and 
cultured on flat surfaces present a significant drawback in drug discovery 
and cell therapy research. Communication and various signal 
transduction between neuronal and glial cells in the in vivo system are 
purely based on a dynamic convoluted systematic network constructed 
and expanded in a 3D manner. Recently, electrospun 3D nanofibre 
scaffolds have gained attention among researchers for their ability to 
mimic the natural 3D microenvironment that cells inhabit. Developing an 
in vitro system which emulates the in vivo 3D habitat of neural cells has 
been a significant challenge.  This thesis reports on the advantages of 
using novel 3D suspended nanofibre membrane technology to create 
better models for both drug discovery and therapeutic implants.  
In this study, we focused on developing a suitable sterile nanofibre porous 
membrane using Polyacrylonitrile (PAN), and Jeffamine® ED-2003 
modified polyacrylonitrile (PJ) to provide favourable conditions for 
neuronal and glial proliferation, differentiation and survival. The study 
was designed, engineered and optimised three different state-of-the-art 
fully suspended nanofibre models that are highly multi-functional and 
suitable for investigating several diseases and chronic conditions. We 
have characterised the growth and survival of human SH-SY5Y 
neuroblastoma, human U-87MG glioblastoma, human ReNcell CX neural 
progenitor and primary neural cells from E18 rat hippocampal tissue on 
      
X 
 
both PAN and PJ nanofibre scaffolds. Our investigations and chronic 
studies have shown extended survival of cells on a scaffold in comparison 
to these cells cultured on the base of cell adherent tissue culture plates 
(TCP). Differentiation cell culture trials have demonstrated that both PAN 
and PJ are capable of supporting cell differentiation and 
immunofluorescence and western blot analysis has shown elevated levels 
of key differentiation marker proteins on the cells cultured on the 
suspended scaffolds compared to TCP.  
Our findings indicate that the new 3D suspended nanofibre scaffolds 
support improved growth, survival and differentiation of both cell 
populations as well as increasing the sensitivity of the cells to Toxins 
when compared to the sensitivity of cells growth of the base of TCPs. 
Moreover, chronic exposures to Toxins using the novel co-culture scaffold 
model has shown prolonged neuronal survival in the presence of 
astrocytes. Together, our findings suggest the potential for the 3D 
nanofibre approach to improve in vitro therapeutic studies and our co-
culture system, which creates a better mimic, should lead to a reduced 
number of animals used for pharmaceutical development and in the 
screening of compounds to find neuroprotective compounds to prevent 
degeneration of neural cells.  
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Chapter 1: Main Introduction 
1.1 Electrospinning  
The process of stretching melted polymer using high voltage and 
fabricating continuous nanoscale fibres with a diameter ranging from sub-
micrometre to nanometre is known as electrospinning. Using electrostatic 
force to produce ultrathin fibre structures was traced back to 100 years, 
and the first patent on this technology was by Formhals in 1934 (Hu, X., 
Liu, Zhou, et al. 2014). This ultra-fine fibre manufacturing technology 
coined in the 1990s from the term “electrostatic spinning” used earlier by 
Reneker and co-workers (Doshi and Reneker 1995; Reneker and Yarin 
2008). This technology has gained considerable interest in several fields 
for its remarkable simplicity, versatility and potential uses in multi-
disciplinary areas. Until now several notable applications of 
electrospinning include filtration (Gopal, Kaur, Ma, et al. 2006; 
Aussawasathien, Teerawattananon and Vongachariya 2008; Schreuder-
Gibson, Gibson, Senecal, et al. 2002), cosmetics products (Gu and Xu ; 
Kusamoto and Tajima ), protective clothing for military (Lee, S. and Kay 
Obendorf 2006; Gorji, Jeddi and Gharehaghaji 2012), nano-sensors 
(Rojas and Pinto 2008; Kowalczyk, Nowicka, Elbaum, et al. 2008), wound 
dressing (Zahedi, Rezaeian, Ranaei‐Siadat, et al. 2010; Rieger, Birch and 
Schiffman 2013), drug delivery (Sill and von Recum 2008; Pillay, Dott, 
Choonara, et al. 2013), enzyme immobilisation (Lu, T., Chen, Shi, et al. 
2008; Shi, Q., Chen, Lu, et al. 2008) and tissue engineering scaffolds 
(Yoo, Kim and Park 2009; Hu, J., Kai, Ye, et al. 2017). 
As shown in figure 1.5, the process of electrospinning makes use of a 
combination of mechanical and electrostatic force to spin fibre using a 
needle with a very fine orifice which is connected and maintained at a 
positive or negative charge by a high voltage DC power supply. When the 
intensity of the electric field has increased the fluid at the tip of the 
capillary tube elongates and forms a conical shape known as the Taylor 
cone. Further increasing the electric field the surface tension of the 
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polymer solution overcomes the electrostatic repulsive force, the liquid 
that spills out of the capillary tube elongates allowing the jet to form a 
fine continuous thin filament which solidifies with solvent evaporation and 
these filaments are collected on to a rotating or stationary grounded 
collector where they accumulate to form a nanofibre matrix (Greiner and 
Wendorff 2007; Reneker and Yarin 2008). 
 
Figure 1. 1 Schematic illustration of the basic electrospinning 
process setup.  
1.1.1 Nanofibres  
Nanofibre is a final product that is obtained by the method of 
electrospinning of polymers. These nanoscale structures are cylindrical 
and can range from nanometers to several micrometres in diameter. The 
polymers are dissolved in various solvents based on needs (Teraoka and 
Teraoka 2002). Nanofibres can be made using a wide range of natural or 
synthetic polymers or a blend of both to enhance different physical 
properties to address a wide range of applications. Examples of natural 
polymers include keratin, silk fibroin, cellulose, collagen, gelatin chitosan 
and alginate (Vasita and Katti 2006; Khajavi, Abbasipour and Bahador 
2016). Examples of synthetic polymers includes poly(3-hydroxybutyrate-
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co-3-hydroxy valerate) (PHBV), poly(lactic acid) (PLA), poly(lactic-co-
glycolic acid) (PLGA), polyacrylonitrile (PAN), polycaprolactone (PCL), 
polyurethane (PU), and poly(ethylene-co-vinylacetate) (PEVA)(Vasita 
and Katti 2006; Khajavi, Abbasipour and Bahador 2016). The diameter 
of nanofibres can differ based on the type of polymers used and also 
based on different parameters used during electrospinning (Reneker and 
Chun 1996). Each polymer imparts unique properties to the nanofibre 
mat, like a large surface area to volume ratio, different porosity, changes 
in mechanical strength, the difference in pore size, flexibility and 
functions. The above properties and functions can also be modified when 
polymers are blended with different additives.  This study has mainly 
focused on a synthetic fibre PAN and blend of PAN with polyetheramines 
commonly known as Jeffamine      
1.1.2 Polyacrylonitrile 
PAN is a synthetic rich carbon source made as semicrystalline organic 
polymer resin with a linear chemical formula (C3H3N)n. PAN melts at 
300°C or when heated at a rate of 50oC per minute when mixed with a 
solvent (Gupta, Paliwal and Bajaj 1998). It is a very flexible polymer with 
a wide range of uses.  PAN is used in making ultra-thin filtration 
membranes, fibres for textile and hollow fibres. Its applications even 
widen from high-tech uses like military purpose and also used to make 
commonly used products like pressure vessels and fishing rods.  
In 1930, Hans Fikentscher and Claus Heuck were the first to synthesis 
PAN in Ludwigshafen, Germany (DE Patent No. 654989). Later in 1931, 
Herbert Rein identified that PAN could be dissolved using ionic liquid and 
in 1938 he spun the first PAN-based fibre using aqueous solutions of 
quaternary ammonium sodium thiocyanate and aluminium perchlorate 
(DE Patent No. 631756). The first mass production of PAN was in 1946 
and was identified that PAN is readily soluble in polar solvents like 
dimethylformamide (DMF), dimethylacetamide (DMA), ethylene and 
propylene carbonates, sodium thiocyanate, zinc chloride and nitric acid 
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(Wu, Chen, Wan, et al. 2012). Electrospun fibres made using PAN are 
highly-hydrophobic (Feng, Li, Li, et al. 2002).   
From all the major applications of PAN, one of the interesting use is its 
prominent role in tissue engineering and biomedical application, including 
replacement of damaged tissue. From a clinical study published on June 
11, 1955, PAN has been used for replacing a portion of the abdominal 
aorta of a dog. The same team has demonstrated several times how PAN 
could be used to create different prostheses and used these in implant 
therapies (Kinmonth, Taylor and Lee 1955). Other research showed that 
four clinical patients who had patch grafting with PAN between 1958 and 
1960 were followed up for a minimum of 17 years and all patients 
exhibited excellent health condition and recovery. Three of these patients 
were successfully reoperated upon, but the fourth patient died 17 years 
after patch grafting because of rupture of an aneurysm. Microscopy in 
three patients showed varying degrees of degenerative changes in the 
aortic wall opposite the patch. There was no evidence of infection or 
foreign body reaction in these parts of the aortic walls (Bergdahl and 
Ljungqvist 1980). The follow-up investigation showed the potential 
medical application along with the robust and inert nature of PAN.  
Carbon-based materials like PAN have been extensively used to 
investigate several cell culture studies. In tissue engineering and 
regenerative medicine scaffolds are typically required to have a 3D 
structure to provide larger surface area and space for cell adhesion, 
migration and tissue formation (Crowder, Prasai, Rath, et al. 2013). PAN 
had exhibited high carbon yield when compared to other precursors 
without alteration in its basic structure when electrospun to fibres or 
made into other products (Wangxi, Jie and Gang 2003). Also, its physical 
properties, morphology and dimensions can be easily modified and 
optimised during fabrication (Chen, J. C. and Harrison 2002). When 
prepared PAN nanofibres have shown high surface-to-volume ration as 
well as interconnected pores and modifiable surface, all of which are 
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preferred cues for tissue engineering and identification of regenerative 
medicines (Xu, C., Inai, Kotaki, et al. 2004).          
1.1.3 Polyetheramines  
Polyetheramines/jeffamine is a highly versatile polymer containing 
primary amino groups attached to the end of a polyether backbone 
generally based on propylene oxide (PO), ethylene oxide (EO) or a 
mixture of both (Huntsman, UK) (Figure 1.6). Based on use and different 
properties, jeffamine comes in various forms as monoamine, diamines 
and triamines. Jeffamine polymer is commonly used as a copolymer to 
alter chemical and physical properties of other polymers. It comes in a 
broad range of molecular weights and amine functionality. Jeffamine 
offers excellent scope to design new compounds and mixtures. It has 
been used as an additive in the full variety of fields and studies to enhance 
the property of the chosen polymers.  
 
Figure 1. 2 Chemical structure of Jeffamine® ED series.  
In a plant biology study, jeffamine-ED was used as an additive to enhance 
the property of a polymer which proved to be efficient in remedying iron-
deficient maize plants. They exhibited very low-antibacterial activity 
against non-pathogenic soil bacteria. The combination of these properties 
renders these new synthetic macromolecular chelating agents promising 
for agricultural applications (Mladenova, Ignatova, Manolova, et al. 2002). 
Another study showed that jeffamine was used as a copolymer with 
Poly(N-isopropylacrylamide) (PNIPAAm) for investigations on 
glioblastoma cells. In the study, the authors have demonstrated the use 
of jeffamine as an additive and have shown a combination of the two 
polymers offers a significant opportunity for studying the 
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microenvironmental regulation of clinically relevant models of 
glioblastoma models in vitro (Heffernan, McNamara, Borwege, et al. 
2017). Jeffamine has a wide range of molecular weight, amine 
functionality, oxide type and distribution. Compounds made from 
Jeffamine reagents provides flexibility in synthetic design. For the most 
part, Jeffamine Reagent products undergo typical amine reactions and 
are low viscosity liquids, exhibiting low vapour pressure. Jeffamine 
reagents originated chemically at the Texaco Chemical Company as 
lubricants and fuel additives and are now most frequently used in 
manufacturing adhesives, coatings, epoxies, and curing agents (Hampton 
Research). Jeffamine was also used in several other application; 
Alexander McPherson published the use of Jeffamine Reagents in a 
crystallisation publication (McPherson 1992). The first protein structure 
solved using Jeffamine reagents was that of Xylose Isomerase in the 
publication by (Lloyd, Gallay, Akins, et al. 1994).         
1.1.4 Nanofibres for In vitro model 
Producing nanofibre scaffolds with a diameter ranging from 100-1000nm 
was introduced to tissue engineering by the method of electrospinning 
during the ’90s (Doshi and Reneker 1995; Reneker and Yarin 2008). Also, 
electrospun nanofibres are capable of providing nanomechanical and 
biodegradation properties allowing embedded cells to proactively interact 
with the provisional functionalised matrix, thus remodelling it to resemble 
natural extracellular matrix (ECM). Traditionally, in vitro neuronal cell 
cultures have been performed using two dimensional (2D) monolayer 
cultures which do not provide a native environment for healthy cell 
growth. Successful engineering of desired tissue has been the ultimate 
goal of tissue engineering where engineering technology and principles 
of biology are applied together to mimic the ECM and the environment. 
Cells were grown on 2D surfaces, such as solid polystyrene tissue culture 
plastic results in remodelling, characterised by changes in gene 
expression, rearrangement of the internal cytoskeleton and altered cell 
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morphology (Vergani, Grattarola and Nicolini 2004). A modelled 
environment similar to a natural habitat can potentially have a significant 
effect on cell performance and also influence the results of biological 
assays. The advantages of using a 3D nanofibre scaffold to mimic the in 
vivo environment are:  
1) It enhances the structure of the cell and physiological relevance of 
experiments performed in vitro (Knight and Przyborski 2014)  
2) Provides greater cell-cell contact, resulting in increased 
intercellular cell signalling (Vasita and Katti 2006),  
3) Supports the cells to differentiate into more complex structures and 
facilitates the development process (Vasita and Katti 2006),  
4) Provides a greater surface area, porosity, enhancing greater cell 
adhesion, and improved access to metabolites, nutrients and 
removal of metabolic waste. Currently, no model is capable of 
replicating all the hallmarks of neural cell degeneration (Peng, Oo 
and Andersen 2010) 
However, in this study, we have created two distinct 3D natural habitats 
with nanofibres that are capable of harbouring neuronal and glial the two 
primary cells involved in neurodegenerative disease. Also, during this 
study, we were able to investigate three different significant hallmarks 
and create a cell model that does not include animals and may be used 
for examining more hallmarks and screen more drugs.        
1.1.5 Application of nanofibres in bioscience  
The exploitation of interactions between biomaterials to create functional 
nanostructures have given rise to an exciting platform for tissue 
engineering. The creative assembly of nanoscaffolds composed of 
peptides, nucleic acid or biopolymers with precise size, shape and spatial 
orientation has allowed researchers to observe the remarkable capability 
of nanofibres regarding exhibiting molecular recognition, interaction and 
compatibility with a variety of cells both in vitro and in vivo. Their 
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therapeutic applications have been investigated hugely over recent years 
leading to a wide range such as nucleic-acid based novel structures for 
drug delivery (Li, H., Labean and Leong 2011), tissue regeneration using 
biomaterials, bioengineering for stem-cell-based organogenesis, neural 
tissue engineering, scaffolds for dental pulp tissue engineering. 
Furthermore, several types of research show the use of electrospun 
nanofibres to regenerate various soft tissues such as skin, blood vessel, 
tendon/ligament (Kumbar, James, Nukavarapu, et al. 2008).  
The functional recovery of neurodegenerative diseases through 
compelling treatments has been difficult due to the unique challenges 
presented by the complex physiology of the central nervous system. 
Current therapeutic strategies aimed at delaying the progression of 
neurodegenerative diseases by a) reducing inflammation for 
neuroprotection to prevent secondary cell death b) replacement of 
damaged neuron supplemented with appropriate factors c) restoration of 
original neuronal structures by promoting neurite regeneration (Bian, 
Wang, Aibaidoula, et al. 2009). Given the limitations of CNS recovery due 
to the poor regenerative capacity of neural tissues, investigations of 
researchers lead to an excellent approach called tissue engineering that 
may provide an opportunity for reconstruction of injured tissues. The 
principle of tissue engineering is based on the general hypothesis that 
mimicking ECM in vitro will provide an intimate interface between 
individual cells that is conducive for various cellular activities from 
adhesion, proliferation and differentiation (Liang, Hsiao and Chu 2007). 
Nanofibrous constructs can be altered based on the application by 
controlling the morphology of the scaffold with suitable biochemical cues 
using a variety of biodegradable and biocompatible components that 
promotes regeneration. The possibility of tailoring artificial scaffolds has 
extended their application in chemical therapy as drug carriers as they 
provide a permissive substrate for cell penetration leading to enhanced 
drug uptake. Cellularised nanofibrous scaffolds have several promising 
advantages for brain tissue reconstruction to bridge structural gaps by 
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re-knitting of injured sites and facilitating endogenous cell migration and 
axonal elongation (Guo, Leung, Su, et al. 2009). Currently, several 
techniques are available for fabricating nanofibres: electrospinning, 
phase separation and self-assembly. The versatility of the electrospinning 
technique has allowed a wide range of tissue engineering platforms from 
cardiovascular to stem cell engineering (Li, Wan-Ju, Tuli, Huang, et al. 
2005). Several research groups have investigated the feasibility of using 
electrospun scaffolds for neural tissue engineering in various models, 
including murine neuronal cells and neuronal stem cell lines. Although 
these findings based on previous research have indicated electrospun 
scaffolds as potential candidates for nerve repair application, research 
conducted by Dr Samuel Stupp on the design of injectable nanostructures 
in spinal tissue has shown that they can self-assemble to rescue damaged 
neurons and rapidly re-grow in a paralysed mouse model. This 
demonstration has encouraged several scientists that someday 
nanotechnology self-assembly will allow researchers to tailor and develop 
personalised treatments for patients in previously unimaginable ways. 
For the use of 3D-scaffolds in regenerative medicine, for purposes such 
as in vivo engraftment or in vitro culture of any progenitor stem cells, 
optimisation of model systems with matrix parameters are essential for 
the fate of the cells. Studies suggest that cell survival and differentiation 
can be hugely influenced by the matrix composition and concentration of 
compounds that interact to promote growth patterns. Given that 3D 
microenvironment provided by scaffold composition can increase the 
survival rate of embedded cells, a study on human neuronal progenitor 
cells showed enhanced differentiation and survival on 3D scaffolds 
functionalised by laminin compared to 2D-cultures (Ortinau, Schmich, 
Block, et al. 2010). 
1.1.6 Nanofibre and tissue engineering    
Among the multiple uses of this technology, tissue engineering is one of 
the most promising areas. The use of biomaterials processed by the 
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electrospinning technique has gained considerable interest for neural 
tissue engineering applications. The underlying rationale based on the 
biomimetic principle that they mimic the physical structure of major 
constructive elements in the native ECM as biologically, almost all of 
organs and tissues are hierarchically organised and synthesised into the 
fibrous form of dimensions down to nanometre scale. It can also provide 
nanomechanical and biodegradation properties allowing embedded cells 
to proactively interplay with the provisional functionalized matrix, thus 
remodelling it to resemble innate ECM (Vasita and Katti 2006). In a tissue 
engineering approach, specific cells loaded on an engineered scaffold may 
promote functional recovery. Well-designed scaffolds can achieve signals 
for cell growth, differentiation, and subsequent tissue formation with 
suitable surface and bulk properties similar to the environmental cue in 
the extracellular matrix. Cell behaviour has been observed to be 
influenced by surface physicochemical properties like topography, surface 
charge and protein adsorption/immobilisation and release (Lee, Y. and 
Livingston Arinzeh 2011). Due to the function of mimicking the naturally 
occurring protein fibrils in the extracellular environment, electrospun 
nanofibres have gained great interest. Each nanofibre has a high surface 
to volume and aspect ratio allowing more surface area contact of the 
scaffold with the cell (Lee, Y. and Livingston Arinzeh 2011). Based on the 
type of material used for electrospinning, the physical and biological 
properties of a scaffold can be determined. Properties like surface 
wettability, mechanical properties and degradation can be manipulated 
by copolymerization or by polymer blending of various synthetic and 
natural, non-biodegradable/ biodegradable materials. 
Scaffolds composed of specific and accurate biomaterials with nano-scale 
features have a high potential of providing structural support that mimics 
natural extracellular ambience facilitating an intimate interface between 
individual neuronal cells in culture. Several biomaterials have been tested 
recently to achieve the purpose, including poly(l-lactic-co-glycolic acid) 
polymer sponges (Darice Y, Scott J, Paul H, et al. 2007), collagen, 
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hyaluronic acid hydrogels (Cui, Tian, Hou, et al. 2006) polycaprolactone 
(PCL) and polydimethylsiloxane-tetraethoxysilane scaffold in animal 
models as brain implants with variable results. Results of (Pan, H., Jiang 
and Chen 2006) show use of PLAGA-dextran to support fibroblast 
attachment and migration within the artificial architecture while 
(Bhattarai, Bhattarai, Yi, et al. 2004) produced similar results with poly 
(p-dioxane-co-L-lactide)-PEG. In 2008, a study by (Novikova, Pettersson, 
Brohlin, et al. 2008) showed that poly-β-hydroxybutyrate (PHB) graft 
seeded with Schwann cells could support & promote spinal cord repair. 
In several cases of CNS injuries, researchers have studied neural stem 
cells (NSC) to possess tremendous therapeutic potential in CNS 
regeneration treatments. For the successful differentiation of NSC, a 
variety of biomaterials have been investigated. Bian et al. demonstrated 
the use of non-cytotoxic and biodegradable implants composed of 
biopolymers such as Polyhydroxyalkanoates (PHA) developed as nerve 
conduits with co-polymers PHBHHx consisting of 3-hydroxybutyrate and 
3-hydroxyhexanoate to repair peripheral nerve damage in vivo animal 
models (Bian, Wang, Aibaidoula, et al. 2009). Evaluation of nanofibres 
composed of biomaterials such as PLA and polyhydroxyalkanoates (PHA) 
have shown similar results indicating strong potentials of PHA matrices 
with PHBHHx for neuronal differentiation of NSC for CNS repair (Xu, X., 
Li, Peng, et al. 2010) Electrospun scaffolds composed of copolymers ε-
caprolactone (PCL) and ethyl ethylene phosphate encapsulated with 
differentiating agents have resulted in enhanced neuronal differentiation 
(Low, Rujitanaroj, Wang, et al. 2013). Comparison between electrospun 
nanofibres composed of PCL and collagen-PCL blend shows that blend of 
natural and synthetic polymers could promote migration of glial cells and 
axonal outgrowth suggesting use as artificial nerve implant (Schnell, 
Klinkhammer, Balzer, et al. 2007). 
The benefit of using 3D nanofibres to regulate specific lineage from stem 
cells as compared to the 2D surface is based on topographical cues 
applied in conjunction with biochemical signals. This was confirmed by 
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(Christopherson, Song and Mao 2009) who suggested that larger 
fibrjoseph005e diameter reduced proliferation and differentiation of rat 
NSCs into neuronal lineage even in the presence of differentiation 
conditions and with smaller diameters higher degree of neuronal 
differentiation was observed in comparison to 2D surfaces.  
A study by (Tysseling-Mattiace, Sahni, Niece, et al. 2008) has 
demonstrated that 3-D peptide amphiphile (PA) nanostructures 
displaying neuroactive epitopes can inhibit glial scar formation and also 
facilitate axon regeneration after spinal cord injury. (Min, Jung, Kim, et 
al. 2013) Showed that PCL nanofibre encapsulated with Spirulina extract 
promoted astrocyte activation that could be used in astrocyte tissue 
engineering for neuronal regeneration. Nanofibres that are designed with 
bioactive peptide epitopes have been used for the selective differentiation 
of neural progenitor cells into neurons (Silva, Czeisler, Niece, et al. 2004).  
In another study, Meiners, et al.2007 reported that surface modification 
of 3D electrospun nanofibres with neuroactive peptides derived from 
human tenascin-C significantly enhanced neuronal cell adhesion, neurite 
growth and survival in vitro as compared to poly(L-lysine)-coated 
coverslips. A study demonstrated that vertically aligned carbon nanofibre 
to deliver an electrical-neural interface to culture PC12 neural cells that 
are suitable for use as implants (Nguyen-Vu, Chen, Cassell, et al. 2007). 
Highly aligned multi-layered nanofibre constructs supplemented with 
astrocytes for neuroprotective effects provide a repair-mediating 
environment guiding axonal growth and bridge lesions (Weightman, 
Jenkins, Pickard, et al. 2014). Several more groups have demonstrated 
in vitro culture of Schwann cells on electrospun aligned nanofibres than 
randomly oriented fibres emphasising on orientation cues ideal for nerve 
regeneration (Subramanian, Krishnan and Sethuraman 2011). An 
investigation showed similar results with neurite expansion from DRG 
explants on Poly-L-lactate nanofibres of high, intermediate and random 
alignments showed robust neurite growth on highly aligned compared to 
CHAPTER I      MAIN INTRODUCTION 
13 
 
random fibres (Corey, Gertz, Wang, et al. 2008). Research also suggests 
that sustained delivery of differentiating agents such as retinoic acid and 
brain-derived neurotrophic factor (BDNF) together with synergistic 
effects of electrospun nanofibre topography enhances neuronal 
differentiation of neural progenitor cells (Low, Rujitanaroj, Wang, et al. 
2013).  
Neural cell proliferation and differentiation through axonal growth has 
been drastically influenced by the degradation rate and mechanical 
performance of synthetic polymeric scaffolds. Synthetic polymers such as 
polydioxanone (PDS) and  PAN- poly (acrylonitrile-co-methyl acrylate) 
have shown to support neural cell growth (Guo, Leung, Su, et al. 2009), 
but proliferation and survival were reported to differ due to orientations 
of the constructs.  The study also indicated the significant role of 
topographical cues that influence nerve regeneration. Addressing neuron-
fibre interactions is critical to allow nanoscaffolds for a range of 
regeneration purposes to be fabricated. Reports also indicate the use of 
polymerisable Polylactic acid (PLA) as a suitable material for synthesising 
neural scaffolds, via 3D soft lithography, as they have shown sustained 
proliferation of human SH-SY5Y cells after photocuring (Koroleva, Gill, 
Ortega, et al. 2012). The ability of PLLA nanofibre substrates on 
coverslips pre-coated with PLGA (poly(lactic-co-glycolic acid) were 
studied to facilitate the growth of primary motor and sensory neurons at 
low plating densities where neuronal alignment on PLLA surpassed 
neurite alignment from explants (Corey, Gertz, Wang, et al. 2008). 
1.2 Neurodegenerative Disease  
According to the Medical research council, around 50 million people live 
with dementia worldwide - with one new case every 3 seconds. 850,000 
people are estimated to be living with dementia in the UK with numbers 
set to rise to over 1 million by 2025. This will increase to 2 million by 
2051. This accounts for a rising number of 127,000 people in the UK 
diagnosed with Parkinson’s (NHS) and there are over 40,000 people with 
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early-onset dementia (onset before the age of 65 years) in the UK Most 
people with neurodegenerative diseases start to express symptoms after 
the age of 50, although 1 in 20 people experience symptoms under age 
of 40 and slightly more common in men than women (De Lau and Breteler 
2006). With a continuous ageing population people affected by 
neuroadaptive disease, it is predicted to rise from 22% to 29% in 2033 
and 31% by 2058 (AgeUK). An individual life affected with 
neurodegenerative disorder will cause dramatic changes in their quality 
of life and affect the life of the family members too. The economic burden 
is estimated at £26 billion annually (Imperial College, London). The cost 
of illness escalates as the disease progresses. The value has varied from 
country to country, but the significant contribution to the price is towards 
patient care and nursing. 
Neurodegenerative disease is a common term used for various range of 
illness that affects the primary functions of neuronal and glial cells in the 
brain. The condition is a chronic progressive loss of the function or death 
of neurons that has caused a very significant disability and reduced 
quality of life for almost 4 million people worldwide (Dorsey, 
Constantinescu, Thompson, et al. 2007; Scott, Dawson and Dawson 
2017). Some of the common neurodegenerative diseases include 
amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, 
and Huntington's disease. The neurodegenerative disorder has become 
an increasing burden to patient, families and the healthcare system 
(Chrischilles, Rubenstein, Voelker, et al. 1998; Nussbaum and Ellis 2003). 
Amyotrophic lateral sclerosis is a specific disease that causes the death 
of neurons controlling voluntary muscles (Rubert Sánchez 2018). 
Parkinson’s Disease is the death of neurons in the substantia nigra a 
region of midbrain resulting in the low supply of dopamine, which is 
responsible for chemical signalling and several other functions in a brain 
(Sadek, Mohammed, Abunbehan, et al. 2019). Alzheimer's is a chronic 
neurodegenerative disease that usually starts slowly and gradually 
worsens over time. It is the cause of 60–70% of cases of dementia and 
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the most common early symptom is difficulty in remembering recent 
events (Burns and Iliffe 2009). Huntington's disease also known as 
Huntington's chorea, is an inherited disorder that results in the death of 
brain cells. The earliest symptoms are often subtle problems with mood 
or mental abilities (Dayalu and Albin 2015). Many kinds of research have 
been performed to study and understand the risk and protective nature 
of the disease. Studies have reported that neurodegenerative 
pathophysiology can only be identified after 70% death of the cells (Davie 
2008). The neuronal degradation can also be observed along with the 
death of astrocytes and the activation of the microglia. The disease is 
known to affect the motor system causing several obvious early 
symptoms like shaking, rigidity, slowness of movement and difficulty in 
walking (Sargetis 2016). At later advanced stages of dementia, 
depression, and anxiety, emotional and sleeping problems 
(Sveinbjornsdottir 2016). The actual cause of the disease is still unknown, 
but several studies believe that it might be genetic and several 
environmental factors (Kalia and Lang 2015). Currently as it stands these 
diseases are incurably resulting in a slow degeneration of neural cells.  
With the current advancement in research many similarities have been 
identified that related these diseases to one another on a sub-cellular 
level. There are many parallels between different neurodegenerative 
disorders including atypical protein assemblies as well as induced cell 
death (Bredesen, Rao and Mehlen 2006; Rubinsztein 2006).  Discovering 
further relevance and similarities can offer hopes to develop therapeutic 
advance that could treat many diseases simultaneously. 
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Figure 1. 3: Schematic diagram showing Neurodegeneration 
pathophysiology associated pathways.  
Idea obtained and recreated from (Qiagen Pathway)  
1.2.2 Midbrain hub of motor movements 
The Midbrain is one of the essential parts of the human brain, consisting 
of motor neurons involved in several activities in the body (Breedlove, 
Rosenzweig and Watson 2007). Midbrain acts as a conduit connecting the 
forebrain above and the cerebellum below. This part of the brain is one 
of the most complicated and superior in terms of complexity and function 
when compared to other regions (Tovote, Esposito, Botta, et al. 2016). 
In the Midbrain, the substantia nigra is a small basal ganglia structure 
that is responsible for motor movements. Due to the high levels of 
neuromelanin and dopaminergic neurons this region of the midbrain 
appears considerably darker (Rabey and Hefti 1990). It consists of two 
regions pars compacta and pars reticulata with very different functions 
and connections. Both of these regions are responsible for the supply of 
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dopamine to several areas of the brain. Pars compacta are formed of 
dopaminergic neurons, and disease like Parkinson’s is characterised by 
the death of neurons in this region (Kim, S. J., Sung, Um, et al. 2003).  
1.2.2.1 Neurons   
Inability to control movements, cases of dementia, problems with mood 
or mental abilities and loss of memory are the common symptoms 
observed in Neurodegenerative disorders. Neuronal cells are the primary 
source of signal transport in the central nervous system of mammals and 
loss of this particular substance in the brain leads to catastrophic 
disorders in the brain. The exact reason for cell loss is still unknown (Kalia 
and Lang 2015). There are roughly about 100 billion neurons in the 
human brain which is responsible for several pathological disturbances 
caused by neurodegenerative diseases. Neurons that are responsible for 
the cause of Parkinson’s disease alone accounts for 2-5% of the total 
population, and they are primarily found in the Midbrain. These neurons 
are called the dopaminergic neurons and are found less in number and 
are found confined to small areas of the brain with projections into 
various parts of the brain (Schultz 2007), even though at such low 
numbers these neurons play a critical role in different brain functions 
including voluntary movements several behavioural processes like mood, 
addiction, reward and stress. Identification and localisation of the brain 
dopamine cell were initially done by Falck-Hillarp histoflourescence 
methods (Falck, Hillarp, Thieme, et al. 1962). The central part of 
mesencephalon contains approximately 90% of the total number of brain 
dopaminergic neurons. Humans have been known to have 590,000 
dopaminergic neurons followed by 165,000 in macaque monkeys and 
45,000 in the rat brain; in the early sixties, the number in humans drops 
to 350,000. (Bogerts, Häntsch and Herzer 1983; German and Manaye 
1993).        
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1.2.2.2 Glial Cells 
Glial cells are non-neuronal cells in the CNS and are also known as 
neuroglia. They are the most abundant cells found in the CNS, ranging 
between 33% and 66% depending on the mammalian species 
(Herculano‐Houzel 2014; Jäkel and Dimou 2017). As being a part of the 
CNS, glial cells do not play a direct role in synaptic interaction and 
electrical signalling but they help to define synaptic contacts, maintain 
the signalling ability of neurons, maintain homeostasis, form myelin and 
provide support and protection for neurons (Jessen and Mirsky 1980; 
Wolosker, Dumin, Balan, et al. 2008) . Glial cells were identified in 1856 
by a pathologist Rudolf Virchow. A differentiated form of glial cells 
includes oligodendrocytes, astrocytes, ependymal cells, and microglia 
found in CNS whereas the satellite cells and Schwann cells are found in 
the peripheral nervous system (PNS) (Purves, Augustine, Fitzpatrick, et 
al. 2001). Oligodendrocytes are mainly responsible for the Myelin sheath 
coating in the CNS, providing the insulation required by neuronal cells for 
efficient electrical signalling (Baumann and Pham-Dinh 2001). Astrocytes 
are the most abundant type of microglia in the CNS. In early days, these 
star-shaped astrocytes were known to be a space filler in the brain but 
later identified that they play a significant role in secretion, absorption, 
neural transmission and maintenance of the blood-brain barrier (Kolb and 
Whishaw 2009). Studies have also shown that both oligodendrocytes and 
astrocytes are directly linked to neurodegenerative diseases (Papuć, 
Kurzepa, Kurys-Denis, et al. 2014). Ependymal cells function as a neural 
stem cell that lines the spinal cord and the ventricular system of the brain; 
and also plays a part in the creation and secretion of cerebral spinal fluid 
(CSF) (Johansson, Momma, Clarke, et al. 1999). Schwann cells play a 
similar role as oligodendrocytes in the PNS and are responsible for 
clearing debris that allows regrowth of PNS neurons (Jessen and Mirsky 
2005). Cells that surrounds the neurons in sensory, sympathetic and 
parasympathetic ganglia are mostly the satellite glial cells (Hanani 2005). 
Satellite glial cells are also responsible for regulating the external 
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chemical environment and like the astrocytes, they interconnect the gap 
junctions in the PNS. They are very sensitive to injury and inflammation 
and contributes to chronic pain (Ohara, Vit, Bhargava, et al. 2008). All 
types of glial cells are responsible for several activities, and functioning 
of a mammalian brain, but astrocytes especially play a direct, active and 
a very critical role in several neurodegenerative diseases (Rappold and 
Tieu 2010; Booth, Hirst and Wade-Martins 2017). 
1.2.2.3 Role of Astrocytes 
Astrocytes also are known as astroglia are star-shaped cells found 
abundant in the brain, covering 20-40% of the total glial population 
(Verkhratsky and Butt 2013). Even though an actual number of 
astrocytes present in the brain is still disputed, several studies have 
clearly shown the role of astrocytes in neurodegenerative diseases. 
Studies on amyotrophic lateral sclerosis (ALS) have demonstrated the 
neuroprotection role of astrocytes “in which the removal of glutamate 
from the extracellular space by astrocytes confers neuroprotection, 
whereas astrocytic release of toxic soluble molecules promotes 
neurodegeneration” (Rappold and Tieu 2010). In recent years the dual 
role of astrocytes which cause damage and protection has been 
thoroughly researched in several experimental models and for a potential 
target for drug discovery (Gorshkov, Aguisanda, Thorne, et al. 2018).  
One of the significant roles of astrocytes in the maintenance of 
neurotransmitters such as glutamate and gamma-aminobutyric acid 
(GABA) (Schousboe, A., Bak and Waagepetersen 2013). They are the 
primary source of enzymes which are needed for neuronal synthesis and 
metabolism.  Lack of this can lead to an increased propensity for neuron 
glutamate excitotoxicity and subsequent cell death (Gorshkov, Aguisanda, 
Thorne, et al. 2018).   Through several secreted factors like 
prostaglandins, nitric oxide, and arachidonic acid astrocytes regulates 
blood flow in the brain (MacVicar and Newman 2015). They are also 
responsible for guiding the formation and maturation of synapses; 
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secreted molecules like apolipoproteinE and thrombospondins by 
astrocytes significantly promotes synapse formation shown in vivo and in 
vitro studies (Risher and Eroglu 2012; Clarke and Barres 2013). Targeting 
control synaptogenesis using astroglia could be a new method to target 
several neurodegenerative diseases. Astrocytes are responsible for the 
regulation of reactive oxygen species (ROS); high amounts of ROS are 
usually generated in the brain due to the high rates of oxidative 
metabolism. Glutathione derived from astrocytes is an essential 
antioxidant that has demonstrated protection against neuronal cell death 
(Drukarch, Schepens, Stoof, et al. 1998; Gorshkov, Aguisanda, Thorne, 
et al. 2018) whereas other studies have also shown that the activation of 
immunological cytokines, such as interferong (IFN-g) and interleukin 1b 
(IL-1b) in astrocytes, can generate harmful ROS causing damage to 
neurons (Sheng, Hu, Feng, et al. 2013). Table 1.1 provides a summary 
of several functions and the role of astrocytes in CNS. 
Table 1. 1: Role of astrocytes associated with multiple regions and 
functions of the brain (Gorshkov, Aguisanda, Thorne, et al. 2018).  
Functions 
and Role 
Biological process Reference 
CNS 
Development 
 Neurons develop first, and 
then astrocytes develop.  
 Guides the migration of neural 
progenitors. 
 Supports Synapsis formation. 
 Produces and maintains 
Myelin.  
(Clarke and 
Barres 2013) 
Barrier 
Function 
 Forms the blood-brain barrier. 
 Gap Fillers 
 Includes barrier properties in 
cerebral and endothelial cells  
 
(Kimelberg and 
Nedergaard 
2010; Sofroniew 
and Vinters 
2010) 
Homeostasis 
 Specialised mechanism to 
regulate fluids 
 Channels neurotransmission 
(Schousboe, I. 
and Winther-
Lindqvist 2013) 
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 Glutamate and GABA 
regulations  
Metabolic 
support 
 Glucose regulation in CNS 
(Sofroniew and 
Vinters 2010) 
Synaptic 
transmission 
 Releases molecules to directly 
activate synapsis 
 Can modulate neuronal 
excitability via their Ca2+ 
 Growth factors can regulate 
synaptic transmission over an 
extended period  
(Clarke and 
Barres 2013) 
Neurovascular 
Support 
 Connects with blood vessels  
 Releases second messengers  
 In response to 
electrophysiological activity, 
regulates changes in blood 
flow.   
(Gordon, 
Mulligan and 
MacVicar 2007; 
Attwell, Buchan, 
Charpak, et al. 
2010; MacVicar 
and Newman 
2015) 
 
Figure 1. 4: Potential neuroprotective pathways of astrocytes. 
Recreated from (Rappold and Tieu 2010).  
Multiple factors can influence a neuron cell death. Conditions like a 
genetic mutation, environmental toxins or maybe combinations of both 
through mitochondrial dysfunction, protein degradation, and oxidative 
CHAPTER I      MAIN INTRODUCTION 
22 
 
stress can lead to cell death. It has been predicted that astrocytic 
neuroprotection can be through the following pathways  
1) The release of glutathione (GSH) which is then cleaved by ɣ-
glutamyltranspeptidase on the astrocyte plasma membrane to generate 
glutamate and cysteinylglycine, which serves as a precursor of neuronal 
GSH synthesis.  
2) The release of neurotrophic growth factor.  
3) Activation of the transcription factor Nrf2 leads to expression of 
genes containing the antioxidant response element (ARE), including 
glutamylcysteine synthetase (GS), which is involved in GSH synthesis.  
4) Activation of the transcription factor Nurr1, which suppresses 
the production of inflammatory cytokines.  
5) Removal and degradation of cytotoxic molecules, such as α-
synuclein. (Rappold and Tieu 2010).    
The cytoplasm of astrocytes contains intermediate filaments that produce 
a distinct protein called glial fibrillary acidic protein (GFAP) which is a 
significant component of these cells. Astrocytes protect the neuronal cells, 
and meaningful activities of these cells are found intertwined neurons, 
myelin and the axons (Benarroch 2005). Post-mortem studies of 
neurodegenerative disease patient brain showed a low density of 
astrocytes expression and GFAP levels when compared to a healthy 
human brain. (Hirsch and Hunot 2009). Several attempts have been 
made to study the neuroprotective property of astrocytes. A recent study 
targeted 5-HT1A receptors in astrocytes to protect neurons in mice 
models.  The study was performed in a co-culture of astrocyte cells and 
neuronal cells, and the results showed that astrocytes via 5-HT1A 
receptors protected neurons against oxidative stress when treated with 
8-OH-DPAT (Miyazaki, Asanuma, Murakami, et al. 2013). A similar study 
on functional engraftment of human ES cell-derived neurons enriched by 
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co-culture with telomerase-immortalised midbrain astrocytes has also 
proved the importance of astrocytes for the survival of neurons under 
various conditions. In the case of several neurodegenerative diseases, 
investigations on the neuroprotective property of astrocytes have 
suggested that survival of astrocytes play an important role directly or 
indirectly in the survival of neurons. Rappold and his co-workers have 
recently demonstrated the possible astrocytic pathway involved in 
neuronal protection, as shown in figure 1.2. A study has also 
demonstrated that extensive damage caused to astrocytes can extend its 
effect to the loss of neuronal cells thus leading to neurodegeneration 
(Rappold and Tieu 2010).  
1.2.4 Neurotoxins 
Neurotoxins, as the name implies, can prove neurologically toxic with 
their specific ability to damage neural components. Below are the four 
major types of neurotoxins that are used in this study to mimic 
neurodegenerative diseases pathophysiology.  
 
Figure 1. 5: Chemical structure for neurotoxins used in this study. 
Commonly used to simulate neural cell degeneration pathophysiology in 
several studies. Image obtained from Sigma Aldrich Rotenone, MPTP, 
MG132, and BSO  
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1.2.4.1 Rotenone  
Rotenone is one of the neurotoxins that have been used cause damage 
to the mitochondria in experimental models to explore the aspects of 
neural degeneration. Previous investigations have proposed several 
mechanisms for rotenone toxicity such as complex I inhibition, increased 
ROS production and effect on mitochondrial DNA replication. Several 
other toxins seem to induce apoptosis by its ability to open the 
mitochondrial transition pore that releases cytochrome-c and consequent 
ATP depletion (Cassarino, Parks, Parker Jr, et al. 1999).  
1.2.4.2 MPTP 
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP) is 
another toxin that causes a syndrome similar to core neurological 
symptoms and neurodegeneration by inducing oxidative stress and 
mitochondrial respiration defect together with an aggregation of proteins 
(Dauer, et al. 2003). Both rotenone and MPTP have been studied to 
behave as respiratory chain inhibitors of mitochondria while MPTP results 
in nerve cell death. A study showed that Ca+ induced mitochondrial 
stress which is associated with inhibition of complex-I as an essential 
factor in neurodegeneration. It demonstrated that Ca+ did not stimulate 
ROS to increase in rotenone-treated rat mitochondria with the presence 
of complex-I (Sousa, et al. 2003).  
1.2.4.3 MG132 
Z-L-Leu-D-Leu-L-Leu-al (MG132) is another type of proteasome inhibitor 
toxin used in many different studies, and it is a peptide aldehyde which 
blocks the proteolytic activity of the 26S proteasome complex (Han, Moon, 
You, et al. 2009). It is capable of reducing ubiquitin-conjugated protein 
degradation in mammalian cells with no changes in its ATPase and 
isopeptidase activity (Kim, D., Kim and Li 1999).  
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1.2.4.4 BSO 
L-Buthionine sulfoximine (BSO) a type of glutamylcysteine synthetase 
inhibitor. It contains Sulfoximine a chemical compound containing 
sulphur double bonded to nitrogen. It reduces glutathione a metabolite 
which plays a significant role in the protection of cells against oxidative 
stress and also plays a minor role in chemotherapy for the treatment of 
cancer (Defty and Marsden 2012). 
1.3 In vitro cell Models for neural cell degeneration  
Due to limitations of live brain tissues, our understanding of neural cell 
degeneration is restricted to studies using post-mortem samples which 
represents the end-stage of disease. Despite interspecies differences, 
several aspects of the pathology displayed in such examples do not 
exactly necessarily mimic the disease phenotype at cellular levels. This 
highlights the importance of modelling of disease phenotype in vitro using 
defined cell populations to make it possible to study neurological 
disorders such as Amyotrophic lateral sclerosis, Parkinson's disease, 
Alzheimer's disease, and Huntington's disease. 
The pathogenesis of neurodegenerative diseases is concurred by multiple 
factors and use of in vitro models using established cell lines, and primary 
cell cultures allow exploring genes/proteins involved in single pathogenic 
mechanisms by offering favourable controlled environment. To improve 
the understanding of neural cell degeneration at cellular levels, 
researchers focus on neurotoxicity (MPP+, 6-OHDA, BSO), excitotoxicity 
(NMDA, glutamate), mitochondrial dysfunction and defects in protein 
degradation. For neurodegenerative diseases like amyotrophic lateral 
sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's 
disease the major hallmark is the progressive loss of neural cells, and 
hence the development of in vitro models of these cell types could enable 
the study of neurodegeneration and novel preventative therapeutics. 
Although there is the only limited availability of human neurons from 
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foetal samples, direct examination of toxicity or protective effects in such 
neurons has been a challenge. Under such scenarios, pluripotent stem 
cells and neural stem cell progenitors are an excellent alternative source 
to ex vivo cultures of immortalised cell lines. 
Besides stem cells, neuronal cell models in particular human 
neuroblastoma SH-SY5Y lineages have been employed due to its 
catecholaminergic neuronal properties (not strictly dopaminergic) and 
ease of maintenance during preclinical validations in neural cell 
degeneration research. SHSY5Y cells have been extensively used for 
differentiating into neuronal cells to characterise of neuronal features 
induced and as a cell model for toxicity studies. Retinoic acid (RA) 
differentiation of SHSY5Y cells demonstrated low proliferation rates with 
pronounced neuronal morphology with expressions of genes related to 
synaptic vesicle cycle, dopamine synthesis/degradation, transporter and 
was found to be more sensitive to 6-OHDA. Use of inhibitors of dopamine 
transporters induced protection against oxidative damage in RA-
differentiated SHSY5Y cells (Lopes, Fernanda M., da Motta, De Bastiani, 
et al. 2017). A recent study indicated that MiR-124-3p could play a 
neuroprotective role in 6-OHDA treated SHSY5Y cells by targeting 
annexinA5 that mediates apoptosis and caspases activity (Dong, Zhang, 
Tai, et al. 2018). Different aspects of neural cell degenerative disease 
progression and novel treatments can be studied by employing 
appropriate experimental animal models. Although current animal models 
do not completely mimic these diseases, major types such as toxin 
models and genetic models have contributed extensively to knowledge 
on neurodegenerative diseases. Several invertebrates such as Drosophila, 
C. Elegans and snail and vertebrates like zebrafish, monkey, rat and 
mouse have been used to research the disease pathogenesis. 
1.3.1 Toxin Models  
A range of toxin models based on neurotoxins has been studied over the 
years to test neuronal degeneration. Main characteristics of neurotoxins 
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such as 6-OHDA, MPTP, rotenone and paraquat have been extensively 
studied on recapitulating hallmarks of neural cells degeneration  
1.3.1.1 6-hydroxydopamine (6-OHDA) 
Neurotoxin-based neural cell degeneration model using intracerebral 
injections of 6-ODHA have shown to be neurotoxic by inhibiting the 
activities of mitochondrial respiratory complexes I and IV (Prajapati, 
Garabadu and Krishnamurthy 2017) along with the production of free 
radicals that induce oxidative stress and mitochondrial dysfunction 
(Hwang 2013). 6-ODHA can also trigger a decrease in glutamine in the 
striatum and an increase in glutamate thereby shifting the steady-state 
equilibrium of Gln-Glu cycle between neurons and astrocytes (Lei and 
Powers 2013)  
1.3.1.2 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) 
Intravenous injections of MPTP could cross the blood-brain barrier (BBB) 
and be shown to induce parkinsonism by being metabolised by mono-
amino oxidase in glial cells and transported into neurons in the form of 
MPP+ (1-Methyl-4-Phenylpyridinium Ion). Further, MPP+ results in 
reduced ATP production and ROS accumulation (Yan, Wang and Zhu 
2013). Besides, MPTP can elevate levels of glutamine and other key 
enzymes of Glu-Gln cycle in the striatum that result in the loss of neurons 
and impaired motor function (Lu, Y., Zhang, Zhao, et al. 2018). Thus, 
MPTP administrations represent to be a classic toxin model. 
1.3.1.3 Rotenone  
Rotenone, a plant root extract is hydrophobic and could cross the BBB, 
independent of dopamine transporters. Like MPTP, rotenone inhibits 
mitochondrial complex I, leading to ROS production and thus 
mitochondrial dysfunction (Terron, Bal-Price, Paini, et al. 2018). A model 
developed by Betarbet showed that intravenous infusions of low doses of 
rotenone in Lewis rats caused selective degeneration of nigrostriatal 
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neurons (Betarbet, Sherer, MacKenzie, et al. 2000) while another group 
showed multisystem degeneration including loss of 54% and 28.5% of 
striatal fibres and neurons respectively (Höglinger, Féger, Prigent, et al. 
2003). The progressive degeneration of neurons in brain might involve 
the contribution of a cascade of neuroinflammatory events that have been 
identified in several in vivo studies. Studies highlight the importance of 
identification of cellular and molecular events associated with 
neuroinflammation in neural cell degenerative models. Cellular responses 
such as oxidative stress and cytokine-receptor mediated apoptosis might 
not only allow us to understand disease progression but also to develop 
therapeutic strategies to downregulate the inflammation process and 
other deleterious events to the slow progression of these diseases (Hirsch 
and Hunot 2009).  
Chronic midbrain slice culture in vitro model was used to determine the 
relevance of rotenone-induced damage to neurons. It was shown that 
treatments with α-tocopherol and coenzyme Q10 attenuated rotenone-
induced oxidative damage. This relevance was also determined in vivo 
models by systemic rotenone infusion that led to increased oxidative 
damage in particular dopamine-rich brain regions known to degenerate 
in brains the patients (Sherer, Betarbet, Testa, et al. 2003). A study 
conducted by (Malagelada, Jin, Jackson-Lewis, et al. 2010) reported that 
neuronal cell death was protected by rapamycin by blocking translation 
of RTP801 protein that is induced in cell and animal models and in 
affected SN neurons of the patients that leads to neuronal death due to 
dephosphorylation of Akt kinases, which is crucial for maintaining cell 
survival.  
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1.3.2 Genetic Models 
Virtually all Alzheimer’s disease models are based on the use of 
transgenic methodologies targeting APP, presenilin, tau or AOPE genes, 
mostly in mice. Amyotrophic Lateral Sclerosis targeted genes include 
those encoding superoxide dismutase 1 (SOD1), (TAR)-DNA-binding 
protein 43 (TDP-43) and DNA/RNA binding protein Fused in Sarcoma 
(FUS). Transgenic models targeting the huntingtin (Htt) gene have been 
developed, providing new experimental opportunities for studying on 
Huntington disease. Since the identification of the huntingtin gene and 
the characteristic expanded CAG repeat/polyglutamine mutation, 
multiple murine genetic models and one rat genetic model have been 
generated. In addition to the different model to investigate neural cell 
degeneration, transgenic worm models using the Nematode C Elegans 
has been used to study genes that are positively linked to familial 
neurodegenerative disease.  Genes such as SNCA/ PARK1/ PARK 4, α-
synuclein, Leucine rick repeat kinase 2 (LRRK2), Parkin RBR E3 Ubiquitin 
Protein Ligase (PRKN), PTEN-induced putative kinase 1 (PINK1), DJ-1 
(Protein Deglycase), ATP13A2 (ATPase Cation Transporting 13A2)  have 
been found to be mutated during neural cell degeneration are widely 
studied using C Elegans with their homologs LRK-1, PDR-1, PINK-1, DHR-
1.1/1.2, CATP-6 respectively. C. Elegans, a microscopic roundworm, have 
orthologs for 60-80% of human disease-causing genes including genes 
implicated in neurodegenerative disease thus indicating the use of this 
model organism in studying particular genes and generation of genetic 
models of several neurodegenerative disorders (Cooper and Van 
Raamsdonk 2018). 
1.3.3 Pre-clinical models of neural cell degeneration  
Acceleration of neural cell degeneration research depends on robust and 
promising preclinical models. Michael J. Fox Foundation has generated 
models that support progress in neurodegenerative disease research. 
Below is the list of models that displays various pathological phenotypes. 
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Table 1. 2: Neural cell models with various pathological 
phenotypes 
Model Advantage Disadvantage 
Genetically 
modified 
 Near physiological 
expression levels and 
standard spatiotemporal 
expressions. 
 Suitable for targeting 
clinically relevant 
pathways. 
 Pathology is either 
absent or present only 
in advanced age. 
 Lack of motor deficits 
in several models. 
Viral vector-
mediated 
overexpress
ion/ 
knockdown 
 Rapid onset of motor 
deficits with 
spatiotemporal control of 
progressive nigral lesions. 
 Facilitates the designing 
of internal control and 
adaptability to multiple 
species. 
 Major drawback 
includes the use of 
supra-physiological 
expression levels. 
α-synuclein 
pre-formed 
fibrils (α 
SynPFFs) 
 Spatiotemporal control of 
progressive nigral lesions 
with protracted time 
course. 
 Suitable for targeting 
extracellular α-synuclein 
and its seeding 
hypothesis. 
 Supra-physiological 
expression levels, less 
robust motor deficits 
and uncertainty of 
relevance of α-
synuclein species with 
human pathology. 
Neurotoxins 
 Spatiotemporal control of 
progressive nigral lesions 
with rapid onset. 
 Robust stereotyped motor 
deficits and oxidative 
stress. 
 Lack of robust alpha-
synuclein pathology 
and clinical relevance. 
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Yeast/ 
zebrafish/ 
Drosophila 
 High-throughput 
screening of therapeutics. 
 Insufficient modelling 
of the human brain 
and complexity. 
 Findings from these 
models require further 
replications in 
mammalian systems 
to understand its 
human relevance. 
Other models include knockout models of transcriptional factors such as 
sonic hedgehog (SHH), pituitary homobox 3 (Pitx3), nuclear receptor-
related protein-1 (Nurr1) and engrailed 1 (EN1) that are key to the 
development and stability of nigrostriatal system (Gonzalez-Reyes, 
Verbitsky, Blesa, et al. 2012; Zhang, Le, Xie, et al. 2012). Disruption of 
mitochondrial transcriptional factor A has resulted in impaired motor 
function and neuronal death, due to degeneration of intraneuronal 
inclusions and nigrostriatal pathways (Good, Hoffman, Hoffer, et al. 
2011). Studies have also suggested that defects in VMAT2 (vesicular 
monoamine transporter) might be an early mechanism leading to 
neuronal death (Taylor, Alter, Wang, et al. 2014), as VMAT2- knockout 
mice demonstrated enhanced MPTP toxicity while VMAT2-overexpressors 
displayed neuroprotection from MPTP toxicity (Lohr, Bernstein, Stout, et 
al. 2014). 
Mimicking of neurodegenerative disease phenotype in animal models 
could be achieved by combining both toxin and genetic-based models as 
a multigene modulated transgenic model. Involvement of miRNA or siRNA 
to the appropriate model system could allow the development of a robust 
model. Use of primary cell culture models to mimic slow the progression 
with cellular damage phenotype could also help in drug discovery, but the 
use of these cells in a 2D tissue culture plastic may give findings that may 
not be entirely true. Every cell model discovered in the past has always 
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involved the use of animals or in vitro tissue culture experiments, yet 
there is not a significant model that has explained the full nature of neural 
cell degeneration or sufficiently reduced the progression without any side 
effects. Methods like cell replacement therapies and models using 
embryonic cells have always focused on replacing the lost neurons by 
injecting engineered cells directly into the affected area without providing 
the support or guidance for cells to grow (Björklund and Lindvall 2000; 
Bjorklund, Sanchez-Pernaute, Chung, et al. 2002). These techniques 
have only shown partial improvements or caused further damage in the 
rodent models. In this study, we have demonstrated the two primary cells 
that form the human brain can be cultured in a 3D nanofibre matrix that 
is capable of providing natural habitat. This model is capable of creating 
an in vivo like study in an in vitro environment allowing researchers to 
understand and analyse the pathophysiology conditions similar to a 
natural state, thus reducing the number of unsuccessful animal and 
human trials. The scaffold embedded with matured embryonic stem cells 
or pre-mature cell may also provide a robust platform in cell replacement 
and implant therapies shortly. Also, the development of a fully conductive 
scaffold and tissue model can help us to understand the electrical activity 
of these cells and improve investigations like DPS. 
1.4 3D Cell Culture  
Cell cultured and studied on two dimensional TCP has been a routine 
practice in many research groups worldwide. Cells cultured in 2D is 
arguably primitive and does not represent the anatomy or physiological 
conditions of a cell in its natural form. Using 3D cultures becomes more 
relevant but requires a multidisciplinary approach, and with advanced 3D 
systems, it becomes more relevant to human and animal physiology, 
leading to possibilities of complex co-culture systems. The use of a 3D 
cell culture system can vary widely based on the purpose which can range 
from tissue engineering for clinical purposes thorough to development of 
implant therapies and models of drug screening. Eukaryotic cell cultures 
have been in practice for more than 40 years, and the most common 
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substrate used for cell growth have been made using polystyrene or glass 
forcing the cells to form of a flat two-dimensional surface (Freshney 
2015). Thousands of published studies ranging from drug screening 
through to developmental molecular biology have relied on 2D surfaces 
for the growth of adherent cells. It has been an assumption that animal 
or human physiology can be accurately reproduced using cellular 
monolayers; however, a 2D surface cannot represent an ECM found in 
native tissue (Haycock 2011).  During the point of intercellular 
communication, many 2D culture experiments fail to consider the 
interplay between different cell types, with many cultures being of a 
single cell type. 2D co-cultures overcome some of these problems but 
mostly not easy to handle and inaccurately reproducing cellular function 
observed within a tissue (Haycock 2011). 
A number of 3D methods have been developed in recent years for a range 
of issues in which the cell culture environment is taking the spatial 
organisation of the cell into account (Abbott 2003; Lee, J., Cuddihy and 
Kotov 2008). The aim is to bridge the gap between the use of whole 
animal and monolayer cell cultures. It is, therefore, necessary to create 
a growth environment that can mimic the native tissue as close as 
possible. However, 3D systems are complex and have several parameters 
to be considered. One critical criterion is the choice of material for the 
scaffold and the source of the cell. Not all three-dimensional culture 
models require a scaffold; however, the use of scaffolds for 3D models 
has certainly increased considerably in the past ten years. Examples 
include highly oriented 3D collagen scaffold to promote directed axonal 
growth, with dorsal root ganglia explants creating a 3D model for 
peripheral nerve regeneration (Bozkurt, Brook, Moellers, et al. 2007), 
Another study demonstrated  grow embryonic, postnatal, and adult 
neural stem and progenitor cells on a collagen and hyaluronan scaffold 
(Brännvall, Bergman, Wallenquist, et al. 2007). A 3D scaffold made of 
poly(lactic-co-glycolic acid)/poly(L-lactic acid) were used for 
differentiating human embryonic stem cells (Levenberg, Huang, Lavik, et 
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al. 2003). Finally, one study compared the viability of hippocampal 
neurons and astrocytes grown on 2D conditions with 3D scaffold prepared 
from the coralline exoskeleton, showing better results for the 3D cultures 
(Peretz, Talpalar, Vago, et al. 2007). Three-dimensional culture models 
can be grouped into the study of whole animals and organotypic explant 
cultures (including embryos), cell spheroids, microcarrier cultures, and 
tissue-engineered models, hydrogels, scaffold-based and bioprinted 
models.  
1.4.1 Cellular Spheroids 
Cellular spheroids are simple three-dimensional models that can be 
generated from a wide range of cell types and form due to the tendency 
of adherent cells to aggregate. Cellular spheroids are created from single 
culture or co-culture techniques using conventional methods like hanging 
drop, rotating culture, or concave plate methods (Castañeda and Kinne 
2000; Timmins, Harding, Smart, et al. 2005; Pampaloni, Reynaud and 
Stelzer 2007). Scaffolds are not required for culturing spheroids and can 
be readily imaged using a microscope. Spheroids have been commonly 
used for high throughput screening and modelling solid tumour growth 
and metastasis studies (Ivascu and Kubbies 2006).   
Table 1. 3 3D Spheroid neural models. Adapted from (Zhuang, Sun, 
An, et al. 2018)  
Cell Type Evaluation Reference 
Mimicking neuronal networks formation 
Rat cortical Neurons within the 
spheroids were 
electrically active. 
Formation of synaptic 
networks 
Laminin secretion 
(Dingle, Boutin, 
Chirila, et al. 2015) 
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Rat cortical cells 
and hippocampal 
cells 
Functional networks 
were observed inside 
the NBB 
The synaptic 
connection between 
NBBs 
(Kato‐Negishi, 
Morimoto, Onoe, et al. 
2013) 
Rat primary NPC Satellites spheroid 
were found around the 
host spheroids. 
Bundle networks were 
found between host 
spheroid and satellite 
(Jeong, Chang, Park, 
et al. 2015) 
Understanding of neuropathology 
Human 
medulloblastoma 
cell line and 
human neural 
stem cells 
Feasibility study, 
Spheroid (co-culture of 
tumor cell and stem 
cell)was treated with 
Etoposide indifferent 
levels, led to ratio 
change of tumor cell 
and stem cell 
(Ivanov, Parker, 
Walker, et al. 2014) 
NT2 cells Differentiated neuro 
spheres enriched in 
mature neurons 
Functional astrocytes 
were obtained by 
stirred suspension 
culture 
(Terrasso, Pinto, 
Serra, et al. 2015) 
Rat cortical cells Disrupted synaptic 
integrity in Abreacted 
group Decreased 
(Choi, Yoon Jung, 
Park and Lee 2013) 
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acetylcholine amount 
in Abreacted group 
SH-SY5Y cell line Neural differentiation 
Increased levels of 
degeneration were 
achieved compared to 
2Dsystem 
(Seidel, Krinke, 
Jahnke, et al. 2012) 
Human midbrain-
derived NPC 
Spheroids contained 
mature neurons with 
abundant synaptic 
connections. Functional 
neurons were 
observed. 
(Simao, Pinto, 
Piersanti, et al. 2014) 
 
1.4.2 Hydrogel models     
One of the significant challenges of treating neurodegenerative disease 
involves transplantation of foetal ventral mesencephalon grafts that 
survive post-transplantation with restored motor functions. It is reported 
that only 20% of these survive (Brundin, Karlsson, Emgård, et al. 2000) 
and researchers have been investigating methods to improve the survival 
of such neuronal grafts post-transplantation. Injectable scaffolds such as 
in situ hydrogels have been assessed to test their efficacy as a delivery 
platform to improve graft survival. An ideal scaffold would enhance cell 
engraftments by providing a supportive microenvironment for cell 
adhesion, deliver growth factors locally and prevent an attack from host 
neuro-immune cells (Orive, Anitua, Pedraz, et al. 2009). Collagen 
hydrogels are popular scaffolds with abundant natural ECM that is widely 
used for several applications such as cartilage engineering 
(Chattopadhyay and Raines 2014), dentistry (Patino, Neiders, Andreana, 
et al. 2002) nucleic acid delivery to balance inflammation and 
angiogenesis (Browne, Monaghan, Brauchle, et al. 2015). A study showed 
that encapsulation of primary neurons in GDNF-enriched collagen 
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hydrogel could significantly improve the survival and functional efficacy 
after intra-striatal transplantation in a rat model (Moriarty, Pandit and 
Dowd 2017). Hydrogels composed of type I collagen and low molecular 
weight hyaluronic acid and polyethene glycol were used to deliver 
secretome from rat adipose tissue-derived MSCs in an active state and 
counteracted 6-OHDA by upregulation of SIRT3, an active protein in 
oxidative stress that positively regulates ROS detoxifying enzyme 
(Chierchia, Chirico, Boeri, et al. 2017). Neuroprotective agents such as 
activins have been studied for their potential neuroprotective effects by 
loading onto hydrogels for implantation into the striatum of a mouse 
model. Activin B loaded hydrogel was shown to significantly reduce 
inflammatory responses and provide substantial cellular protections and 
improved behaviour in mice post-surgery (Li, Juan, Darabi, Gu, et al. 
2016). These studies suggest the potential applications of biomaterials in 
brain repair and neural transplantations for degenerative diseases. 
1.4.3 Engineering based scaffolds for neural tissue construction 
Materials like hydrogel and Matrigel has been frequently used in tissue 
engineering approaches. However, few studies suggest that these 
materials are poorly defined and have variations between each batch and 
several types of research have been notably carried out in replacing these 
materials (Lancaster, Renner, Martin, et al. 2013; Dixon, Shah, Rogers, 
et al. 2014; Caiazzo, Okawa, Ranga, et al. 2016). Extensive materials 
have also been investigated and modified to incorporate diverse chemical 
or physical cues to reconstruct tissue environment with enhanced 
authenticity. solid materials, such as PLGA, PLLA, PCL, Gelatine, Collagen, 
alginate, polyethylene glycol, silk fibroin have been widely explored for 
constructing neural tissue models. Compared to gel-like structures 
engineered solid materials are easily amendable according to the 
topographic and physiological cues.   Depending on the specific biological 
interest, both natural and synthetic materials have been carefully defined 
to mimic the physiological conditions, and each material has its pros and 
cons. A study demonstrated synergistic effects of matrix and signalling 
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molecules on mESC differentiation comparing neuronal response when 
cultured on 2D substrates vs 3D scaffolds made of type 1 collagen and 
Matrigel, gelatine and peptide-RAD16-II. Robust neural differentiation and 
neurite outgrowth was observed in 3D scaffolds, and the study leads to 
instructive guidance for engineering 3D neural tissue environment 
(Kothapalli and Kamm 2013). Another study used highly porous layered silk 
protein-based scaffold to mimic the cerebrum and coated it with polylysine 
to represent the grey matter. Then the structure was combined with collagen 
gel to fill up the central zone of the silk to mimic the white matter. After 
optimising several parameters, the research group was able to maintain 
viable and functional macroscopic neural tissue blocks for nine weeks with 
robust axonal development and network interconnectivity were detected in 
the silk-collagen region, and random disperse of neurons were seen in the 
pure collagen region. The results demonstrated the critical effects of matrix 
mechanical stiffness on neural network formation. Models based on cell 
biology depends on cell organisation and response whereas engineering-
based models are based on piecing together the necessary components to 
represent the microenvironment of tissue with high complexity and fidelity. 
By incorporating well-defined components necessary chemical and physical 
cues for a cell survival, 3D engineering-inspired models are capable of 
presenting the cells with a more consistent and control able 
microenvironment (Irons, Cullen, Shapiro, et al. 2008; Ren, M., Du, Acero, 
et al. 2016).    
1.4.4 Microfluidic technology models 
Microfluidic based 3D models are a multidisciplinary approach which is 
developed at an intersection of biotechnology, nanotechnology, 
biochemistry, physics, chemistry and engineering. The system has a 
designed for practical applications for low volume of fluids for automation, 
multiplexing and high-throughput screening. This technique is a very 
different form of the 3D culture system. The System manipulates the fluid 
flow to define the culture environment. Complex methods like co-culture 
of cells, control over cell patterning, perfusion flow, ECM/material 
organisation and soluble factor gradients generation can be achieved via 
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microfluidic platforms (Bhatia and Ingber 2014; van Duinen, Trietsch, 
Joore, et al. 2015). Microfluidics is made with high lithography resolution, 
good optical clarity and excellent repeatability (van Duinen, Trietsch, 
Joore, et al. 2015). The technique has been widely used in   recapitulating 
the predominant features of neurological diseases, mimicking the cortical 
structure, modelling brain environment like the BBB and directing neurite 
growth (Kunze, Giugliano, Valero, et al. 2011; Park, JiSoo, Lee, Jeong, et 
al. 2015; Bang, Na, Jang, et al. 2016). Mimicking gradients of ECM 
involves the components, mechanical stiffness, signalling factors that can 
have a great impact on the process of the tissue.  A study demonstrated 
an effective gradient form an effective path for cell survival and cell 
density. The study combined a 3D model with a spatially gradated 
hydrogel and u-87 cell to create a model to study the heterogeneous 
nature of glioma microenvironment. The system was designed with two 
parts, a micro-fluidic diffusive mixer and a connected mould (Pedron, 
Becka and Harley 2015). Similarly, another study demonstrated 
mimicking neuronal network formation. The group created a 3D 
microfluidic model filled with Matrigel to represent a primary rat cortical 
neuronal circuit. The study showed higher rate of neurite elongations 
resulting in approximately 1500µm long axonal bundles (Bang, Na, Jang, 
et al. 2016).  
Many similar studies have been reported using the microfluidic 
technology 3D models, which offers high fidelity and possibility of control 
over culture conditions. Despite the advantages, several limitations 
remain. The fluid flow needs to be well balanced and controlled; if not, 
the system suffers bubble formation compromising cell viability. The 
intricate design of the fluid flow is facilely manipulated in vitro, and it 
may be difficult to introduce to in vivo or clinical applications (Bhatia and 
Ingber 2014; Zhuang, Sun, An, et al. 2018). 
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1.5 Novelty of This Study 
The human brain is a highly complicated 3D structure made of the 
neuronal and glial cell population that is yet to be fully discovered and 
understood (Herculano-Houzel 2009). Understanding the dynamics of the 
electrical activity that constitutes the primary signalling method of the 
brain, how nerve cells make connections creating circuits for multiple 
purposes, how recall of memories work and how signals are translated to 
movements and behaviours. The tiniest error in the system can affect the 
entire network both chemically and morphological leading to several 
brain-related issues. Several neurological disorders have been identified 
that are caused by such changes in the brain, but the reason for the 
changes remains unknown or are not fully understood for several 
neurodegenerative disorders. It is clear that these diseases is caused by 
the loss of neural cell function in the brain, but the reason for the death 
of the cells is still under debate, and the cause not yet identified. The 
most important unresolved issue is the development of a neuroprotective 
therapy capable of slowing, reversing or stopping the process of 
neurodegeneration.  As described previously, current treatments are only 
useful in controlling the symptoms in the early stages, but these are 
accompanied by irreversible side effects. All the current research in 
neurodegenerative diseases are focusing efforts to either identify the 
actual cause or to replace the lost and damaged cells. Scientists have 
been trying to meet these through both in vitro and in vivo animal study. 
In vitro studies on protein misfolding, abnormal autophagy, Ubiquitin-
proteasome system (UPS) dysfunction, oxidative stress, mitochondrial 
dysfunction, altered protein phosphorylation and other targets have 
always been investigated using 2D cell cultures for a disease that exists 
in a 3-dimensional structure (Gai, Yuan, Li, et al. 2000; Ghosh, Mondal, 
Mohite, et al. 2013; Covell, Robinson, Akhtar, et al. 2017). Several types 
of research are being conducted to identify new drugs or to modify 
existing drugs.  Most drug-related studies are conducted on animals and 
demand a high usage of animals with high research costs and as yet have 
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had poor outcomes. Several animal models have been developed to 
investigate novel treatments to identify factors associated with the cause, 
stop or slow the disease. However, most models are unsuccessful in 
meeting their intended target (Duty and Jenner 2011; Blesa and 
Przedborski 2014). Significant types of animal model for 
neurodegenerative diseases are toxic models addressing the hallmarks 
and genetic models. Toxic models are endpoint studies leading to the 
death of animals, and genetic models involve causing overexpression or 
knockouts. Unfortunately, these diseases are multi-faceted, and just one 
model cannot be a complete model to fully understand or investigate the 
condition (Jackson-Lewis, Blesa and Przedborski 2012). Current research 
focuses on developing strategies to delay disease progression by 
replacement of damaged neurons using stem cells or restoration of 
original neuronal architecture or by promoting neurite regeneration. 
Currently, there are no drugs that are capable of stopping the slow loss 
of neurons in a patient, and there are no a suitable in vivo, in vitro or in 
silico models to study these diseases for drug discovery.  
1.5.1 Structure of this study 
This study has focused on investigating how various electrospun 
nanofibres composed of synthetic polymers such as polyacrylonitrile 
(PAN), PAN/Jeffamine (PJ), support cell adhesion and proliferation. To 
demonstrate how the model can be suitable for different types of 
neurodegenerative research,  different types of cells that are commonly 
used in neurodegenerative disorder investigations were examined.  The 
first was human SH-SY5Y neuroblastoma cell line, the second human U-
87MG glioblastoma cell lines, and the third human RenCellCX a neural 
progenitor stem cell line and finally embryonic neurons and astrocytes 
from rat brain. The nanofibre materials were evaluated for their ability to 
provide better cell growth, support survival and were further used to 
develop a suitable cell model for the investigation of several 
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neurodegenerative diseases and a model to identify endpoints that are 
suitable for screening neuroprotective compounds 
The main aims of the project were:  
1. Use the electrospinning technique to produce bio-active 
scaffolds which include mixtures of aligned and non-aligned 
fibres, where the fibre consists of chosen polymers. 
2. Identify a suitable method to sterilise the bio-active nanofibre 
scaffold while maintaining integrity and function. 
3. Optimise nanofibre compositions to support the growth and 
survival of neuronal and glial from 3 different cell types    
4. Investigate the effect of neural cell degeneration paradigms 
using the 3D system in comparison to conventional 2D culture 
processes. 
5. Evaluate cell to nanofibre interaction and development of a 3D 
microenvironment  
6. Develop a co-culture model and identify suitable endpoints of 
relevance to neuronal function, differentiation and survival that 
can be monitored within the 3D setup. 
7. Identify suitable in-vitro designs which deliver endpoints which 
track those measured or observed in vivo, and that can be 
measured with a high throughput system.  
8. Assess and integrate a range of known and novel 
neuroprotective agents with  3D nanofibre cell model to promote 
neuronal survival and enhance neurotrophic support and 
prevent neurodegeneration. 
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Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Cell Culture 
2.1.1.1 Cell Lines 
Human SH-SY5Y neuroblastoma, (CRL-2266) American type culture 
collection (ATCC), UK  
Human U-87 MG glioblastoma, (HTB-14) ATCC, UK  
Human ReNcell CX neural progenitor cells, (SCC007) Merck Millipore, UK  
Primary neurons and glial derived from E18 C57 Mouse hippocampal brain 
tissue, BrainBits, UK  
2.1.1.2 Cell Culture Reagents 
2.1.1.2.1 Cell Culture Media 
SH-SY5Y- Dulbecco's Modified Eagle Medium (DMEM) F-12 (1:1) mix with 
15mM Hepes, L- Glutamine – (BE12-719F) Lonza, Berkshire, UK 
U-87 MG- Eagle's Minimum Essential Medium (EMEM) w/o L-glutamine 
(BE12-127F) – Lonza, UK 
ReNcell CX- Knockout DMEM /F-12 (12660012) GIBCO/Life Technologies 
(UK), Recombinant Human Fibroblast Growth Factor Basic (FGFb), 
(PHG0024) GIBCO/Life Technologies (UK), Recombinant Human 
Epidermal Growth Factor (EGF), (PHG0311) GIBCO/Life Technologies 
(UK), Stempro neural supplement, (A1050801) GIBCO Life Technologies 
(UK), 
Primary neurons:  Hibernate® EB (HEB; Hibernate E®/B27®/ 
GlutaMAX™), NbActiv1™ medium (Neurobasal®/B27®/GlutaMAX™). 
4500 BrainBits, UK, papain (BrainBits® PAP 6 mg), Hibernate E-Ca (HE-
Ca) 
Primary astrocytes: NbASTRO BrainBits, UK 
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2.1.1.2.2 Common Cell Culture Reagents   
Accutase, (A6964) Sigma-Aldrich, UK  
Foetal Bovine Serum, (11573397) Invitrogen Gibco  
Hybridmax filter sterilised Dimethylsulfoxide (DMSO) (D2650) – Sigma 
Aldrich, UK 
Laminin from mouse EngelbrethHolm-Swarm (EHS), (11243217001) 
Sigma-Aldrich, UK  
MEM non-essential amino acid solution (M7145) – Sigma Aldrich, UK 
Penicillin-Streptomycin (DE17-603E) - Lonza, UK 
Phosphate Buffered Saline without Ca2+ and Mg2+ (BE17-516F) - Lonza, 
UK 
Sodium Pyruvate Solution 100 mM (BE13-115E) - Lonza, UK 
Trypan blue solution [0.4% (v/v) solution] (T8154) – Sigma Aldrich, UK 
Trypsin-EDTA (BE02-007E) - Lonza, UK 
2.1.2 Plastic, Glassware and other materials 
9” silanized Pasteur pipette to an opening of ~0.5 mm (BrainBits, UK). 
10 ml syringe tube luer-lok tip, Becton and Dickinson, UK 
15 ml and 50 ml red capped tubes – Sarstedt, UK 
21 gauge tube grade 304 cuts to length 100mm with back point one end, 
Stainless Tube and Needle Company, UK 
3M 425 Conductive Aluminium Tape (R06933), RS Components  
6 well, 12well, 24well and 96 well sterile tissue culture plates – Sarstedt, 
Leicester, UK 
Cell culture flasks (T25, T75 and T175) – Sarstedt, UK 
CHAPTER II                                                     MATERIALS & METHODS 
45 
 
Corona discharged Polyester Sheets 600mm X 300mm clear polyester 
75microns thick, Nano Products, UK  
Cryovials - Sarstedt, UK 
Leit Adhesive Carbon Tabs 12mm (AGG3347N), Agar Scientific, UK 
Leit Adhesive Carbon Tabs 25mm (AGG3348N), Agar Scientific, UK 
Pipette filter tips (10 μl, 200 μl and 1000 μl) – Dutscher Scientific, France 
Polypropylene sterilin tubes – Sarstedt, UK 
PTFE tubing 1/31 inch bore size, Altec, UK 
SEM Specimen Stubs, 12.5mm dia (AGG301), Agar Scientific, UK 
SEM Specimen Stubs, 25mm dia (AGG399), Agar Scientific, UK 
SLS Coverslips No 0 15mm Dia (MIC3278) Scientific laboratory supply, 
UK 
Sterile serological pipettes (5ml, 10ml and 25ml) - Sarstedt, UK 
2.1.3 Chemicals and reagents 
3-(4,5-dimethylthiaol-2-yl)-2,5-diphenyltetrazoulium bromide (MTT) 
(M2128) – Sigma Aldrich, UK 
Accugel 29:1 (40% solution) acrylamide (A20068) – GeneFlow Ltd UK 
Adenosine 5’-triphosphate, ATP (A3377) - Sigma Aldrich, UK 
B27 Supplement 50X, (17504001) ThermoFisher, UK 
Bicinchoninic Acid (BCA) kit (BCA1-1KT 
Bovine serum albumin (A2153) – Sigma Aldrich, UK 
Cell Counting Slides for TC10™/TC20™ Cell Counter, Dual-Chamber 
(1450015) BioRad, UK 
Cell Titer Glo 3D cell viability assay kit (G9681), Promega, UK 
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CoolBlue MAX protein gel stain (R2034A) – Interchim Ltd, UK 
Copper phthalocyanine 3, 4’, 4”, 4” tetrasulphonic acid tetrasodium salt 
(245356) – Sigma Aldrich, UK 
Copper (II) Sulphate (451657), Sigma-Aldrich, UK 
Dibutyryl-cAMP (D0627) Sigma-Aldrich, UK 
Dimethylformamide (D1331) Fisher Scientific, UK 
Folin & Ciocalteu’s phenol reagent (F9252) Sigmar-Aldrich, UK 
Hexafluoro-2-propanol (105228) Sigma Aldrich, UK 
Instant BlueTM protein stain (ISB1L) – Expedeon Ltd, UK 
Jeffamine® ED-2003 Polyetheramine Mw2000, Huntsman, USA 
L-Buthionine-sulfoximine, (B2515) Sigma-Aldrich, UK 
Marvel milk powder, Marvel, UK 
MG132 (M8699) Sigma-Aldrich, UK 
Nitrocellulose 0.22 μm pore size (WP2HY00010) – Labtech Ltd, UK 
Phalloidin conjugates with TRITC (P2141) - Sigma Aldrich, UK 
Polyacrylonitrile Mw150,000 (181315) Sigma-Aldrich, UK 
Polycaprolactone Mn80,000 (440744) Sigma-Aldric, UK 
Poly-L-lysine solution, (P4707) Sigma-Aldrich, UK  
Precision Plus protein all blue standards (161-0376) - Bio-Rad 
Laboratories Ltd, UK 
Protease inhibitor cocktail (P8340) – Sigma Aldrich, UK 
Retinoic acid (R2625) Sigma-Aldrich, UK 
RIPA Buffer (R0278) Sigma-Aldrich, UK  
Rotenone (R8875) Sigma-Aldrich, UK 
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SDS PAGE Tank Buffer (10 X) Tris-Glycine SDS (9-0032) - Geneflow Ltd, 
UK 
Sodium bicarbonate (S5761), Sigma-Aldrich, UK 
Sodium butyrate (B5887) Sigma-Aldrich, UK 
Sodium dodecyl sulfate (L3771), Sigma-Aldrich, UK 
Sodium hydroxide (S8045), Sigma-Aldric, UK 
Tetramethylethylenediamine (TEMED) (T9281), Sigma-Aldrich UK 
Tris Base (Tris-Ro), Sigma-Aldrich, UK   
Tris-Glycine Electroblotting Buffer (10X) (B9-0056) – Geneflow Ltd, UK 
TritonX (X100), Sigma-Aldrich, UK 
Tween 20 (P1379), Sigma-Aldrich, UK 
VECTASHIELD® mounting medium with DAPI (H-1500) – VECTOR 
Laboratories, UK 
VECTASHIELD® mounting medium with propidium iodide (H-1300) – 
VECTOR Laboratories, UK 
2.1.4 Equipment 
Aida image analyser software (version 4.03) - Raytek Scientific Ltd, 
Germany 
Automated Cell Counter (TC20™), BioRad, UK. 
BioRad model 680 microplate reader - Bio-Rad Laboratories Ltd, UK 
CBS isothermal liquid nitrogen storage system 2300 series – Sanyo 
medical division, UK 
CO2 laser cutter, (SP500), Trotec, UK 
Eppendorf research pipettes (P10, P100 and P1000) 
ES sputter coater (Q150R), Quorum Technologies, UK  
CHAPTER II                                                     MATERIALS & METHODS 
48 
 
Euromex camera (CMEX 5), Euromex microscopes, Holland 
Farnell L3OB stabilised power supply, Farnell, UK 
FLUOStar OPTIMA - BMG Labtech, UK 
FujiFilm FLA-5100 gel scanner - Fujifilm Life Sciences Products, Sheffield, 
UK 
Fujifilm intelligent dark box - Fujifilm Life Sciences Products, Sheffield, 
UK 
Glassman high voltage power supply, Glassman Europe Ltd, UK 
iblot – Invitrogen Lifesciences Ltd, UK 
iMark microplate reader spectrophotometer, BioRad, UK  
Leica CLSM laser confocal scanning microscope - Leica, Germany 
MIKRO 22R microcentrifuge – Hettich Ltd, Germany 
Mini wet blotting apparatus – Geneflow, UK 
MiniClima humidity control EBC 11, MiniClima, Austria 
Mini-Protean III - Bio-Rad Laboratories Ltd, UK 
Mini-Protean tetra - Bio-Rad Laboratories Ltd, UK 
Nanodrop 8000 – Labtech International Ltd, UK 
NE-1002X Syringe pump, New Era Syringe Pump Systems Inc, USA 
Nikon digital net camera DN100 – Nikon Ltd, Japan 
Nikon Eclipse TS 100 inverted microscope – Nikon Ltd, Japan 
Nikon Eclipse TS 100 inverted microscope - Nikon, Japan 
Ohaus Scout Pro balance - Fisher Scientific Ltd, UK 
Olympus BX51 fluorescence microscope – Olympus, Japan 
Olympus CK ULWCD light microscope – Olympus Ltd, Japan 
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Olympus microscope (CKX31), Olympus, UK 
Phenom ProX TM G2 PRO desktop Scanning Electron Microscope by 
Lambda photometrics, UK 
Philips pH meter model PW9409 – Pye-Unicam, UK 
Power Pac 3000 power supply - Bio-Rad Laboratories Ltd, UK 
Protean IEF cell – Bio-Rad Laboratories Ltd, UK 
REVCO Ultima II -80 °C Freezer – Biocold Laboratories, UK 
Rotor-gene 3000 Thermal cycler – Corbett Research Ltd, Germany 
Sanyo CO2 incubator MCO-17AIC - Sanyo Gallenkamp PCL, Leicestershire, 
UK 
Sanyo Harrier 18/80 refrigerated centrifuge - Sanyo Gallenkamp PCL, 
Leicestershire, UK 
Scanning Electron Microscope (JSM – 7100F), JEOL, UK  
SM1 magnetic stirrer – Stuart Scientific Ltd, UK 
Soniprep 150 - MSE Scientific instruments, UK 
Stuart Heating block model SBH10D – Geneflow Ltd, UK 
Stuart orbital shaker model SSL1 – Geneflow Ltd, UK 
Stuart vortex mix model SA7 - Geneflow Ltd, UK 
Telesto II OCT, Thor Labs, UK 
Ultrasonic welder, China 
Ultra flex III TOF/TOF mass spectrophotometer – Brucker Daltonics Ltd, 
UK 
Walker class II safety cabinet – Walker safety cabinets Ltd, UK 
Water bath 20 -90 °C – Grant Ltd, UK 
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2.1.5 Antibody 
2.1.5.1 Primary Antibody 
Table 2. 1: List of Primary antibodies 
Antibody Name 
Molecular 
Weight 
KDa 
Host 
Species 
Application Supplier 
Monoclonal anti 
α- Tubulin 
50 Mouse 
IF – 1:200 
WB 1:10,000 
Sigma 
Aldrich 
(T 6074) 
Polyclonal anti-
Actin 
42 Rabbit 
IF – 1:200 
WB 1: 5000 
Sigma 
Aldrich 
(A 2066) 
Polyclonal anti 
GFAP 
50 Rabbit 
IF- 1:1000 
WB-1:5000 
GeneTex 
(GTX108711) 
Monoclonal anti 
neurofilament- H 
(Phosphorylation 
independent) 
200 Mouse 
IF- 1:400 
WB- 1:1000 
Sigma-
Aldrich 
(N0142) 
Phosphorylated 
anti-
Neurofilament H 
(NF-H), SMI34- 
200 Mouse 
IF- 1:500 
WB-1:500 
BioLegend 
(835504) 
Monoclonal anti-
Synaptophysin 
37 Rabbit 
IF- 1.1000 
WB- 1:5000 
Abcam 
(ab32594) 
Monoclonal anti-
βIII tubulin 
50 Mouse 
IF- 1:500 
WB- 1:1000 
Abcam 
(ab52623) 
CHAPTER II                                                     MATERIALS & METHODS 
51 
 
Monoclonal anti- 
β actin 
42 Mouse 
IF- 1:500 
WB- 1:1000 
Abcam 
(ab8226) 
Monoclonal anti 
vinculin 
110 Rabbit 
IF- 1:500 
WB- 1:5000 
Abcam 
(129002) 
 
2.1.5.2 Secondary Antibodies  
Polyclonal horse anti-mouse IgG HRP conjugated antibody (#7076) – Cell 
Signaling Technology, UK 
Polyclonal goat anti-rabbit IgG HRP conjugated antibody (#7074) – Cell 
Signaling Technology, UK 
Polyclonal bovine anti-goat IgG HRP conjugated antibody (805-035-180) 
– DakoCytomation Ltd, UK 
Alexa Fluor 488 donkey anti-mouse IgG (A21202) - Invitrogen Ltd, UK 
Alexa Fluor 488 donkey anti-goat IgG (A11057) – Invitrogen Ltd, UK 
Alexa Fluor 488 donkey anti-rabbit IgG (A-21206) – Invitrogen Ltd, UK 
Alexa Fluor 568 goat anti-mouse IgG (A11004) - Invitrogen Ltd, UK 
Alexa Fluor 568 donkey anti-rabbit IgG (A10042) – Invitrogen Ltd, UK 
Alexa Fluor 647 donkey anti-rabbit IgG (A31573)- Invitrogen Ltd, UK 
Alexa Fluor 532 goat anti-mouse IgG (A11002)- Invitrogen Ltd, UK 
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2.2 Methods 
2.2.1 Design engineering and laser cutting  
The first step of this study was engineering a suitable design that can be 
used to form different orientations of nanofibres. Models to produce 
suspended nanofibre scaffolds were designed using AutoCAD 3D software 
which was then converted a file supported by Corel Draw for the laser 
cutter. The constructed design was loaded into a Trotec CO2 laser cutter 
which was later implemented and cut to accurate measurements on a 
polyester sheet. Three different models were carefully designed suitable 
for various type of studies, each with its unique orientations.  Each design 
was made for producing a random nanofibre, aligned nanofibre and radial 
nanofibre. Details on each design explained below, but this study was 
majorly performed on random nanofibre models.  
2.2.1.1 Suspended random nanofibre scaffolds 
The design and process fabricates fully suspended random nanofibre 
scaffolds.  The design was built on a 600mm X 300mm layout with an 
array on 10mm circles spaced at 20mm centre to centre as shown and 
explained in Figure 2. 1. The design was made on a 75 µm thick polyester 
sheet using a Trotec Co2 laser at 100% speed 28% power and 1000 pulse 
per inch (PPI). The model consists of two sheets a bottom sheet on which 
the fibres are collected and an identical top layer which is used to secure 
the fibre. After the fibres are spun, the sheets were ultrasonically tack 
welded and secured in place before cutting into the desired size to fit 
appropriate well plates. The fibres were laser cut at 80% speed and 50% 
power to create 20mm circular discs to fit in 12 well plates, as shown in 
Figure 2. 2.      
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Figure 2. 1: Schematic representation of random fibre design with 
measurements 
 
Figure 2. 2: Random fibre cross-sectional view.  
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2.2.1.2 Aligned nanofibre  
This method of fabricating fully suspended aligned nanofibre design was 
developed in-house and has been filed for a patent (UK patent application 
number GB2553316A). The design is capable of containing both random 
and aligned fibre in a single scaffold.  The design was engineered on 
AutoCAD and was made on a 75 µm thick polyester sheet using a Trotec 
CO2 laser at 100% speed 28% power and 1000 PPI. The design comprises 
of three layers of 600mm X 300mm polyester sheet. Two identical top 
layers to secure the fibre and a modified bottom layer to create aligned 
orientation of fibres. The top sheet Figure 2. 3A consists of an array of 
two parallel rectangles with an ellipse in the middle and the bottom sheet 
Figure 2. 3B with just the rectangles matching the dimensions as the top 
sheet. The design was built based on the aspects as described in Figure 
2. 3. The top and the bottom layers were ultrasonically welded together 
before electrospinning. The combined sheet was placed on a rotating 
collector with the top sheet facing upwards. After the electrospinning, the 
bottom sheet was detached, and the top layer was secured with an 
identical sheet to secure the fibres. The sheets were ultrasonically tack 
welded and secured in place before cutting into the desired size to fit 
appropriate well plates. The final layer was laser cut at 80% speed and 
50% power to a 20mm circular discs to fit in a 12 well plate Figure 2. 4.    
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Figure 2. 3: Schematic diagram for aligned fibre template.   
A Top sheet and B bottom sheet design used for obtaining aligned fibre.  
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Figure 2. 4: Aligned fibre cross-sectional view.  
2.2.1.3 Radial nanofibre  
The radial nanofibre design was constructed based on the same principle 
as the aligned fibres. To obtain this type of orientation of fibre, it requires 
three layers; two top sheets and one bottom layer sheet. The design 
comprises two outer circles and one inner circle. Further details and the 
dimensions of the model are explained in Figure 2. 5 A and B.  With the 
design, and it was possible to build fibres that were random orientation 
within the outer circle and radially aligned to the concentric centre circle 
of random fibres, forming an eye-shaped structure. The top and the 
bottom sheets were ultrasonically welded together before electrospinning. 
The combined sheet was placed on a rotating collector with the top layer 
facing upwards. After the electrospinning, the bottom sheet was detached, 
and the top layer was secured with an identical sheet to secure the fibres. 
The sheets were ultrasonically tack welded and secured in place before 
cutting into the desired size to fit appropriate well plates. The final layer 
was laser cut at 80% speed, and 50% power to a produce 20mm circular 
discs to fit in 12 well plates Figure 2. 6.    
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Figure 2. 5: Schematic diagram Radial fibre design.  
A Top sheet and B bottom sheet design used for obtaining radial fibre.  
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Figure 2. 6: Radial fibre cross-sectional view  
2.2.2 Electrospinning solution preparation  
Polyacrylonitrile (Mw 150,000) and Jeffamine® ED-2003 were dissolved 
in N, N-dimethylformamide (DMF). These two polymers were used to spin 
nanofibres in this study. Considering the density of DMF is 944kg/m3, to 
make 10wt% of PAN in DMF, 2g of PAN was dissolved in 19ml of DMF. 
Jeffamine was used as a dopant with PAN to control the degree of 
hydrophilicity; to make 5wt% Jeffamine in 10wt %PAN in DMF, 0.117g of 
Jeffamine® along with 2.22g of PAN was dissolved in 20 ml of DMF. The 
polymers were prepared in a glass bottle and were heated at a 50°C 
overnight with constant stirring. After the polymers were completely 
dissolved in the solvent and before electrospinning, each batch of 
polymers was tested for viscosity using a Capillary Breakup Extensional 
Rheometer  
2.2.2.1 Rheometer measurement  
The extensional and breakup time of the polymeric solutions were 
measured using a HAAKE™ CaBER™ 1 Capillary Breakup Extensional 
Rheometer. A tiny amount of polymer (less than 0.2ml) was gently placed 
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between the two rods located at the centre of the machine creating a 
liquid bridge about 500± 50 µm in length connecting the two ends of the 
rod as shown in Figure 2. 7.  
 
Figure 2. 7: Schematic representation of HAAKE™ CaBER™ 1  
Capillary Breakup Extensional Rheometer polymer loading region. 
HAAKE™ CaBER™ 1 image obtained from (Thermo Fisher) 
The polymer is then exposed to a rapid extensional step by moving the 
upper rod upwards, therefore creating a polymer filament (Figure 2. 8).   
The balance of the surface tension, viscosity and elastic forces control the 
filament evolution as a function of time. The surface tension is trying to 
“pinch off” the filament while the extensional rheological properties of the 
fluid are trying to prevent this process. A laser micrometre measures the 
midpoint diameter and break time of the gradually thinning fluid filament 
after the upper plate has reached its final position.  
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Figure 2. 8: Schematic representation of polymer filament 
formation and measurement using the HAAKE™ CaBER™ 1 
Capillary Breakup Extensional Rheometer works. 
2.2.3 Electrospinning 
A schematic representation of the in-house built electrospinning set up 
used in this study is shown in Figure 2. 9. The entire system is secured 
in a well-insulated enclosure with minimum exposure on any metal apart 
from the grounded metal collecting drum. The chamber is also equipped 
with a recirculating humidity control system, as well as an activated 
carbon filter solvent extraction system. The main components are a 
syringe pump, capillary tube, blunt end needle, rotating collector drum 
and a high voltage supply. The required amount of polymer was filled in 
a 10ml Luer-Lok™ syringe and connected to a Luer-Lok™ needle. Then 
approximately 110cm length PTFE tubing with 1/31 inch bore size is 
connected to the Luer-Lok™ needle. The polymer is manually pushed 
through the tubing until it reaches ¾ of the tube’s length. 21 gauge size 
needle with one sharp and one blunt end is connected to the other side 
of the PTFE tube with the sharp end pushed  10mm inside the tube.  The 
filled syringe is then loaded into the syringe pump and set at 1ml/hour 
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pumping speed, and the blunt end needle is guided through an acrylic 
holder and connected to a high voltage supply which is placed 300mm 
away from the surface of the collector. When a sufficiently high voltage 
is supplied to the polymer droplet from the needle, the surface of the 
polymers becomes charged. When the electrostatic repulsion overcomes 
the surface tension, the droplet stretches, causing a jet of fluid to be 
formed at the apex of the extended conical drop, also known as the Taylor 
cone. 
The solvents desolvates and the polymer cools in flight then further 
elongates by an electrostatic repulsion process causing Rayleigh 
instability forming into the fibre. The fibres overcome the surface charge 
and are finally deposits on the collector rotating anti-clockwise with an 
assembled polyester sheet wrapped and fixed in place using aluminium 
tape. After the fibre have been laid the excess fibre surrounding the 
outside sheet is removed by cutting with a hot knife along the edges of 
the sheet. The drum is then set to rotate in clockwise direction, and the 
sheets are gradually pulled away from the drum and placed on the 
welding station. Depending on the type of design used the excess sheets 
are detached, and then the fibres are ultrasonically secured with an 
identical top sheet and laser cut to fit well plates. The laser-cut scaffolds 
were stored in a clean sealed container for further use. Multiple samples 
from each batch of spinning were investigated for fibre diameter, 
hydrophobicity and scaffold thickness using SEM, contact angle and an 
OCT analysis respectively.     
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Figure 2. 9: Schematic representation of our in-house built 
electrospinning system 
With self-contained environment, needle station, controlled humidity, 
controlled high voltage supply, recirculating solvent extraction and 
rotating collector. 
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2.2.3.1 SEM analysis 
Integrity and morphology of produced fibre samples were analysed using 
the Phenom ProX desktop SEM. Random samples from each batch of 
electrospun fibres were selected and were mounted on a 25mm SEM stub 
using double-sided carbon tape. Fibre samples were sputter-coated with 
10mm gold using an Edwards S150B splutter coater before SEM analysis. 
Different location of the scaffold was analysed for defects, deformations 
and damage at different magnification. Diameter and pore size 
distributions of samples were analysed using Phenom ProX FibreMetric® 
software. To analyse diameter and pore size multiple images at various 
positions and magnifications were taken then transferred into the 
FibreMetric® software. The software randomly chooses 100 different 
regions from images to measure fibre diameter and the pore sizes are 
examined throughout the entire image. Crossover regions overlapped 
fibre and fibres deep within the mat were manually deselected from the 
measured data. Raw data was extracted, and the mean values of the 
nanofibre diameters and pore size area were obtained and graphical data 
was produced using graph pad prism software.  
2.2.3.2 Contact angle analysis 
An angle formed with the interaction of liquid-solid and liquid-vapour 
interface is defined as the contact angle Figure 2. 10. It quantifies the 
hydrophobicity of a material’s surface when a liquid drop is rested, 
spreads or contracts on the surface. There are several methods to 
determine the contact angle. In this study, we have chosen to use a user-
defined baseline MATLAB code created by Dr Andrew Edwards from NTU, 
UK. The programme is capable of determining a contact angle with an 
accuracy of ± 1o for contact angles greater than 5o. Random samples 
were selected from each batch of fibres. Samples were placed on the 
examination station and using a pipette, distilled water (10µl) was 
dropped in the centre of the scaffold, and the dispersion of the water 
droplet was recorded for approximately 10 sec using a high-speed camera.  
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A water contact angle of fewer than 90 degrees is considered to indicate 
a hydrophilic surface and, if greater than 90 degrees, a hydrophobic 
surface (Förch, Schönherr, Schonherr, et al. 2009). There are three major 
parameters involved in a contact angle measurement: the solid surface, 
the liquid and air. When the droplet comes in contact with the surface a 
force () is exerted by the surface tension at three different interfaces: 
the liquid-surface (LS), liquid-vapour (LV) and solid vapour (SV) Figure 
2. 10. When the droplet is in equilibrium the forces are balanced forming 
an equation: SV=LS+LV cos that can be rearranged to cos=
SV-LS
LV
 to 
identify the contact angle.  
 
Figure 2. 10: Schematic representation of contact angle 
measurement to identify the hydrophobicity of a surface.  
2.2.3.3 Optical Coherence Tomography  
Optical Coherence Tomography (OCT) is a new imaging technique based 
on backscattered or back-reflected light. This technique can be used to 
obtain high-resolution images, a cross-sectional tomograph of samples 
and internal microstructure of the various material and biological systems. 
The OCT setup used in this study is an in-house designed system with a 
supercontinuum broadband laser (Telesto II from Thor Labs, UK) with a 
central wavelength of 1300nm and the bandwidth of the wavelength 
ranges from 1100nm-1500nm. The images are obtained at a resolution 
in the depth z-direction at 5.5µm and the XY direction at 20µm. Three 
randomly chosen samples in each batch were used to identify the 
thickness for the spun fibres. High-resolution images were obtained for 
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both dry and wet samples. Samples were measured suspended between 
two supports and wet by adding a drop (approx. 10µl) of ethanol causing 
the loose fibre strands to settle, creating a clear and better measurement.       
2.2.3.4 Nanofibre sterilisation analysis 
Before using the nanofibre scaffolds for cell biology experiments, it was 
essential to identify a suitable method of sterilisation that did not 
compromise the integrity and morphological properties of the fibre. The 
fibres were exposed to 70% (v/v) ethanol soaking, exposed to 256 nm 
UV light and antibiotic treatment (100 units/ml penicillin, 100μg/ml 
streptomycin).  Each test was exposed for 30 minutes, 8 hours and 24 
hours.  Subsequently, scaffolds were transferred to a 15ml tubes with 
5ml sterile distilled water under sterile conditions. The tube was 
vigorously vortexed to disperse any microbes present on the fibre into 
the sterile distilled water.  Under sterile conditions, 1 ml of water from 
that tube was transferred to an agar plate and was evenly spread across 
using a sterile L-shaped glass rod. The plate was then incubated at 370C 
for 14 days to investigate any bacterial or fungal growth.           
2.2.4 Cell Culture  
2.2.4.1 Clonal Cell lines  
2.2.4.1.1 Human SH-SY5Y neuroblastoma 
SH-SY5Y cells were cultured in sterile growth medium containing 
DMEM/F12 supplemented with 10% (v/v) heat inactivated foetal bovine 
serum (FBS), 2 mM glutamine, 100 units/ml penicillin, 100μg/ml 
streptomycin and 0.1mM non-essential amino acids (NEAA) in tissue 
culture flasks and maintained at 37˚C in a humidified chamber of 95% of 
(v/v) air /5 %( v/v) CO2. When the cells were 80% - 90% confluent, they 
were sub-cultured by trypsinisation. Briefly, cells were washed in PBS and 
then incubated with 1-2ml of 1x trypsin for 5 minutes at 37˚C. Trypsin 
activity was neutralised by serum-containing medium. Cell detachment 
was aided by tapping gently on the sides of the flask.  The detached cells 
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were transferred into a tube and pelleted by centrifugation at 300g for 5 
minutes. The resultant pellet was re-suspended in growth medium and 
counted using a haemocytometer. The required number of cells (250,000 
cells in a T25 flask and 1,000,000 cells in the T75 flask) was transferred 
to a sterile tissue culture flask containing pre-warmed growth medium. 
2.2.4.1.2 Human U-87 MG glioblastoma  
U-87 MG cells were cultured in sterile growth medium containing EMEM 
supplemented with 10% (v/v) heat inactivated foetal bovine serum (FBS), 
2 mM glutamine, 100 units/ml penicillin, 100μg/ml streptomycin, 0.1mM 
non-essential amino acids and 1mM sodium pyruvate in tissue culture 
flasks and maintained at 37˚C in a humidified chamber of 95% of (v/v) 
air /5 %( v/v) CO2. When the cells were at least 80% confluent, they 
were sub-cultured by trypsinisation. Briefly, cells were washed in PBS and 
then incubated with 1-2 ml of 1x trypsin for 5 minutes at 37˚C. Trypsin 
activity was neutralised by medium with 10% serum. Cell detachment 
was confirmed under a light microscope, and cells that have not detached 
were further detached by either tapping gently on the sides of the flask 
or by squirting media using a pipette over the region.  The detached cells 
were then transferred into a tube and pelleted by centrifugation at 300g 
for 5 minutes. The resultant pellet was re-suspended in growth medium 
and required number of cells (250,000 cells in a T25 flask and 1,000,000 
cells in the T75 flask) was transferred to a sterile tissue culture flask 
containing pre-warmed growth medium. 
2.2.4.1.3 Viable cell count and seeding  
To estimate viable cell numbers an equal volume of diluted cell 
suspension and 0.4% (v/v) trypan blue solution were mixed in a 
microfuge tube. Viable cells (colourless cells) were counted using a 
haemocytometer. The cell density was estimated using the following 
calculation:  
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Cells/ml = Average cell count (1 mm2) X 104 X dilution factor 
The required number of cells to achieve a specific cell density in a known 
volume of growth medium was then calculated. The required cell density 
was seeded into an appropriate culture vessel and incubated 37˚C in a 
humidified chamber of 95% of (v/v) air / 5 %(v/v) CO2. 
2.2.4.1.4 Cryo-preservation of cells  
Cells were frozen in liquid nitrogen for long-term preservation. Cells were 
seeded in either a T25 or T75 flask and harvested while in the log phase 
of growth. Briefly, cells were washed in PBS and then incubated with 250 
μg/ml trypsin (100 μl for T25 flask and 500 μl for a T75 flask) for 5 
minutes at 37˚C and then centrifuged at 300g for 5 minutes. The 
supernatant was discarded, and the cell pellet was resuspended in 1 ml 
of ice-cold freezing medium [(10 % (v/v) DMSO in FBS] and transferred 
into freezing vials. These freezing vials were moved to -80°C freezer for 
24 hours and then transferred into a liquid nitrogen storage facility for 
long-term storage. 
2.2.4.1.5 Revival of cryo-preserved cells  
The freezing vial containing the Cyro-preserved cells was removed from 
the liquid nitrogen storage. The contents were quickly thawed in a 37°C 
water bath and transferred into a sterile tube containing ample growth 
medium to dilute the DMSO. The tube was centrifuged at 300 g for 5 
minutes. The supernatant was discarded, and the pellet was resuspended 
in 1 ml of growth medium and transferred into a T25 flask containing 
appropriate growth medium. Cells were maintained according to the 
requirements for each cell types.  
2.2.4.1.5 Neural cell differentiation  
SH-SY5Y and U-87MG cells were induced to differentiate by culturing cells 
at 5 x 104 cells/well in growth media for 24 hours. Following attachment, 
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growth media was removed and replaced with serum-free media 
supplemented with differentiation agents. In the case of SH-SY5Y cells, 
media was supplemented with retinoic acid (1µM) and B27 supplement 
(1 %). Whereas U-87MG cells were supplemented with dibutyryl cyclic 
adenosine monophosphate (dbcAMP; 0.3 mM) and B27 supplement (1%) 
for up to 5 days. Cells were cultured at 37oC in 5% CO2. During 
differentiation, the medium was changed after every 48 hours for 5 days.  
2.2.4.2 Neural progenitor cells ReNcell CX  
2.2.4.2.1 Laminin coating  
All tissue culture flasks and plates used to culture ReNcell CX were coated 
with laminin for 24 h prior to cell seeding. For coating, 1mg/ml laminin 
from EngelbrethHolm-Swarm murine sarcoma basement membrane 
(Sigma–Aldrich) was thawed at room temperature, then diluted to 20 
μg/ml final concentration in Neurobasal® medium (Gibco) alone. 
Sufficient laminin solution was added to cover the surface of the required 
tissue culture vessel (e.g.  2 ml and 5 ml volumes were used to coat a 
T25 and T75 flasks, respectively). Coated flasks were incubated at 37°C 
in a 5 % (v/v) CO2 incubator for at least 4 hours before use; otherwise, 
flasks were pre-prepared and stored at 4°C for 24 h. before cell seeding, 
the laminin coating solution was aspirated and rinsed with sterile PBS. 
2.2.4.2.2 ReNcell CX maintenance medium 
ReNcell CX cells were maintained in KnockOut™ DMEM: nutrient mixture 
F-12 (DMEM/F-12) low osmolality medium without HEPES buffer. The 
medium (500 ml) is supplemented with recombinant human epidermal 
growth factor (EGF) (10 μg/ml; Gibco), basic fibroblast growth factor 
(FGFb) (10 μg/ml; Gibco), StemPro® neural supplement (10 ml; Gibco), 
L-glutamine (0.5 mM), penicillin (100 units/ml) and streptomycin (100 
units/ml).  
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2.2.4.2.3 Revival of cryo-preserved cells  
A vial of cryopreserved ReNcell CX cells was removed from the liquid 
nitrogen storage and thawed quickly by incubation in a 37oC water bath 
for 1-2 min. The outside of the vial was wiped with 70% v/v ethanol to 
sterilise, and the cells were transferred into a Sterilin tube using a 2 ml 
sterile pipette. After the cells have been transferred into the tube, 9 ml 
of maintenance medium was added dropwise (pre-warmed to 37oC) to 
avoid osmotic shock and the consequent reduction in cell viability and 
was mixed gently. Then centrifuged at 300g for 5 min. Following 
centrifugation, the supernatant was decanted to remove any residual 
cryopreservation medium, and the resultant pellet was resuspended in 1 
ml of pre-warmed maintenance medium using a sterile pipette. The cell 
suspension was seeded into a laminin-coated T25 or T75 flask containing 
4 ml or 10 ml, respectively, of fresh pre-warmed maintenance medium. 
The cells were incubated for 24 h at 37 ˚C in a humidified atmosphere of 
95% air/5% CO2; then the medium was changed for fresh pre-warmed 
maintenance medium.  The monolayer was incubated until it reaches 
80% confluent and the medium was changed every 48hours. Upon 
confluence, cells were passaged for experiments or cryopreserved for 
later use. 
2.2.4.2.4 Sub-culturing of ReNcell CX cells 
ReNcell CX cells were passaged by careful removal of the maintenance 
medium from the coated flask and rinsing the monolayer with pre-
warmed PBS for 1 min. Cells were detached by the addition of 1-2 ml of 
pre-warmed accutase (Gibco) according to the size of the flask (e.g. 1 ml 
for T25 and 2 ml for a T75 flask). The monolayer was incubated with 
accutase for 2 min in a 37°C incubator, and cell detachment was 
monitored using an inverted light microscope. Accutase’s action was 
quenched with fresh growth medium in the proportion 2:1, and the cell 
suspension was transferred to a sterilin tube and centrifuged for 5 min at 
300g. The resultant pellet was resuspended in 1 ml of maintenance 
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medium by pipetting gently back and forth to break up the pellet. Using 
a Pasteur pipette, one-fifth of cell suspension was placed in a laminin-
coated T25 flask containing 4 ml of maintenance medium (or 10 ml in a 
T75 flask). The flasks were then incubated at 37°C in a humidified 
atmosphere of 95% air/5% CO2 and monitored until the cells reached 70-
80% confluence 
2.2.4.2.5 Viable cell count and seeding 
Upon reaching 80% confluency, cells were detached and harvested by 
centrifugation at 300g for 5 min as described in section 2.2.4.2.4. The 
cell pellets were resuspended in 1 ml of maintenance medium and 
counted using an automated cell counter. Briefly, 10µl of cell suspension 
and 10µl of trypan blue (0.4% v/v) solution was mixed at room 
temperature. A 10µl aliquot of the mixture was loaded into a chamber of 
TC20 counting slide which was then carefully inserted into the cell counter. 
The total viable cells count were calculated and displayed based on 1:1 
cell dilution. The cell density per ml value was obtained to determine the 
volume of suspension necessary to seed.       
2.2.4.2.6 ReNcell cell differentiation  
Prior to the induction of ReNcell CX cell differentiation, cells were seeded 
and maintained at 37oC in a humidified atmosphere of 95% air/5% CO2 
for 24 h to allow cell recovery. Maintenance medium was then carefully 
removed by aspiration and replaced with neural cell differentiation 
medium containing StemPro® neural supplement (10 ml; Gibco), L-
glutamine (0.5 mM), penicillin (100 units/ml) and streptomycin (100 
units/ml) with no mitogens.  
2.2.4.3 Primary Cells  
Embryonic rat brain tissue samples were obtained from BrainBits, UK. 
Neural cell populations were obtained from embryonic day 18 rat 
hippocampal tissues. The tissue samples were shipped as vials containing 
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Hibernate EB (HEB; 2ml) medium; a combination of Hibernate 
E/B27/GlutaMAX medium. The company did not disclose concentrations 
of each component in the media. For an optimal neural cell yield, the 
tissue was used immediately upon delivery although it could be stored 
for 1 week at 4-8oC.   
2.2.4.3.1 Preparation for tissue processing  
The tissue culture wares were prepared by coating with poly-L-lysine (PLL) 
(50µg/ml) and incubated at 37oC for 1-4 hours for immediate use or 
stored at 4oC for later use. Before using, the PLL was aspirated, and the 
surface was rinsed with ddH2O and dried under a laminar hood. The cell 
dissociation solution was prepared by dissolving 6 mg (2mg/ml) sterile 
papain in 3 ml of Hibernate E-Ca (HE-Ca) without B27 medium and 
incubated for 10min at 30oC.  
2.2.4.3.2 Cell dissociation and seeding  
The same method of cell dissociation was used to obtain both neurones 
and astrocytes. Using the silanised Pasteur pipette, the HEB solution was 
carefully removed and saved in a sterile tube for later use. A 2ml aliquot 
of cell dissociation solution was added to the tissue vial and incubated for 
10 min at 30oC with gentle agitation for 5 min. The cell dissociation 
solution was carefully removed without disturbing the tissue sample and 
replaced with HEB solution. Using the silanised Pasteur pipette, the tissue 
was triturated for 1 minute and left undisturbed for a 1 min to allow cell 
aggregates to settle. The supernatant containing the dispersed cells were 
transferred to a 15ml sterile tube and centrifuged at 200g for 1 minute.  
The supernatant was decanted, and the pellet was resuspended in 
NbActive media for neurons and NbAstro media for astrocytes. A 20µl 
aliquot of cell suspension was mixed with 80µl of trypan blue (1:5 
dilution), and cell number was determined using an automated cell 
counter. The desired number of cells were calculated and seeded in PLL 
coated plates or flask and incubated at 37oC in a humidified atmosphere 
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of 95% air and 5% CO2. For the first 4 days of culture, the cells were 
maintained in the appropriate media with 1% (v/v) gentamycin and 1% 
(v/v) glutamate. Following 4 days of growth, the medium was replaced 
with NbActive medium alone for neurones and NbAstro medium alone for 
astrocytes. Every 4-5 days, half of the old medium was replaced with 
appropriate fresh growth media.    
2.2.5 Cell Culture on nanofibre scaffolds 
Fibres made from PAN, PAN with Jeffamine® (PJ) were the two types used 
to make scaffolds used for the study. All the experiments were performed 
using scaffolds in a 12 well tissue culture plate with 5 X104 cells/well, i.e. 
3 x105 in each 12 well plate unless mentioned otherwise.  Also, as a 
comparison to 2D cultures, the same number of cells were seeded in 
separate 12 well plates with round coverslips in each well. The same 
method of culturing was followed through the study for all the type of 
fibre orientations and cell types.  
2.2.5.1 Nanofibre Sterilisation before cell seeding 
Each nanofibre scaffolds were sterilised before using it for cell culture. 
For the entire study scaffolds were sterilised using 70% ethanol. The 
scaffolds were exposed to 256nm UV light during spinning and laser cut 
to fit 12 well size tissue culture plates. The scaffolds were stored in a 
clean, sterile container. Under a laminar flow hood, the scaffolds required 
for an experiment were picked using sterile tweezers and transferred into 
a sterile pot with lid containing 70% ethanol (10-20ml). The substrates 
were soaked in ethanol for 30 minutes with a gentle swirl every 10 
minutes. To neutralise the ethanol, the substrates were then washed in 
PBS gently three times for five-minute periods on a shaker. After that, 
the PBS was decanted and replaced with the culture medium for 
equilibration and stored for immediate use.          
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2.2.5.2 Clonal cells 
Both SH-SY5Y and U-87 MG cells were maintained either in a T25 or a 
T75 flask throughout the study. The maximum passage number used for 
experiments was no more than P30. Before seeding the cells on fibres, 
the cells from the flask were harvested by trypsinisation and centrifuged 
at 300g to obtain a pellet as described in section 2.2.4.1. Meanwhile, 
nanofibre scaffolds were sterilised in 70% ethanol as described in section 
2.2.5.1. Each scaffold was picked using a sterile tweezer and placed into 
a 12 well plate. After obtaining a pellet, the required number of cells were 
counted and calculated as described in section 2.2.4.1.3. Total volume 
from the cell suspension was determined and was transferred to 12 ml of 
culture media and was gently mixed. From the mixture, 1 ml (5x104 
cells/well) was transferred to plates with scaffolds and coverslips. The 
plate was then incubated at 37°C in a humidified atmosphere of 95% air 
and 5% CO2.      
2.2.5.3 ReNcell CX 
ReNcell CX was cultured and maintained in a T25 flask throughout the 
study. The maximum passage used for the experiment was maintained 
below P10. The cells were subcultured as described in section 2.2.4.2.5. 
Fibres were sterilised with 70% ethanol as described in 2.2.5.1. After 
obtaining a pellet, the required number of cells were counted and 
calculated as described in section 2.2.4.2.4. Total volume from the cell 
suspension was determined and was transferred to 12 ml of culture media 
and was gently mixed. From the mixture, 1 ml (5x104 cells/well) was 
transferred to plates with scaffolds and coverslips. The plate was then 
incubated at 37°C in a humidified atmosphere of 95% air and 5% CO2.         
2.2.5.4 Primary Cells 
Rat primary E18 neural cells were directly seeded on fibres and coverslips. 
As these cells cannot be passaged, the cells were not maintained in flasks 
for further use. The cells were dissociated from rat brain tissue samples 
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as described in section 2.2.4.3.2. After obtaining a pellet, the required 
number of cells was calculated as described in section 2.2.4.3.2. Total 
volume from the cell suspension was determined and was transferred into 
12 ml of culture media and was gently mixed. From the mixture, 1 ml 
(5x104 cells/ml) was transferred to plates with scaffolds and coverslips. 
The plate was then incubated at 37°C in a humidified atmosphere of 95% 
air and 5% CO2 
2.2.6 Cell Viability assay 
2.2.6.1 Trypan blue exclusion assay 
The trypan blue exclusion assay is an indicator of cell membrane integrity 
and is excluded by viable cells. Trypan blue was used to measure the 
viability of cells treated in the presence or absence of several different 
agents for a defined time period or during cell passaging to determine 
the total number of viable cells. The cell suspension was mixed with 1:1 
with trypan blue (0.4% (v/v)) and counted in a haemocytometer chamber. 
In each case, total and dead cells (stained blue) were counted. The mean 
viable cell number was expressed as a percentage of the total cell count. 
2.2.6.3 CellTiter-Glo® 3D 
The Cell Titer-Glo 3D is an ATP dependent homogenous method to 
determine the number of viable cells in a 3D cell culture.  This is a ready 
-to use reagent from Promega which monitors and detects the metabolic 
activity of a viable cell through its ATP production. When added to the 
cells the homogeneous mixture results in cell lysis and generation of a 
luminescent signal proportional to the amount of ATP expressed which is 
directly proportional to the number of viable cells in the culture. Cell Titer-
Glo 3D is capable of robust penetration into microtissues and 3D cultures 
with greater sensitivity. CellTiter-Glo® 3D is used at several stages of this 
study to investigate treatment-based analysis.  Cell Titer-Glo 3d is added 
in equal volume as the media in each well. After the required treatments, 
500µl of media is removed from each well and replaced with 500µl of Cell 
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Titer-Glo 3D. To induce cell lysis, the cultured cells were vigorously mixed 
for 5-10 min on a plate shaker. The plate was then incubated at room 
temperature for 30 minutes, and the luminescence was recorded.        
2.2.7 Cell Proliferation assay 
To understand the level of attachment and proliferation of the cell types, 
cells were harvested and seeded at 5 × 104/well on both PAN and PJ 
nanofibre scaffolds.  After 48hours, cell laden fibres were methanol fixed 
and stained with Coomassie Brilliant Blue dye to visualise cell attachment. 
To monitor the level of proliferation and prolonged survival, each cell 
types were cultured on each fibre type for 11 days alongside 2D tissue 
culture plastic surface (control) with media changes every 48 hours. All 
samples were tested for cell viability using the MTT assay after each 48-
hour period. 
2.2.7.1 MTT cell metabolic Assay 
Cell metabolism were  assessed by MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazoulium bromide) reduction assay (Mosmann 1983; 
Berridge, Herst and Tan 2005). MTT can be accumulated by viable cells 
and reduced by mitochondrial dehydrogenase enzyme to form formazan 
crystals. The accumulated formazan is then solubilised in DMSO and 
detected using a spectrophotometer at 570nm. Tetrazolium dye reduction 
is generally assumed to be dependent on NAD(P)H-dependent 
oxidoreductase enzymes largely in the cytosolic compartment of the cell 
(Berridge, Herst and Tan 2005). Therefore, reduction of MTT and other 
tetrazolium dyes depends on the cellular metabolic activity due to 
NAD(P)H flux.  Cells with a low metabolism reduce very little MTT and in 
contrast, rapidly dividing cells exhibit high rates of MTT reduction. The 
assay conditions can alter metabolic activity and thus tetrazolium dye 
reduction without affecting cell viability.  
Throughout this study, MTT assay was used to investigate the increase in 
the metabolic activity of the cells in the proliferation of cells on fibre study 
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and investigation of toxins on cells. When the assay was performed for 
the cell on fibre, the scaffolds were transferred to a fresh plate before 
adding MTT. 100 µl of 5 mg/ml MTT was added to each well to make a 
final concentration of 0.5mg/ml. The plate was incubated for 1 hour at 
37 ˚C in humidified atmosphere of 95 % of (v/v) air / 5 % (v/v) CO2. 
The medium was removed from the wells, and 100 µl of DMSO was added 
into each well to solubilise the formazan product. The absorbance was 
measured at 570nm using a microplate reader. The results were 
expressed as percentage change in MTT reduction compared to control 
2.2.8 Effect of glial ECM on neurons 
The U-87MG cells were cultured, and upon reaching 80% confluency, the 
cells were washed several times with PBS to remove any trace of the 
media. Then 3-5ml of sterile distilled water was added to each well and 
incubated in room temperature for 5-10 minutes. The cells absorb the 
water and undergo osmotic shock causing the cell walls to rupture and 
explode, leaving the ECM intact.  The lysed cells were confirmed under a 
light microscope, and the cell debris was removed by several washes with 
distilled water. 1X103 cells of SH-SY5Y were seeded into the same plate 
and in a fresh plate (control). Both plates were then incubated at 37°C in 
a humidified atmosphere of 95% air and 5% CO2 for 14 days. The cell 
growth was monitored every 48 hours.  
2.2.9 Sample preparation for microscopy 
2.2.9.1 Methanol fixation 
All cell types were seeded in individual 12 well plates with PAN fibres, PJ 
fibres and coverslips at a density of 50,000 cells per well. Following 
treatment, cells were washed with PBS and fixed with ice-cold 90 % (v/v) 
methanol/1X Tris-Buffered saline (TBS) for 20 minutes at – 20 ˚C.  
2.2.9.2 Immunofluorescence antibody staining  
Following the methanol fixation, the Cells were then permeabilised for 10 
minutes using 1% Triton X-100 in TBS at room temperature and were 
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blocked with 3 % (w/v) BSA/TBS-Tween (0.1 %) for 1 hour at room 
temperature. The plates were then incubated with the relevant primary 
antibody diluted in 3 % (w/v) BSA/TBS-Tween (0.1(v/v) %) and 
incubated overnight at 4 ˚C in a humidified chamber. The following day 
slides were washed thoroughly with 0.1 % (v/v) Tween-20 in TBS. The 
slides were then incubated with Anti-IgG alexafluor conjugated secondary 
antibody diluted in 3 % (w/v) BSA/TBS-Tween [0.1% (v/v)] for 2 hours. 
The slides were then washed to remove all unbound secondary antibody. 
Each sample from each well was removed and placed on glass slides with 
anti-fade mountant vectorshield containing DAPI or propidium iodide 
nuclear stain and covered with a glass coverslip. The coverslip was sealed 
with clear nail varnish, and slides were viewed using an Olympus 
fluorescence microscope. 
2.2.9.3 Scanning electron microscopy 
SEM microscopy was used to examine and analyse cell attachment and 
morphology on nanofibre and coverslips at greater magnification and 
higher resolution.  After the completion of experimental incubations, cells 
were fixed in 90% (v/v) methanol in TBS at -20oC for 30 minutes. After 
fixation, cells were dehydrated by sequential incubation in ethanol at 30% 
(v/v), 50% (v/v) 70% (v/v) 80% (v/v), 90% and 100% for 10 min with 
gentle agitation (Braet, De Zanger and Wisse 1997; Parameswaran and 
Verma 2011). After the final dehydration step, samples were air-dried for 
15 min before mounting on SEM carbon stubs and sputter-coated to a 10 
nm thick gold layer. Samples were characterised with a Phenom ProX 
desktop SEM at 10kV.     
2.2.10 Protein levels identification 
2.2.10.1 SDS-PAGE electrophoresis  
2.2.10.1.1 Total protein cell lysate from cell grown on TCP  
Total protein cell lysates were prepared from an entire 12 well plate to 
ensure parity with nanofibre samples. Samples (12 wells) were pooled to 
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obtain sufficient protein for analysis.  To prepare total protein extracts, 
cells were scraped from the monolayer using a cell scraper, pooled and 
transferred to a 15ml tube. The cells were pelleted at 300g for 5 minutes 
and washed twice in PBS. Dependent on pellet size, the sample was 
resuspended in total lysis buffer (100-200µl) containing 1% (v/v) 
protease inhibitor cocktail and transferred to a pre-cooled microfuge tube. 
The total protein extract was heated to 100 °C for 5 minutes in a heating 
block and subsequently sonicated (3 x 5-second bursts on power setting 
no.6) on ice. Lysates were then centrifuged at 300g for 5 minutes at 4°C 
to pellet insoluble material. The supernatant was carefully pipetted to a 
fresh microfuge tube and stored at -20°C for quantification.  The protein 
content of each sample was quantified using Mini Lowry’s method (Lowry, 
Rosebrough, Farr, et al. 1951).  
2.2.10.1.2 Total protein extraction from fibre 
Similarly, to culture plates, nanofibres from an entire 12 well plate were 
pooled to obtain enough protein for analysis. Cell laden nanofibre 
scaffolds from each well were transferred to a 15ml tube with ice-cold 
PBS. Nanofibres were centrifuged at 300g for 5 minutes and resuspended 
in ice-cold PBS. The step was repeated a few times to remove any trace 
of media. After the final centrifugation, PBS was decanted and total lysis 
buffer (approx.100-200µl) with 1% (v/v) protease inhibitor cocktail was 
added and transferred into a pre-cooled microfuge tube. The samples 
were then subjected to heat and cold shock treatment by boiling at 
100 °C for 5 minutes in a heating block and immediately placed on ice. 
The samples were then sonicated (3 x 5-second bursts on power setting 
no.6) in ice and centrifugation at 300g for 5 minutes at 4°C. The 
supernatant containing all the protein was carefully pipetted to a fresh 
microfuge tube and stored at -20°C for quantification.  The protein 
content of each sample was quantified using Mini Lowry’s method 
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2.2.10.1.3 Protein quantification by mini Lowry 
The protein concentrations were calculated by performing a Mini Lowry 
assay. Bovine serum albumin (BSA) standards were prepared to generate 
a standard curve for estimating the protein concentration of the cell 
lysates.  BSA (1mg/ml) standards of required dilutions were made from 
a stock solution of 1mg/mL as given shown in table 2.2. 10µL of cell 
extract was taken and made up to 100µL using distilled water. All samples 
and standards were thoroughly mixed by vortexing. Aliquots of 1mL 
Lowry reagent (100ml sodium carbonate Na2Co3/ sodium hydroxide 
solution NaOH+ 2ml of 1 % Copper sulphate solution and 2ml of 2.7% 
Sodium tartrate solution) was added to all the tubes & incubated at room 
temperature for 15 minutes. Then 100µL of Folin-Ciocalteau (diluted 1:1 
with distilled water) reagent was added to all the tubes, vortexed before 
incubation at room temperature for a minimum of 30min. Development 
of blue colour was observed based on the amount of protein present. 
After 30 minutes, 100µL from each sample was transferred to a 96 well 
plate to measure the absorbance at 750nm. The amount of protein 
present in each experimental sample was calculated by comparing to a 
standard curve generated from the BSA standards.    
2.2.10.1.4 Preparation of resolving gel 
As per the manufacture's guidelines, the gel was prepared using the Bio-
Rad protean III or tetra apparatus. For the separation of proteins of 
interest, a 10 % (w/v) polyacrylamide gel was used.  A total volume of 
10 ml polyacrylamide gel was made as described in table 2.2. Just before 
the gel was poured into the gel casting set up 50µl of 10 % (w/v) 
ammonium persulphate (APS) and 10µl of N, N, N′, N′-
Tetramethylethylenediamine (TEMED) was added to induce gel 
polymerisation.  The casting setup consisted of 2 glass plates arranged 
with the short plate facing forward. The gel was poured (approx. 7.5 ml) 
between the two-plate leaving approximately 2 cm at the top for the 
application of a stacking gel. The gel was overlaid with isopropanol (IPA) 
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to create a smooth gel interface. The resolving gel was left to polymerise 
at room temperature for 1 hour. The separation of proteins within a 
sample is varied depending on the percentage of acrylamide within the 
resolving gel. The table below details the composition and preparation of 
the resolving gels. 
Table 2. 2: Preparation of acrylamide resolving gel mixes for SDS-
PAGE 
Reagents 7.5% 
(w/v) 
gel 
10.0% 
(w/v) 
gel 
12.5% 
(w/v) 
gel 
15.0% 
(w/v) 
gel 
40% Acrylamide (29:1) 1.9 ml 2.5 ml 3.0 ml 3.75 ml 
1.5 M Tris buffer pH8.8 2.5 ml 2.5 ml 2.5 ml 2.5 ml 
10% (w/v) SDS 100 µl 100 µl 100 µl 100 µl 
Distilled water 5.5 ml 4.9 ml 4.4 ml 3.65 ml 
Total  10 ml 10 ml 10 ml 10 ml 
APS 50 µl 
TEMED 10 µl 
2.2.10.1.5 Preparation of stacking gel 
Once confirming the resolving gel had polymerised, the IPA was washed 
and removed using a filter paper. A total volume of 50ml 4% (w/v) 
stacking gel was prepared as described in table 2.3, and 2.5ml was used 
to prepare each gel.   12.5µl of 10 % (w/v) APS and 5 µl of TEMED were 
added to 2.5 ml of stacking gel mix per gel. Immediately, starting from 
one corner of the plate, the comb was placed slowly and carefully within 
the gel to form wells avoiding any air bubbles or deformation. The 
stacking gel was left to polymerise for approximately 30- 45 minutes at 
room temperature. Once the gel had polymerised, the comb was removed. 
The gel was then placed into a Bio-Rad SDS-PAGE protein separation 
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apparatus which was filled with SDS-PAGE running buffer (2.5 mM Tris 
pH 8.3; 192 mM glycine; 0.1 % (w/v) SDS). 
 
Table 2. 3: Preparation of acrylamide stacking gel mix for SDS-
PAGE 
Reagents 4% (w/v) gel 
40% Acrylamide (29:1) 10 ml 
0.5 M Tris buffer pH 6.8 25 ml 
10% (w/v) SDS 1 ml 
Distilled water 14 ml 
Total  50 ml 
APS (for every 2.5ml) 12.5 µl 
TEMED (for every 2.5 ml) 5µl 
 
2.2.10.1.6 Preparation of samples for separation by SDS-PAGE 
Mini Lowry determined the total volume of the sample required to load 
20µg of protein. The known volume of sample was diluted with an equal 
volume of 2X concentrated reducing sample buffer (0.2 M Tris-HCl pH 6.8; 
8 % (w/v) SDS; 40 % glycerol; 200 mM dithiothreitol; 0.02 % (w/v) 
bromophenol blue) heated to 100°C for 5 minutes in a heating block. The 
total mixture was then loaded to each well with 10µl of molecular weight 
marker loaded in one of the wells for each gel. The proteins were 
separated by one-dimensional SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) using the BIO-RAD protean III or tetra kits. Initial voltage 
was set to 80V until the samples reached the interface between stacking 
and resolving gel then the voltage was set to 130V for 1-1.5 hours.  
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2.2.10.2 Western Blotting 
Western blotting is a common technique used to transfer protein from an 
SDS-PAGE gel to a nitrocellulose membrane to identify a protein of 
interest. Two types of western blotting techniques were available; wet 
blotting was preferentially used for transferring high molecular weight 
proteins, and semi-dry blotting was used for lower molecular weight 
proteins. The proteins of interest in this study ranged between 30-200 
kDa, so the experiment was conducted using a wet blotting transfer. The 
proteins were electrophoretically transferred into a 0.22µm pore 
nitrocellulose membrane (Towbin, Staehelin and Gordon 1979). After 
separating the proteins using the SDS-PAGE gel was completed, the two 
glass plates were separated, the gel was carefully transferred to distilled 
water in a tray. Four pieces for the filter paper, one nitrocellulose 
membrane was cut to the same size as the gel and pre-soaked in Tris-
glycine along with two wire mesh. The entire set was assembled as a 
blotting sandwich starting from cathode side with the cloth mesh then 
two filter papers then the nitrocellulose and the gel on top of the 
membrane which was then followed by two more filter papers and the 
mesh. The assembly was secured and submerged in a tank with a blotting 
buffer with the membrane facing the anode. The transfer was set at 30 V 
for 16 hours. The transfer of proteins was evaluated by staining the 
nitrocellulose membranes with 0.05 % (w/v) copper-phthalocyanine 3, 
4’,4’’,4’’’ tetrasulphonic acid tetrasodium salt in 12 mM HCl. The copper 
stained membrane image was captured using a Fujifilm CCD camera, and 
then the membrane was destained with 12 mM NaOH solution.       
2.2.10.3 Immunoprobing for proteins 
After the transfer procedure, the nitrocellulose membranes were blocked 
with 5% (w/v) marvel/TBS-tween (0.1% v/v) at room temperature for 1 
hour. Then, the blot was immersed in primary antibody diluted in 3% 
(w/v) marvel/TBS-Tween (0.1% (v/v)) at the relevant concentrations as 
listed in Table 2.1. The blot was then incubated overnight with gentle 
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shaking on an orbital shaker at 4 °C in the cold room. Blots were then 
washed 4X15min with TBS-tween. The blots were then probed with 
appropriate HRP conjugated secondary antibody diluted in 3% (w/v) 
marvel/TBS-Tween (0.1% (v/v) for 2 hours at room temperature with 
gentle shaking followed by four 15min washes with TBS-Tween.  After 
washing, the blot was placed on a black laminated sheet and sprayed 
with Merck RapidStemTM enhanced chemiluminescence reagent. 
Following the one-minute incubation, the excess reagent was removed 
using a filter paper. The blot was then placed into the Fuji dark box and 
developed using FUJIFILM CCD camera. 
2.2.10.4 Quantification of western blots  
The intensity of protein immunoblot bands was quantitatively analysed 
using an Aida image analyser. The pixel intensity of equal-sized area 
around the bands was obtained and quantified depending on the number 
and intensity of pixels in each area. Changes in the sample loading were 
corrected against a housekeeping protein (loading control), and the 
corrected protein bands were expressed as a percentage of the control.   
2.2.11 Toxins investigation 
The biochemical changes and physical abnormalities as seen in neural cell 
degeneration were mimicked by the addition of various toxins which could 
impair normal cell functionality (Sherer, Betarbet, Stout, et al. 2002). 
The investigation was conducted on both traditional 2D culture surfaces 
and on nanofibre scaffolds to establish the adverse effect of these toxins. 
Four different toxins capable of causing different biochemical changes 
were used to conduct this study. Rotenone and MPTP, to induce complex 
1 inhibition; MG132, to induce proteasome inhibition; and BSO, a 
glutamylcysteine synthetase inhibitor to reduce glutathione levels.  Both 
neuronal and glial cells were seeded at a density of 50,000 cells/well on 
nanofibres and tissue culture plates (TCP). After 24 hours, the fibres were 
transferred to a fresh plate to avoid cells that may not have attached to 
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the fibre. All samples were incubated for an additional 24 hours at 37 °C 
with 5% CO2. 48 hours later, the media from both TCP were replaced with 
media containing Toxins at final concentrations as shown: Rotenone, 0.5 
µM and 2.5 µM; MPTP, 10 µM and 100 µM; MG132, 0.1 µM and 0.5 µM; 
and BSO, 2 mM. After the addition of toxins, all samples were incubated 
under the same conditions for 72 hours. Following incubation, both TCP 
were tested for cell viability using the MTT and CellTiter-Glo® 3D viability 
assays as described in section 2.2.6.  
2.2.12 Co-Culture Model to investigate the effect of Toxins 
A co-culture system of neuronal and glial cells using both traditional 2D 
cultures and nanofibres was utilised. Cells were initially cultured 
individually on different surfaces prior to constructing a mixed co-culture 
and incubating the neural populations in the same well. The co-culture 
model consisted of two layers as described in Figure 2. 11. The construct 
was either made with the 2D surface (layer 1) then a spacer and then a 
scaffold (layer 2) or with scaffold as both layers separated by a hollow 
spacer.  
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Figure 2. 11: Schematic representation of the experimental setup 
designed to create a co-culture system. 
Each layer harboured a different neural cell type with three different 
experimental setups;  
1. The neuronal cells on the plate and glial on fibre  
2. Glial cells on the plate and neuronal cells on the fibre and  
3. Both neuronal and glial cells on individual fibres.  
Based on the three-experimental set, both neuronal and glial were 
seeded individually at a density of 50,000 cells/well, cultured for 48 hours 
and induced to differentiate with B27 supplement for five days at 37°C 
with 95 % air and 5% CO2 supply. After five days the experiment was 
arranged as shown in figure 2.14. Also, 0.5µM rotenone, 0.1µM MG132 
and 2 mM BSO were added to the co-culture, which was incubated at 
37°C with 95 % air and 5% CO2 supply for 20 days to recreate a longer-
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term, chronic model. Every 72 hours the co-culture was separated, and 
the fibres were transferred from each well into a fresh culture dish to 
measure viability, and fresh media with toxins were replaced for the 
remaining wells. Cell viability was examined individually for each scaffold 
and plate using CellTiter-Glo® 3D viability assay kit.  
2.2.13 Statistical analysis 
The data was generally presented as mean ± the standard deviation (SD). 
Statistical analysis was performed on all datasets, and all analysis was 
conducted using the Graph Pad Prism for Windows Version 7.02. P-values 
<0.05, <0.01 or <0.001 were considered statistically significant and were 
indicated within figures as  * p<0.05 , **p<0.01 or ***p<0.001. 
2.2.13.1 Polymer absorbance analysis  
The absorbance data obtained was statically analysed using unpaired 
two-tailed T-test. The data obtained were normally distributed (as 
ascertained by the Kolmogorov-Smirnov Test for Normality). The data 
consists of a distinct control and test set with a clear statistical intention 
to test for differences within these two populations.  The critical area of 
a distribution is two-sided testing whether a sample is greater than or 
less than a certain range of values. The data were represented as one 
control which was independently compared to two variables showing a 
significant difference compared to the control. 
2.2.13.2 Rheology measurement  
In this data, two-parameter were analysed to include Strain diameter vs 
time and Strain diameter vs strain rate for both PAN vs PJ polymer. The 
statistical analysis chosen for this study was Unpaired t-test with Welch's 
correction due to the two variables (PAN and PJ) have normal 
distributions with equal variance. The Welch's t-test was used for unequal 
variances, but the assumption of normality was maintained. 
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2.2.13.3 Nanofibre Diameter and Pore size measurement 
One hundred different measurements were analysed for each sample. 
The data is represented in an even mean distribution among the one 
hundred measurements with standard error and standard error mean (±). 
2.2.13.4 Proliferation and Viability analysis 
Throughout the study, values obtained for proliferation and viability 
assessments were converted to a percentage of the corresponding control, 
thereby assigning the control values as 100%.  
The data obtained were normally distributed (as ascertained by 
the Kolmogorov-Smirnov Test for Normality).  Statistical analysis was 
performed using the Two-Way ANOVA with Sidak’s multiple comparisons 
tests. The two-way ANOVA compares the mean differences between 
groups that have been split into two independent variables (Plate and 
Fibre) and the Sidak multiple comparisons was applied to and compare 
each time point against the two variables.  
P-values for significance were indicated within figures as * p<0.05 , 
**p<0.01 or ***p<0.001. 
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Chapter 3: Nanofibre fabrication and analysis  
3.1 Introduction 
The synthesis of nanofibres fabrication dates back over four centuries 
(Tucker, Stanger, Staiger, et al. 2012; LF Nascimento, S Araujo, R 
Cordeiro, et al. 2015). However, the first attempt to manufacture 
nanofibre by electrospinning occurred between 1934 and 1944 by the 
scientist Anton Formhals (Tucker, Stanger, Staiger, et al. 2012). The 
words nanofibre and electrospinning came to light and was started to be 
commonly used among scientist and researchers only by the late 20th 
century (LF Nascimento, S Araujo, R Cordeiro, et al. 2015).  In this 
current modern scientific world, nanofibre manufacture has taken many 
turns, and the methods of fabrication have been significantly revised. 
Over the years, the number of applications of and research with 
electrospun nanofibre has dramatically with many different methods of 
forming nanofibres being developed to meet production requirements. 
Table 3.1 summarises the recent developments in nanofibre fabrication 
methods along with each methods advantages and disadvantages (Nayak, 
Padhye, Kyratzis, et al. 2012).  
All the electrospun nanofibre scaffolds used in this study were produced 
using a purpose-built electrospinning system. It consists of an interlocked 
humidity-controlled chamber with recirculating airflow. The organic 
solvents used to dissolve polymers to form electrospinning solutions are 
removed using activated carbon filters. This helps to maintain a stable 
environment needed to produce high-quality nanofibres. The set up 
within the chamber is relatively simple; it consists of a blunt-end needle 
which is fed with a polymer solution and connected to the high voltage 
positive supply. The needle is held at a fixed distance from a metallic 
cylindrical drum which can be rotated about its axis. This research set up 
has several advantages such as consistent diameter, controlled pore size, 
controlled fibre mat thickness, environment-friendly, and can be used to 
coat up to B1 size laser cut plastic sheets.      
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Method Fibre diameter Advantages Disadvantages Reference  
Needless 
Electrospinning  
200–800 nm Higher production rate  The vast spread of 
fibre diameter  
(Yarin and 
Zussman 
2004) 
Bubble 
Electrospinning  
No information 
available 
Low cost, high production 
rate. Clogging free  
The solvent used 
cannot be 
recovered, 
excessive use of 
solvents  
(Liu, G., Qiao 
and Guo 1996; 
Liu, Y. and He 
2007) 
Electroblowing  40–120 nm Higher production rate  Solvent recovery (Wang, X., Um, 
Fang, et al. 
2005) 
Cylindrical porous 
hollow tube 
300–600 nm Higher production rate  The intricate 
design of the setup 
(Varabhas, 
Chase and 
Reneker 2008) 
Microfluidic 
manifold 
85–350 nm Simple, spin multiple 
polymers, control over the 
deposition  
Solvent recovery (Srivastava, 
Loscertales, 
Marquez, et al. 
2008) 
Roller 
electrospinning 
144 nm Avg. Higher production rate  Not possible low 
mol. Weight 
polymers 
(Cengiz and 
Jirsak 2009) 
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Melt 
electrospinning 
(Electrical 
heating) 
16 ± 10.7 mm for 
molten fibres and 
560nm ± 90 nm for 
solid fibre 
Solvent-free approach  Mostly amorphous 
fibre, thermal 
degradation 
(Zhou, Green 
and Joo 2006) 
Coaxial melt 
electrospinning 
Avg. 150 nm Encapsulation, suitable for a 
wide range of materials  
Complex setup (McCann, 
Marquez and 
Xia 2006) 
Melt 
electrospinning 
(LASER heating) 
Avg. ~1 mm No electric discharge, 
suitable for a polymer with 
a high melting point, less 
thermal degradation   
Amorphous fibres, 
unstable.  
(Ogata, 
Yamaguchi, 
Shimada, et al. 
2007) 
Meltblowing Less than 500 nm Higher production rate Breaking of fibres 
and bead 
formation 
(Brang, Wilkie 
and Haggard 
2008; Bodaghi 
and Sinangil 
2009) 
Melt extrusion Avg. diameter 
150 nm–400 nm, 
 
Consistent fibre diameter  Short lengths of 
fibre, fibre length: 
60 µm 
(Li, Huayi, Ke 
and Hu 2006) 
Flash-spinning 500 nm Higher production rate Short lengths of 
fibre 
(Nayak, 
Padhye, 
Kyratzis, et al. 
2012) 
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Drawing  60 nm Simple, long and continuous 
fibre  
The lower 
production rate 
and no uniform 
diameter  
(Tong, L. and 
Mazur 2008; 
Xing, X., Wang 
and Li 2008) 
Pressurised gas less than 3000 nm Suitable for spinnable fluids  Complex process (Reneker, 
Chun and 
Ertley 2002) 
Force spinning Micron and submicron  The lower electric field, 
simple process, high 
production rate  
High temperatures 
required 
(Lozano and 
Sarkar 2009) 
Jet-blowing 10 nm to 50 mm Formation of composites 
does not require the use of 
harsh solvents  
Complex process (Sen, Bedding 
and Gu 2005) 
Melt-spinning Less than 1000nm Suitable for many solvents 
and polymers, simple  
Degradation of 
polymers during 
spinning  
(Huang, 
Marshall, 
Armantrout, et 
al. 2012) 
Table 3. 1: Other methods of nanofibre fabrication
CHAPTER III            NANOFIBRE FABRICATION AND ANALYSIS 
92 
 
3.1.1 Content of this chapter  
In this chapter, we have demonstrated the use of two synthetic polymers 
Polyacrylonitrile and Jeffamine® to fabricate biocompatible nanofibre 
scaffolds that allow cells to attach, proliferate, and survive. In support of 
this chapter, the engineering designs, method of polymer preparation, 
electrospinning parameters, and the range of fibre orientations which can 
be produced using a patented method will be explained. This chapter will 
also focus on the quantification of the nanofibre and scaffolds produced 
and explain the different and most suitable methods for nanofibre 
sterilisations. Although the work developed routes to produce scaffolds 
with three different nanofibre orientations, namely random, aligned and 
radial, the scaffolds used to develop the neurodegenerative in vitro model 
was random non-woven scaffolds.    
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3.2 Results 
3.2.1 Engineered designs 
Random, aligned and radial fibres designs developed in this study were 
made on the 75µm thick polyester sheet. The laser focus was positioned 
to the surface of the sheet or 15mm from the focusing lens on the Trotec 
laser cutter. Arrays of the aperture design were laser cut, and the speed 
and power combinations were adjusted to identify the settings which 
produced dimensionally accurate and clean cuts to the polyester sheets. 
This optimisation process determined that a laser cutting setting of 80% 
of the maximum speed and 28% of maximum power produce acceptable 
dimension control and clean edges on a Trotec SP500 laser cutter       
 
Figure 3. 1: Laser speed and power settings optimisation.  
The figure shows the microscope image of designs made on the polyester 
sheet using a CO2 laser cutter with different power and speed. The arrows 
indicate the damage caused on the polyester sheet due to the incorrect 
parameter for the laser    
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In Figure 3. 1, A and B show a design cut with fully optimised laser setting 
with accurate dimensions and clean-cut edges. C-J shows the various 
type of damage that can be caused to the design when wrong laser 
settings are applied. Faults like excessive melting (C), improper cutting 
(D, E, and F), shape deformation (G), deposition caused due high laser 
power (H), and change in the measurement of the design is the common 
damage observed due to incorrect laser settings.       
3.2.2 Polymer preparation 
Two synthetic polymers, polyacrylonitrile (PAN) and Jeffamine® ED 2003 
were dissolved in DMF. 10wt% (w/w) PAN and 10wt% PAN with 5wt% 
Jeffamine® ED-2003 (PJ) were used to make nanofibre for this study. The 
mixture was heated at 50°C overnight with constant stirring. When the 
fully dissolved electrospinning solutions have no contaminants, the PAN 
solutions will be very pale-yellow, and PJ will be pale red (Figure 3. 2). 
Consistency among a different batch of the polymer was measured using 
a spectrophotometer. The absorbance of both PAN and PJ was measured 
by adding 100µl of both polymers and solvent in a 96 well plate, and an 
endpoint measurement was obtained at 540nm. Compared to DMF,    
10wt% PAN had an average absorbance of 40%±2% and adding 5wt% 
Jeffamine® the average absorbance was measured to be at 75%±2% of 
PJ polymer (Figure 3. 2).   In general, the dissolved polymer was stored 
at 4°C in a sealed container for up to 4 weeks and heated to room 
temperature before use.    
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Figure 3. 2: PAN and PJ polymers dissolved in DMF.  
The figure shows when PAN and PJ are entirely dissolved in DMF; PAN 
appears in pale yellow, and PJ appears in pale red. The absorbance of 
both polymers was measured at 540nm compared to the DMF. Obtained 
values were converted to percentage setting control values to 100%. 
Results are expressed at the mean ratio + SEM n=5 *P<0.001 against 
polymer vs solvent determined by unpaired two-tailed Student-T test.  
3.2.3 Electrospinning solution rheology properties  
After the PAN and PJ polymer formulations were prepared overnight by 
constant stirring at 50°C, the viscosity of both types of polymers was 
measured using the HAAKE™ CaBER™ 1 Capillary Breakup Extensional 
Rheometer. The polymers were bought to room temperature before a 
small volume of each polymer was loaded on the Rheometer as described 
in section 2.2.2.1. Shear viscosity and strain breakup time were 
measured. For PAN the shear viscosity was measured to be   7.102 E-1 ± 
1 Pa.s  with a calculated breakup time of 2.98E-1 ±0.5 seconds, and for 
PJ polymer solution the shear viscosity was measured to be at  7.030 E-
1± 1 Pa.s with a calculated breakup time of 2.18 E-1± 0.5 seconds for PJ 
formulation (Figure 3. 3). A minor change was observed to the breakup 
time of PJ compared to PAN. Consistent data were obtained from every 
new batch.  
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Figure 3. 3: PAN and PJ viscosity measurement.  
Graph A show both PAN and PJ polymers change in strain diameter Vs 
time and graph C shows the strain diameter vs the strain rate. Results 
are expressed at the mean ratio ± SEM P<0.05 against PAN 10% vs PJ5% 
determined by Unpaired Welch’s Two-tailed student-T tests.    
3.2.4 Electrospinning 
After investigating the viscosity of PAN and PJ polymer solution, each 
polymer is loaded into a 10 ml syringe for electrospinning as explained in 
section 2.2.3. When the high voltage is applied the polymer stretches 
creating nanofibres. To obtain continuously spun nanofibres, it is 
essential to form a continuous jet flow which was achieved by optimising 
the high voltage supply (Figure 3. 4).  
 
Figure 3. 4: Schematic representation of jet flow formation. 
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Depending on the viscosity and the flow rate of each polymer solution the 
voltage can vary. Both PAN and PJ was spun at 1ml/ hour flow rate, and 
the fibres were obtained at 21kV and 18kV for PAN and PJ respectively. 
The distance between the needle and the collector was set continuously 
to 30cm. During the electrospinning process, the relative humidity (RH) 
was 65%, and the air temperature was 21°C the stability over a typical 
electrospinning deposition run is shown in Figure 3. 5.  The spun sheet 
was carefully detached from the collector, and the fibres were secured 
with an identical top sheet. The sheets were securely stored and were 
laser cut to fit well TCP. From every batch, the sample was randomly 
chosen to investigate fibre diameter, pore size, contact angle analysis, 
and membrane thickness.    
 
Figure 3. 5: Temperature and humidity analysis during 
electrospinning.  
The data is obtained from the Extech RHT10 temperature and humidity 
analyser that records the information throughout the electrospinning 
process. Graph A show the temperature recorded at 21°C for 2.5 hours 
and Graph B shows the humidity maintained at 65% throughout the 
process.    
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Table 3. 2: Electrospinning parameters for PAN and PJ 
Polymer 
Needle to 
Collector 
distance 
Flowrate Voltage RH Temp Total vol 
PAN 30 cm 1ml/hr 21 kV 65% 21°C 2.5 ml 
PJ 30 cm 1ml/hr 18 kV 65% 21°C 2.5 ml 
3.2.4.1 Random Nanofibre Scaffolds  
To obtain random fibres, the design was engineered on the polyester 
sheet as explained in section 2.2.1.1. A single sheet with an array of laser 
cut 1cm hole was used to obtain fully suspended random fibres. To 
improve the sterility, the laser cut sheets, and the collector was wiped 
with 70% ethanol before the electrospinning process. The sheet was 
wrapped around the collector and secured with aluminium tape. The 
electrospinning was set according to the parameters shown in Table 3. 2, 
and a total volume of 2.5 ml of the polymer was collected in the form of 
fibres on the design.   
3.2.4.1.1 SEM and FibreMetric analysis  
The distribution of the nanofibre diameter and the pore size and 
orientation of the nanofibre scaffolds were analysed by processing the 
Phenom ProX SEM images with FibreMetric image analysis software 
available in the Phenom Suite on the Phenom desktop SEM. Selected 
samples were coated with 10nm of gold and prepared for SEM as 
described in section 2.2.3.1. The fibre bed was thoroughly examined for 
any form of defects or damage in multiple areas. Images obtained at 
6000X magnification are transferred into FibreMetric software to analyse 
for fibre diameter and pore size as explained in section 2.2.3.1.  
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Figure 3. 6: PAN SEM and FibreMetric analysis data.  
Image A-D show SEM analysis for damage on the fibre at different 
magnification of a chosen area. Graph E shows the fibre diameter and F 
represents the pore size. The frequency of the distribution for fibre 
diameter and pore size was calculated along with mean and standard 
deviation (SD) using graph pad prism   
 
Figure 3. 7: PJ SEM and FibreMetric analysis data.  
Image A-D show SEM analysis for damage on the fibre at different 
magnification of a chosen area. Graph E shows the fibre diameter and F 
represents the pore size. The frequency of the distribution for fibre 
diameter and pore size was calculated along with mean and SD using 
graph pad prism   
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The average diameter for a 10% PAN Electrospun at 1ml/hour rate in 
21kV with 2.5ml of total deposition was 524nm ± 108nm with pore size 
of 0.50 µm2 ± 0.10 µm2 (Figure 3. 6) and the average diameter of 10% 
PAN with 5% Jeffamine® electrospun at 1ml/hour rate at 18kV was 
520nm ± 110nm with a pore size of 0.60 µm2 ± 0.05 µm2 (Figure 3.7)  
Table 3. 3 Diameter and pore size based on electrospinning parameters 
Polymer Flowrate Voltage 
Total 
volume 
Diameter 
(nm) 
Pore size 
(µm2) 
PAN 1ml / hr 21 kV 2.5 ml 524±SD:108 0.50±SD:0.10  
PJ 1ml / hr 18 kV 2.5 ml 520±SD:110 0.60±SD:0.05  
3.2.4.1.2 Contact angle measurement 
The hydrophobic properties of both PAN and PJ fibre scaffolds were tested 
using contact angle analysis as described in section 2.2.3.2. A high-speed 
camera video was set to run for 10 sec, and a drop of water was placed 
on the centre of random fibres scaffold. The wetting dynamics of the 
scaffold was video recorded and measured for 10 sec. The Drop Shape 
Analyser (DSA) software measure the changes in the shape of the droplet 
for the recorded period and calculates an average contact angle for 10 
sec. The DSA determined that random fibre scaffold made with PAN was 
hydrophobic with an average contact angle of 112.7°. The addition of 5% 
Jeffamine® made the scaffold hydrophilic and with complete wetting.  The 
PJ scaffold average contact angle was measured to be at 0° at the end of 
10-sec measurement (Figure 3. 8)  
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Figure 3. 8: Random fibre contact angle analysis.  
Image A shows PAN fibre is hydrophobic with the water droplet staying 
stagnant on the surface of the scaffold and Image B shows PJ fibre is 
hydrophilic where the water droplets wet into the scaffold. The image was 
obtained from a screenshot of a 10-sec high-speed video recording, and 
the average data was obtained with DSA for the 10sec video recording. 
Table 3. 4: Contact angle based on electrospinning parameters  
Polymer Flowrate Voltage Total vol Contact angle 
PAN 1ml / hr 21 kV 2.5 ml 112.7° 
PJ 1ml / hr 18 kV 2.5 ml 0° 
3.2.4.1.3 Scaffold thickness measurement  
OCT is capable of internal imaging structure of a material or generating 
a cross-sectional tomographic image of a thin low light scattering sample. 
An OCT instrument describes in section 2.2.3.3 was used to determine 
the total thickness of the scaffold membrane. Randomly chosen scaffolds 
were tested for thickness in both dry and wet state as described in section 
2.2.3.3. Analysis of the image was performed on wet samples as wetting 
the samples created an upper and lower liquid interface, and this provided 
a better structure to measure with less scattering. The thickness was 
measured using image J software at three different locations as shown in 
figure 3.9. The thickness of the scaffolds was measured to be an average 
of 33.5 µm for PAN and 30 µm for PJ (Figure 3. 9).  
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Figure 3. 9: OCT measurement for random PAN and PJ scaffold. 
Image A shows the region of PAN scaffold measured using OCT and image 
B shows PJ scaffold. Both samples were wetted with ethanol prior to 
obtaining the OCT image. The area between the arrows indicates the 
suspended fibre.  The arrows represent the point of measurement for 
each scaffold using image J software. 
 
Table 3. 5: Random Scaffold thickness based on electrospinning 
parameters 
Polymer Flowrate 
Total  
volume 
Membrane 
thickness 
Total 
thickness 
PAN 1ml / hr 2.5 ml 33.53 µm 183.53 µm 
PJ 1ml / hr 2.5 ml 30.02 µm 180.02 µm 
3.2.4.2 Aligned nanofibre 
Aligned nanofibre scaffolds were manufactured using our patented 
process as explained in section 2.2.1.2. Accordingly, two laser-cut sheets 
were ultrasonically tack welded together and placed on the rotating drum 
with the top sheet outermost. Both PAN and PJ fibres were deposited 
during separate runs to form aligned nanofibres. Both fibre types were 
electrospun with 1ml/hour flow, with 2.5 ml of the solution being 
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converted to fibre. Electrospinning parameters were the same as those 
used for random fibre scaffolds, notably 21kV for PAN and 18kV for PJ.  
3.2.4.2.1 SEM and FibreMetric analysis  
The samples were coated with 10nm of gold and prepared for SEM as 
described in section 2.2.3.1. At different magnifications, the fibre bed was 
thoroughly examined for defects and damage. Images obtained were 
transferred into FibreMetric software to analyse for fibre diameter and 
pore size as explained in section 2.2.3.1. The patent-pending process 
creates aligned fibre scaffold inserts which have three regions, an aligned 
fibre region and two random fibre regions (Figure 3. 10). Diameter and 
pore size was measured for each type. For PAN the average diameter and 
pore size for the random region of the scaffold was 570nm ± SD: 124nm 
and 0.57µm2 ± SD: 0.05 µm2 respectively. The average diameter and 
pore size for the aligned region was 424 nm ± SD: 50 nm and 0.22 µm2± 
SD: 0.09 µm2 respectively (Figure 3. 11). Similar to PJ the average 
diameter and pore size for the random region of the scaffold were 550nm 
± 120nm and 0.56µm2 ± 0.05 µm2 respectively. The average diameter 
and pore size for the aligned region was 439 nm ± 50 nm and 0.24 µm2± 
0.09 µm2 respectively (data not shown). 
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Figure 3. 10: Aligned nanofibre design SEM imaging.  
The design consist of two regions. The two rectangle region forming 
random fibres and the centre ellipse region harbouring the aligned fibres.    
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Figure 3. 11: FibreMetric data for Aligned PAN fibre scaffold.  
In this image Graph, A and B show the diameter and pore size of the 
random fibre region and Graph C and D represents the diameter and pore 
size of the aligned fibre region receptively.  
Table 3. 6: Aligned fibre FibreMetric data based on electrospinning 
parameters 
Polymer 
Flow 
rate 
Total 
volume 
Random region Aligned region 
Diameter 
(nm) 
Pore size 
(µm2)  
Diameter 
(nm) 
Pore size 
(µm2)  
PAN 
1ml / 
hr 
2.5 ml 
570 ± 
SD:124 
0.57 ± 
SD: 0.05 
424 ± 
SD: 50 
0.22 ± 
SD: 0.09 
PJ 
1ml / 
hr 
2.5 ml 
550 ±  
SD:120  
0.56 ±  
SD: 0.05 
439 ± 
SD: 50 
0.24± 
SD: 0.09 
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3.2.4.2.2 Contact angle measurement  
Both aligned PAN and PJ were tested using contact angle analysis as 
described in section 2.2.3.2. The aligned fibre inserts consist of two types 
of region, and the hydrophobic nature of both was tested using DSA. For 
PAN aligned fibre inserts the random region showed hydrophobic nature 
with a contact angle measured to be at 110.8° (Figure 3. 12 A) and in 
the aligned region the contact angle was measured to be at 130.2° 
(Figure 3. 12 C). When aligned fibre made with PJ fibre, the contact angle 
for the random region and the aligned region was measured at 0° at the 
end of the 10sec reading (Figure 3. 12 B and D). Aligned PJ fibre 
expressed a higher wetting rate compared to the random PJ whereas 
aligned PAN showed a high hydrophobic nature compared to random PAN 
 
Figure 3. 12: Aligned fibre contact angle analysis.  
The scaffold consists of two regions. Image A and B shows analysis of the 
random region for PAN and PJ fibre respectively and Image C and D show 
the analysis of the aligned region of PAN and PJ respectively. The image 
was obtained from a screenshot of a 10-sec high-speed video recording, 
and the average data was obtained with DSA for the 10sec video.    
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Table 3. 7:  Aligned fibre contact angle data based on electrospinning 
parameters 
Polymer 
Flow 
rate 
Total  
volume 
Random 
region 
Aligned region 
PAN 1ml / hr 2.5 ml 110.8° 130.2° 
PJ 1ml / hr 2.5 ml 0° 14.2° 
3.2.4.2.3 Scaffold thickness measurement 
Similar to the random design the thickness of the aligned fibre membrane 
was analysed using OCT. The total thickness of the scaffold sandwiched 
between two polyester sheets was measured using the OCT. Three 
randomly chosen scaffolds were tested for thickness in both dry and wet 
state as described in section 2.2.3.3. Each region of the aligned fibre 
design was measured separately. The rectangles on either side were 
carefully cut, and the OCT was performed on both rectangles and the 
ellipse region of the design. The thickness was measured using image J 
software at three different locations as shown in Figure 3. 13. For PAN 
fibre the thickness of the two rectangular random areas was 33.5µm and 
34.2µm. The average thickness of the aligned area was measured to be 
at 26.7µm. Both PAN and PJ fibres showed similar thickness in the 
membrane when spun at 1ml/hour rate with a total deposition of 2.5ml.    
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Figure 3. 13: OCT measurement for aligned PAN fibre scaffold. 
Image A and C show the random region of the aligned fibre design and 
image B shows the aligned region of the design. Each area was 
individually measured under OCT and analysed individually. The area 
between the arrows indicates the suspended fibre.  The arrows represent 
the point of measurement for each scaffold using image J software. 
 
Table 3. 8: Random Scaffold thickness based on electrospinning 
parameters 
Polymer Flow rate 
Total 
volume 
Membrane thickness  
Random 
region 
Aligned 
region 
Random 
region 
PAN 1ml / hr 2.5 ml 33.5 µm 26.7 µm 34.2 µm 
PJ 1ml / hr 2.5 ml 32.6 µm 26.2 µm 32.9 µm 
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3.2.4.3 Radial Nanofibre 
The radial nanofibres were achieved by a two-sheet design made based 
on similar principle as the aligned fibre design. Two sheets made as 
described in section 2.2.1.3 were ultrasonically welded and wrapped 
around the collector drum. The radial fibre design is an innovative model 
that holds a random fibre at the peripheral area with radially aligned fibre 
travelling to the centre forming into a region of random fibre at the 
epicentre. Both PAN and PJ polymers were electrospun on the radial fibre 
design using the standard parameters used with every other design in 
this study. Post spinning the sheet was carefully removed from the 
collector and secured with an identical top sheet; then the base sheet 
was detached carefully. The design was laser cut to well plate size and 
was examined using a Phenom ProX SEM.   
3.2.4.3.1 FibreMetric analysis  
Multiple samples were chosen and sputter coated with 10nm gold for SEM 
analysis. The samples were analysed the radial formation using a light 
microscope and SEM analysis (Figure 3. 14). Similar to the aligned fibre 
design, the radial fibre design also consists of regions with different 
orientation of fibres.  The outer and centre region hold random fibres, 
and the space between the two had radial fibre formation. Diameter and 
pore size was measured for both regions. The diameter of fibres in the 
random region was measured at 458nm ± 170nm, and the radial region 
had a fibre diameter of 245nm ± 68 nm and bother regions had variable 
pore size.      
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Figure 3. 14: SEM and FibreMetric analysis for PAN radial fibres. 
In this panel, image A and B shows a light microscope image of the 
scaffold and C-H shows the different regions analysed under the SEM. 
The graph I shows the fibre diameter for radial region and Graph J shows 
fibre diameter for the random regions in the radial design. The regions at 
which the image and measurement were taken has been indicated 
accordingly on image A and B.  
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3.2.5 Nanofibre sterilisation  
Following the electrospinning of fibres and laser cutting the scaffolds, it 
was essential to sterilise the fibre scaffolds before introducing it to 
biological samples. The nanofibres were not manufactured in a sterile 
environment and may contain contaminants that can cause interference 
and fungal or bacterial contaminations when introduced to biological 
samples. Several techniques are available for nanofibre sterilisation, but 
each method of sterilisation can vary based on the material. It was 
essential to identify the most suitable method that does not compromise 
the properties and morphology of the fibres.  
3.2.5.1 Ethanol treatment 
Ethanol is a commonly used disinfectant that is very safe and effective to 
use. A 70% ethanol concentration is capable of killing single-celled 
organism as diluted alcohol causes coagulation of protein at a slower rate 
than absolute alcohol thus penetrating the cell before being blocked 
causing the entire cell to coagulate leading to the death of the cell. From 
each batch few scaffolds sample were soaked in 70% ethanol for 30 
minutes, 8 hours and 24 hours then tested for the presence of any 
microbes in an agar plate for 14 days as described in section 2.2.3.4. Few 
fibres were soaked under same conditions then washed in sterile distilled 
water and were investigated for any changes in the physical and 
morphological properties using SEM, FibreMetric analysis, contact angle 
and OCT. No Microbial growth was observed for 14 days at all three-time 
points but samples exposed for more than 30 minutes showed surface 
damage like a crack in fibre surface, brittleness, rough and a substantial 
increase in the fibre diameter.  Similar results were observed on both 
PAN (Figure 3. 15) and PJ (Figure 3.16) fibre scaffolds.  
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3.2.5.2 Ultra-violet treatment 
UV is another commonly used method of sterilisation source that is widely 
used to disinfect materials and surfaces. A UV light box with a wavelength 
of 256 nm peak output (figure 3.17) was used to investigate the UV 
sterilisation of nanofibres. The fibre scaffolds were exposed for 30min, 8 
hours and 24 hours and the further tested for microbial growth on agar 
TCP for 14 days as described in section 2.2.3.4.  Few samples were 
exposed under the same conditions and analysed for damage and any 
changes in the physical properties.  Fungal and bacterial contamination 
was observed on 30-minute exposure and 8-hour exposure for both PAN 
(figure 3.18) and PJ (figure 3.19) scaffolds. Reduction in nanofibre 
diameter was observed on both PAN and PJ when exposed over 30 
minutes, and DSA analysis demonstrated PAN samples exposed for 8 
hours and 24 hours have transformed from hydrophobic to hydrophilic. 
 
Figure 3. 17: UV Sterilisation box wavelength measurement.  
The wavelength was measured using an Ocean Optics spectrometer 
USB2000 with Ocean Optics Spectra suit.   
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3.2.5.3 Antibiotic treatment 
Antibiotics are commonly used in cell culture media to prevent any 
microbial growth. Penicillin or streptomycin for antibacterial and 
amphotericin B for antifungal were used to treat nanofibres. Both 
antibiotics were mixed in a 50:50 ratio and the scaffolds were soaked for 
30 minutes, 8 hours and 24 hours. After the incubation period, the fibres 
were tested for any contamination as described in section 2.2.3.4.  
Simultaneously, few samples were exposed under the same conditions 
and analysed for any damage or change in physical properties caused 
due to the antibiotics. When the samples were analysed under SEM, 
residues from the antibiotics were seen trapped between the fibres 
causing damage and reduced pore size. Scaffolds treated for 24 hours 
were severely damaged and not suitable for further high magnification 
investigation, fibre diameter or contact angle investigations. The 24 hours 
exposed fibres were very brittle and broke at the slightest disturbance.  
Scaffolds treated for 30 minutes and 8 hours had bacterial contamination 
from the 7th and 9th day respectively (figure 3.20). No changes in the 
surface property were observed on both PAN and PJ scaffolds when 
treated for a short period.   
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3.3 Discussion 
First and foremost a significant part of the study was to create a robust 
fabrication process capable of producing sufficient high quality 
biocompatible suspended nanofibre scaffolds.  As explained in the 
methods section 2.2.1, the design was laid out using AutoCAD, and DXF 
file formats were used to trepan a laser beam to cut out features on 
polyester sheets. With optimised laser settings precise apertures with 
sharp, well-defined edges were produced. Parameters including the focal 
distance, speed, and power altered the quality of the apertures drastically. 
Non optimised settings resulted in excessive melt back, burning, non-
continuous cuts, substrate warping and dimensional changes of the 
design (Figure 3. 1 C-J). It was essential to use the optimised laser 
parameters for all the nanofibre scaffold inserts used in the project 
because of this sharp edge with less than 1% variation from the required 
dimensions (Figure 3. 1 A and B). Biomaterial scaffolds can support and 
provide a suitable habitat for the cells to attach, proliferate and 
differentiate (Chan, B. and Leong 2008). In this study, PAN, a synthetic 
resin, was chosen for synthesising nanofibre scaffolds based on their 
beneficial structural properties reported from its various applications.  
Jeffamine® is a synthetic molecule containing terminal amine groups at 
the end of a polyethene oxide polymer. This was mixed with PAN and 
DMF to produce PAN/Jeffamine® nanofibres. PAN is a commonly known 
polymer and used in many applications in different industries. Up to the 
late 90s, PAN was used for many medical and clinical purposes (Shiono 
and Usukura 1994; Okrongly, Lamons and Okarma 1994). Several recent 
investigations have also demonstrated the use of PAN in medical 
industries for blood separation and to manufacture nanocomposite 
composite for electrical conductivity (Kizildag, Ucar and Onen 2018; 
Ushiro, Takahashi and Ueno 2018). Whereas Jeffamine® range of 
additives is used to introduce amine groups to change the surface 
properties of polymers.  Recently Jeffamine® has also been used for 
several other biological applications including the creating quantum dots 
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for immunoassays and to produce hydrogel to support in vitro cell growth 
(Zimmermann, Bittner, Stark, et al. 2002; Speranskaya, Beloglazova, 
Lenain, et al. 2014). 
Both PAN and PJ polymers were widely used in this study to make 
suspended nanofibre scaffolds well plate inserts.  The polymers were 
electrospun on a pre-cut design to achieve random fibres, aligned fibres 
and radial fibres.  Each fibre orientation has its properties and unique 
applications. The Scaffolds were produced with our in-house built 
electrospinning system, which uses a blunt-end needle and a rotating 
collector within a controlled humidity chamber housed in a temperature 
controlled room maintained at 65% relative humidity and 21°C 
respectively (Figure 3. 5). Before electrospinning PAN and PJ, the 
polymers was tested for viscosity using the HAAKE™ CaBER™ 1 Capillary 
Breakup Extensional Rheometer. The extensional Rheometer 
measurements clearly showed that both PAN and PJ had a similar range 
of viscosity with an identical strain diameter and a slight difference in the 
breakup time (Figure 3. 3). This has clearly shown that the addition of a 
5wt% of Jeffamine® to PAN has only caused a minor change in the 
viscosity of PAN. The polymers were capable of free flow when pumped 
at 1ml/hour rate in a PTFE deliver tube, and the fibres were obtained at 
21kv for PAN and 18kv for PJ. A complex interplay of surface, rheology, 
shapes and electrical charges is the root for electrospinning.  A 
combination of these factors interacts in multiples ways creating 
electrified jets for causing the polymer solution to stretch and form into 
nanofibres. When an electrical potential of the surface is increased to a 
sufficient value, the electrical forces act in opposition to and dominate 
the surface tension of the fluid causing the jet of the fluid to eject 
(Reneker and Yarin 2008).  Another critical factor is the flow rate during 
the spinning.  Unoptimised flow rate causes beaded fibre and thicker 
diameter and short drying time before landing the collator causing 
polymer splash.  Each polymer requires an optimised flow rate based on 
the polymer properties and the type of fibre required. Other team 
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members investigated several flow rates, and both PAN and PJ were 
optimised and spun at 1ml/hour flow rate throughout the study.   
Random fibres were made using an array of 1cm circle design on a 
600X300mm polyester sheet as described in section 2.2.1.1. Using the 
design randomly woven nanofibres were achieved with an average fibre 
diameter ranging between 500-600nm for both PAN and PJ fibres with a 
pore size of 0.50µm2-0.60µm2. Fibre Diameter and the architecture of the 
surface can influence the growth of cells. A study by Chen, et al. in 2009 
demonstrated that 3T3 fibroblast was able to attach and proliferate better 
on a 428nm diameter nanofibre scaffold than larger diameter fibres up to 
1- 1.5µm. The proliferation of cells was very slow on thicker fibres 
compared to the smaller fibres (Chen, M., Patra, Warner, et al. 2007). 
Another study also explained that fibres with a diameter of 1.1µm showed 
no significant advantage for human adipose-derived stem cells regarding 
attachment and proliferation (Tuin, Pourdeyhimi and Loboa 2016). 
However, numerous studies have suggested the benefits of smaller fibre 
diameter when it is maintained below 1µm (Sisson, Zhang, Farach‐Carson, 
et al. 2010; Noriega, Hasanova, Schneider, et al. 2012).  
The water contact angle measurement techniques used in this study was 
developed inhouse by Dr Andrew Edwards from the physics department 
at NTU, UK. The techniques are performed using a high-speed camera 
and the software measured the disperse of the water droplet using a 
defined MATLAB code. The first critical evaluation of liquid droplet 
interactions with fibres was conducted by Cassie and Baxter (Cassie and 
Baxter 1944). The cassie-Baxter equation in describing a liquid droplet 
wetting contact angle θCB on a fibrous network containing pores was using 
cosθCB= ƒ1 cosθY- ƒ2: where θY is the Young contact angle of liquid on a 
fibre, ƒ1 is the total solid-liquid interfacial area and ƒ2 is the liquid-air 
interfacial area at the contact plane with the liquid droplets (ƒ1+ ƒ2=1). 
As considered by Cassie-Baxter regime the regular porosity and random 
surface roughness creates air pockets when liquid is sitting on the surface 
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of a fibrous network. A macroscopic contact angle between an water 
droplet and the irregular electrospun nanofiber network, θmCB, can be 
defined from a meta-stable Cassie-Baxter consideration with a formula of 
cos=
R(π‐θ) 
d + R
COSθnano +
R 
𝑑+𝑅
 𝑠𝑖𝑛𝜃𝑛𝑎𝑛𝑜 − 1  where R is the nanofibre radius 
and d is the distance between two adjacent fibre. Our water contact angle 
study showed that PAN is hydrophobic, and PJ is hydrophilic. In depth 
investigation is required to understand the software developed by Dr 
Andrew and to validate the obtained contact angle values in this study.  
But several studies have confirmed the hydrophobicity properties of PAN 
as hydrophobic and Jeffamine® as hydrophilic (Kobayashi, Nagai, Wang, 
et al. 1996; Krakovský, Pleštil and Almásy 2006; Alarifi, Alharbi, Khan, 
et al. 2015). Studies have also shown PAN is a suitable polymer for 
surface modification and by adding 5wt% Jeffamine® to 10 wt% PAN 
converted the surface of PAN fibres to hydrophilic nature (Jung 2004; 
Shen, Li, Jiang, et al. 2009).  
OCT is a technique commonly used for measuring the internal structure 
of the biological tissue, especially used in ophthalmology to measure the 
retina.  It can also be used as a quality control tool for measuring the 
thickness of tissue scaffolds prior to cell culture (Vizzeri, Weinreb, 
Gonzalez-Garcia, et al. 2009; Zotter, Pircher, Götzinger, et al. 2013). 
Using our in-house built OCT setup, we were able to identify an average 
non-woven nanofibre membrane thickness of 33.5µm and 30µm for PAN 
and PJ respectively (Figure 3. 9). Increase in the total volume of 
deposition leads to an increase in the thickness of the membrane. 
The aligned and radial nanofibre scaffolds are of a unique design requiring 
careful construction and fabrication. Scaffold inserts produce using the 
patent-pending method can include multiple fibre orientations in a single 
scaffold insert. Over the years, several methods have been used to 
produce aligned fibres. Some methods include coating nanofibre over two 
sharp and parallel knife edges  (Theron, Zussman and Yarin 2001), 
coating finer onto plastic film on a high speed rotating drum (Sundaray, 
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Subramanian, Natarajan, et al. 2004), coating multiple parallel copper 
wire drum  collector (Katta, Alessandro, Ramsier, et al. 2004), dual 
vertical wire collector (Chuangchote and Supaphol 2006), rotating jet 
(Khamforoush and Mahjob 2011), inclined gap collector (Park, Suk Hee 
and Yang 2011). The most current and commonly used techniques are 
the high-speed rotation (Haider, Al-Zeghayer, Ali, et al. 2013). All the 
available techniques have significant drawbacks such as high cost, 
significant modifications, the risk of injury, unhandleable end products, 
inconsistent and not suitable for cell-based studies. The invented and 
adopted technique only requires constructing a design as described in 
section 2.2.1.2 and does not require the use of high-speed drums or any 
other modification within an electrospinning system.  
The random fibre region had an average diameter and pore size of 570nm 
and 0.57µm2 respectively. The aligned region had fibres with lesser 
diameter and pore size, which was measured to be at an average of 
424nm and 0.22µm2 receptively. The electrostatic field which develops 
between two rectangular regions forces a charged fibre over one region 
to travel and stretch to reach the opposite region which is instantaneously 
at a lower potential. The stretching of the fibres creating aligned fibre 
scaffolds with reduced nanofibre diameter, reduced membrane thickness 
and pore size when compare to non-woven fibre regions. The rectangular 
part of the design is wholly exposed to the conducting surface. As there 
are two low potential surfaces on either side of the ellipse, the 
electrostatically charged nanofibre is drawn to one on the rectangles 
where it forms a bridge of nanofibre, which spans the rectangular hole.  
Because the bridge acts to prevent the nanofibre from reaching the 
surface of the low potential drum, an electrostatic charge starts to build 
up.  At the moment when the charge build is sufficient to repel or re-
direct the nanofibre, the nanofibre moves to the next nearest lowest 
potential region which is the other rectangle associated within the unit.  
The nanofibre takes the shortest path and creates a fibre, which is 
orthogonal to the major axis of the ellipse. This process continues for all 
CHAPTER III            NANOFIBRE FABRICATION AND ANALYSIS 
125 
 
units.  Both areas in the sheet with aligned and random fibres are 
suspended and can be accessed from both sides. The hydrophobicity data 
showed a contact angle of 130.2° for the aligned region of PAN, which 
was close to superhydrophobic a contact angle measured above 150° is 
considered as a superhydrophobic surface, and the study suggests that 
aligned PAN fibred can be superhydrophobic and can produce a contact 
angle of 170° (Feng, Li, Li, et al. 2002). This phenomenon may have 
caused due to the thin fibres and smaller pore size compared to the 
random region whereas PJ fibre had no changes observed in the 
hydrophobicity. Both regions of the design remained hydrophilic in PJ 
scaffolds, but the wetting rate was comparatively higher on aligned fibre 
that random fibres.  
Similar to the aligned fibres radial fibre was designed using the same 
design principles. The fibre diameter in the radial region was measured 
to be at an average of 250nm-350nm and in the random region was 
measured to be at 450nm-600nm. Further investigations were not carried 
out as the current model as it is still under investigations and remodelling 
to produce a fully bioactive radial fibre suitable be for a retinal study. 
Minimal literature on models to create radial fibre are available. A study 
by Jingwei Xie, et al. 2010 showed the application of radial fibred for a 
wound healing and tissue regeneration application. The study used a 
pointed electrode surrounded by a ring electrode as a collector. The study 
has mentioned that the fibres were collected on a piece of aluminium foil 
but did not clearly explain how the fibres were transferred from the foil 
to a suitable scaffold based model for culturing cells (Xie, J., MacEwan, 
Ray, et al. 2010). Another very recent study by Jeong In Kim, et al. 2018 
from Chonbuk National University created a model by modifying the 
collector with copper wire and metal pins creating a contact lens shaped 
fibre scaffold for retinal study. The study was performed using cells 
extracted from the whole eye of a rabbit and did not clearly explain the 
handling and transfer of the scaffold to a fully functional cell culture 
system (Kim, J. I., Kim and Park 2018). All the currently existing systems 
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require modification of the electrospinning procedure and do not allow an 
easy handling or a practical method to use the manufactured scaffolds.  
Our radial fibre scaffolds model were produced in large numbers (>200 
per deposition run) on polyester sheets that were converted into well 
plates inserts suitable for easy handling and multi-stacking for in vitro 
co-culture systems which mimic in vivo tissue thus presenting an 
opportunity to reduce unnecessary testing on animals.   
Sterilisation is an integral part of this study. Several techniques are 
currently available to sterilise nanofibres. Conventional techniques used 
are gamma treatment, autoclave, dry heat, vacuum, plasma treatment, 
ethanol, UV and electron beam treatments (Yixiang, Yong, Liao, et al. 
2008; Duszyer, Koral Koc, Hockenberger, et al. 2013; Dai, Ronholm, Tian, 
et al. 2016; Rediguieri, Sassonia, Dua, et al. 2016). Every method has 
its advantage and disadvantages. In this study, the fibres were tested 
with 70% ethanol, UV treatment and antibiotic treatment for three-time 
points. Fibres treated with 70% ethanol did not have any form of 
microbial growth when tested on agar plate, but fibres exposed over 30 
minutes in ethanol showed morphological, especially increase fibre 
diameter and cracking due to solvent absorption, as well as a reduction 
in pore size of the materials. Likewise, fibre treated with UV showed no 
contamination for fibres treated for 24 hours, but contamination was 
observed on agar plates on both 30 minute and 8-hour exposures. Fibres 
exposed for 8 hours and 24 hours demonstrated nanofibre degradation 
resulting in thinner fibres, increase in pore size and changes in the 
hydrophobicity of PAN to hydrophilic. When the fibres were soaked in the 
antibiotics, fungal and bacterial contamination was observed at 30 min, 
and 8-hour treatment and no contamination was observed when treated 
for 24 hours. When examined under SEM, fibres exposed for 8 hours had 
modified surfaces and breaks, with residues trapped in the pores. Fibres 
exposed for 24 hours were very brittle and completely damaged 
unsuitable for performing further tests.   
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Based on the results from each sterilisation techniques investigated, the 
study was performed using a combination of all the three techniques. The 
collector drum and the polyester sheets were wiped with 70% ethanol 
before depositions. A 60W UV-C lamp was added to the electrospinning 
system below the collator, and the fibres were exposed to a 254nm peak 
output UV light as the fibre was spun and deposited on to the sheet. 
Before introducing the cells into scaffolds, the scaffolds were soaked in 
70% ethanol for 10 minutes, washed 2-3time in PBS to normalise the 
ethanol then pre-soaked in the cell culture media with antibiotics for 10 
minutes.  Following these series of steps has maintained an absolute 
sterile nanofibre through the study without any compromise in the 
nanofibre integrity or morphology.  
3.4 Conclusion    
In summary, this chapter has demonstrated the various steps involved in 
producing a functional nanofibre scaffold that can be used in the 
investigation of neural cell degeneration. The chapter has shown the 
importance of using optimised laser cutting parameters for producing 
sheets. The chapter has demonstrated three different designs to produce 
nanofibre scaffolds that can be used for a wide range of in vitro models. 
With the in-house built electrospinning system, designs were converted 
into individual, fully suspended, thin, 3D nanofibre scaffolds with either 
hydrophobic PAN or hydrophilic PJ fibres. The chapter has also shown the 
various parameters of each design including surface properties and 
membrane thickness measurements. From the investigation of 
sterilisation techniques, the chapter has demonstrated the importance of 
identifying a suitable sterilisation method which does not weaken or 
modify the desired physical or chemical properties of the scaffolds. Even 
though the chapter has shown three different models of nanofibre design, 
only the random fibre scaffold was used to create a cell model for neural 
cell degeneration.        
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Chapter 4: Immortalised cell line scaffold model 
4.1 Introduction 
Immortalised human neural cell lines are modified cells of brain origin 
(e.g. neurone and glia) from that are able to continuously proliferate and 
grow when provided with the necessary growth factors. There are several 
types of immortalised human cell lines, derived primarily from primary 
and secondary tumours or from stem cells. Human cell lines are essential 
tools in research and are widely used as a model to study several complex 
biological systems and disease processes (Kaur and Dufour 2012). 
Immortalised human cells lines are often used in research in place of 
primary cells with several advantages, including cost-effectiveness, 
availability, accessibility, and to avoid potential ethical concerns (Kaur 
and Dufour 2012). Vaccine production, testing drug metabolism and 
cytotoxicity, antibody production, the study of gene function, generation 
of artificial tissues and synthesis of biological compounds and therapeutic 
proteins are currently performed with immortalised human cell lines 
(Macdonald 1990; Gomez-Lechon, Donato, Castell, et al. 2003; Schurr, 
Foster, Centanni, et al. 2009).   
This part of the study has primarily focused on an immortalised SH-SY5Y 
human neuroblastoma and U-87 MG human glioblastoma cell line. Both 
SH-SY5Y and U-87MG cell line are widely used to investigate neural cell-
related studies. Several studies have shown SH-SY5Y cells are capable of 
differentiating into matured neurons (Avola, Graziano, Pannuzzo, et al. 
2018; Sang, Liu, Wang, et al. 2018) also, U-87MG can be induced to 
differentiate into astrocytes (Xing, F., Luan, Cai, et al. 2017) thus making 
these two cell line very suitable an investigation related to neural 
characterisation for neurodegenerative disease on nanofibre scaffolds. 
The preliminary aim of this study was to develop a suitable nanofibre 
model to characterise and investigate neural cells degeneration. Due to 
the reason like cost-effectiveness, readily available and easy to culture 
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and maintain both SH-SY5Y and U87-MG cells were chosen to perform 
preliminary investigations on PAN and PJ nanofibre scaffolds.     
4.1.1 SH-SY5Y Human Neuroblastoma 
SH-SY5Y cell line is a human-derived cell isolated from a metastatic bone 
tumour biopsy obtained from a four-year-old female with neuroblastoma. 
SH-SY5Y (ATCC® CRL-2266™) cells are a subline of the parental line SK-
N-SH (ATCC® HTB-11™) which were further subcloned three times; first 
to SH-SY, then to SH-SY5, and finally to SH-SY5Y. SH-SY5Y were 
deposited to the ATCC® in 1970 by June L. Biedler (Kovalevich and 
Langford 2013). SH-SY5Y cells are capable of expressing dopaminergic 
markers and have been used to investigate several neurodegenerative 
disorders such as amyotrophic lateral sclerosis, Parkinson's disease, 
Alzheimer's disease, Huntington's disease, neurogenesis and other brain 
cell characterisations. One of the major limiting factors for neurones 
derived from primary mammalian embryonic CNS tissues is that the cells 
can no longer be propagated once they terminally differentiate into 
mature neurons.  Transformed cells like SH-SY5Y neuronal-like cell line 
are commonly used in vitro studies to overcome this limitation.  
4.1.1.1 Undifferentiated and differentiated SH-SY5Y cells  
SH-SY5Y neuroblastoma cells are capable of possessing a more mature, 
neuron-like phenotype with modification of the cell culture medium; 
benefiting neuroscience research.  As the cells were derived from human, 
SH-SY5Y possesses various human-specific proteins and other 
components that may lack in the primary animal model.  Both 
undifferentiated and differentiated forms of these cells are used for in 
vitro studies. The choice is based on the type of study conducted. When 
differentiated, the cells demonstrate specific changes like the formation 
of neurite extensions, increases in electrophysiology activity, activated 
synapses that express synaptophysin and neuron-specific enzymes, 
neurotransmitter receptors (Påhlman, Ruusala, Abrahamsson, et al. 1984; 
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Adem, Mattsson, Nordberg, et al. 1987; Lopes, Fernanda Martins, 
Schröder, da Frota Júnior, Mário Luiz Conte, et al. 2010). Undifferentiated 
SH-SY5Y cells are characterised morphologically by neuroblastoma-like, 
non-polarized cell bodies with few, truncated processes (Kovalevich and 
Langford 2013). The undifferentiated cells lack mature neuronal markers 
and proliferate continuously and also classed as catecholaminergic 
neurons (Påhlman, Ruusala, Abrahamsson, et al. 1984; Xie, H., Hu and 
Li 2010).  Depending on the method of differentiation, mature cells can 
produce neurite extensions and become distinctly polarised.  Several 
methods exist for SH-SY5Y differentiation. One of the most common 
methods is by adding retinoic acid (RA) to the cell culture media. The 
retinoic acid treatment has been shown to promote survival of SH-SY5Y 
cells through activation of the phosphatidylinositol 3-kinase/Akt signalling 
pathway and upregulation of the antiapoptotic Bcl-2 protein (Itano, Ito, 
Uehara, et al. 1996; Lopez-Carballo, Moreno, Masia, et al. 2002). A study 
has also demonstrated that SH-SY5Y cells differentiated with RA had 
higher viability than undifferentiated cells when exposed to toxin-
mediated cell death induced by 6-OHDA, MPTP, or its metabolite MPP+ 
(Cheung, Lau, Yu, et al. 2009). Other commonly used differentiating 
agents include dibutyryl cyclic AMP (dbcAMP) that increases intracellular 
cyclic AMP levels a promoting gene expression leading to differentiation 
(Sanchez, Jimenez, Carrera, et al. 2004). Indeed, SH-SY5Y cells treated 
with dbcAMP promoted neurite extensions and high expression of GAP 43; 
a mature protein associated axonal processes (Kume, Kawato, Osakada, 
et al. 2008). Further studies have also shown that dbcAMP treatment also 
leads to a significant increase in tyrosine hydroxylase (TH) 
immunoreactivity and the cellular content of noradrenaline in a protein 
kinase A (PKA)-dependent manner (Itano, Ito, Uehara, et al. 1996; Kume, 
Kawato, Osakada, et al. 2008). According to these studies, both dbcAMP 
and RA differentiated SH-SY5Y cells showed similar morphological 
phenotypes. A few studies have also shown that B27 supplementation 
can influence SH-SY5Y differentiation (Kovalevich and Langford 2013). 
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B27 supplement is used as a part of primary neuronal cultures to support 
the low- or high-density growth and short- or long-term viability. These 
studies have shown SH-SY5Y cells were able to produce long neurite 
extensions and also showed high expression of some differentiation 
markers when supplemented with B27 (Sayas, Moreno-Flores, Avila, et 
al. 1999; Mathiasen, McKenna, Saporito, et al. 2004).   
4.1.1.2 Markers of Differentiation 
Several studies suggest different methods of differentiation. 
Undifferentiated SH-SY5Y cells can be characterised based on markers of 
proliferation like the proliferating cell nuclear antigen (PCNA) or with 
immature neuronal protein markers such as nestin and morphologically 
resembling immature catecholaminergic neurons (Cuende, Moreno, 
Bolanos, et al. 2008; Lopes, Fernanda Martins, Schröder, da Frota Júnior, 
Mário Luiz Conte, et al. 2010). A significant decrease in differentiation-
inhibiting basic helix-loop-helix transcription factors ID1, ID2, and ID3 
are observed when these cells are differentiated with RA (Lopez-Carballo, 
Moreno, Masia, et al. 2002). When differentiated, SH-SY5Y cells express 
several mature neuronal protein markers including βIII-tubulin, 
microtubule-associated protein-2 (MAP2), synaptophysin, NeuN, synaptic 
associated protein-97 (SAP-97), neurofilament heavy chain (NHC) and 
neuron-specific enolase (NSE). Studies have also shown the increased 
expression of differentiation-promoting genes NEUROD6 and NEUROD1 
when treated with differentiating agents (Lopez-Carballo, Moreno, Masia, 
et al. 2002).   
4.1.2 U-87 MG Human Glioblastoma  
U-87 MG human glioblastoma is a commonly used cell line for brain 
cancer research and some neurological disorders. Uppsala 87 Malignant 
Glioma (U-87 MG) consists of an epithelial morphology which was first 
obtained in 1966 from a 44-year-old female patient at Uppsala University 
(Allen, Bjerke, Edlund, et al. 2016).  Initially, the cell line was handed 
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over to the Memorial Sloan Kettering Cancer Centre in 1973, and in 1982 
it was obtained by ATCC. U-87MG cells have been used for several studies 
like a neurodegenerative disease, and other CNS related disease. A recent 
study on destabilising drug Siramesine on glioblastoma has U-87MG cell 
as one of the glioblastoma models to understand the effect of the drug 
(Jensen, Petterson, Halle, et al. 2017). Several other studies have shown 
that U-87MG is a good cell line to perform co-culture models with SH-
SY5Y cells. A study published in 2015 has shown that Glial U87 cells 
protect neuronal SH-SY5Y cells from the indirect effect of radiation by 
reducing oxidative stress and apoptosis in a co-culture system (Saeed, 
Xie, Xu, et al. 2015). Moreover, another study has shown Sal-treated co-
cultures of SH-SY5Y and U-87 MG cells induced remarkable proliferation 
of THP-1 cells in a U87 glial cell-dependent manner (Wang, F., Ni, Wang, 
et al. 2015). Though a study published in 2016 found that the U-87MG 
used from the ATCC was identified to be non-identical to its original Short 
Tandem Repeat STR (Allen, Bjerke, Edlund, et al. 2016) still several valid 
and publishable studies are still performed using U-87MG cells and is a 
great candidate for investigating the neurodegenerative disease.   
4.1.2.1 Differentiated U-87 MG Cells 
Glial cells are an essential part of the brain. They are the supportive cells 
in the CNS (Jessen and Mirsky 1980).  Unlike neurons, they do not 
conduct electrical impulses, but instead, they are found between and 
around neurones providing neurotrophic support and physiological 
insulation (Wolosker, Dumin, Balan, et al. 2008). Oligodendrocytes, 
astrocytes, ependymal cells, Schwann cells, microglia, and satellite cells 
are the different types of glial cells. Human U-87 MG glioblastoma cell 
line is one of the commonly used cells for studies related to glial cells, 
and they can differentiate to glial subtypes. Studies have demonstrated 
that RA and dbcAMP can be used to differentiate U-87 MG cells to 
astrocytes (Shi, Z., Lou, Zhao, et al. 2013; Xing, F., Luan, Cai, et al. 
2017). In this study, we have used dbcAMP as one of the differentiating 
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agents to transform U-87 MG to a more astrocytic phenotype.  Cyclic AMP 
plays an important role in regulating cell growth, metabolic pathway 
signals and the cell cycle (Stork and Schmitt 2002). Studies have shown 
that cAMP activation results in a decrease in proliferation, reduced growth 
of xenografted brain tumours (Yang, Jackson, Woerner, et al. 2007; 
Goldhoff, Warrington, Limbrick, et al. 2008) and expression of   glial 
fibrillary acidic protein (GFAP); an intermediate filament protein that is 
found highly expressed in astrocytes (Jacque, Vinner, Kujas, et al. 1978; 
Venkatesh, Srikanth, Vengamma, et al. 2013). This also leads to stellate-
like cell structures that resemble astrocytes in vivo. Studies have shown 
that GFAP is expressed in U-87MG cells and it is upregulated when 
differentiated to a more astrocytic-like phenotype using RA or dbcAMP 
(Das, Karmakar, Patel, et al. 2005; Restrepo, Smith, Agnihotri, et al. 
2010; Xing, F., Luan, Cai, et al. 2017). In this study we proposed 
astrocytic differentiation of U-87MG cells using conventional approaches 
but also explored the use of B27 supplementation.    
4.2 Content of this chapter  
In this chapter, we have demonstrated the use of PAN and PJ nanofibre 
scaffolds to harbour SH-SY5Y cells and U-87MG cells. We have shown the 
morphological changes when cultured on different models and surfaces 
of nanofibre scaffolds. The cells were investigated for a long period of 
survival, therefore, making it suitable for chronic studies. To demonstrate 
the prolong survival, we have investigated a proliferation viability study. 
The chapter also describes the outcome of multiple differentiating agents 
when exposed to both SH-SY5Y and U-87 MG cells cultured on both tissue 
culture surface and nanofibre scaffolds. The structural changes and 
protein expression for both cells when cultured on fibres have been 
thoroughly studied and compared with cell-cultured on 2D surfaces. 
Several microscopy techniques and protein detection analysis have been 
shown in this chapter as evidence for cell attachment, proliferation and 
differentiation.  The chapter also demonstrates the effect of inhibitor that 
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is capable of mimicking neural cell degeneration pathophysiology on both 
cell type and the effect has been compared in cells cultured on the 2D 
surface and nanofibre scaffolds.  Co-culture system using nanofibre 
scaffold was developed to identify suitable endpoint parameters of 
relevance to neuronal and glial function, differentiation and survival that 
can be monitored within the 3D setup.  
4.3 Results 
4.3.1 Culturing and subculturing  
Cells obtained from ATCC were stored in liquid nitrogen and revived when 
needed. Revived cells were cultured, harvested, bulked and preserved in 
liquid nitrogen for future use. Both SH-SY5Y and U-87MG cells were 
maintained under 30 passages. Upon reaching 30 passages, a new batch 
of cells was revived and cultured for experiments. Every new batch of 
cells was routinely examined with immunofluorescence imaging stained 
for neurofilament for SH-SY5Y and GFAP for U-87MG to ensure there has 
not been a mix-up or cross-contamination of cells. Both undifferentiated 
SH-SY5Y and U-87 MG cell showed a low expression of neurofilament 
(Figure 4. 1 C) and GFAP (Figure 4. 1 D), respectively.    
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Figure 4. 1: SH-SY5Y and U-87MG microscope image.  
(A and C) Represents SH-SY5Y human neuroblastoma and (B and D) 
Represents U-87MG human glioblastoma cell line. Both cells were 
monitored for morphological changes under a light microscope and with 
immunofluorescence regularly.     
4.3.2 Cell culture on nanofibres scaffolds 
Cells were cultured in tissue culture flasks, and upon reaching 80-90% 
confluency, the cells were trypsinised and seeded on to nanofibres as 
explained in section 2.2.5. Before cell seeding, the fibres were ethanol 
sterilised as described in section 2.2.5.1. 50,000 cells/well were seeded 
in each well with nanofibre scaffolds and incubated at 37°C in a 
humidified atmosphere of 95% (v/v) air and 5% (v/v) CO2.    
4.3.2.1 Unsuspended random nanofibre   
Initially, the nanofibre scaffolds were obtained on an A1 size plain 
polyester sheets with no designs. The fibres were manufactured using 
electrospinning, as explained in section 2.2.3. Once the fibres were 
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deposited the sheets were cut into square shapes (10 mm X 10 mm) to 
fit into a 6 or a 12 well plate as shown in Figure 4. 2. The fibres were 
sterilised with 70% ethanol and placed into each well. Both SH-SY5Y and 
U-87MG cells were harvested and individually seeded into wells 
containing the nanofibre sheets. The TCP was then incubated at 37°C in 
a humidified atmosphere of 95% air and 5% CO2 for 48 hours  
 
Figure 4. 2: Unsuspended nanofibre on a polyester sheet.  
A1 size polyester sheet wrapped around the collector drum to obtain fibre. 
Nanofibre sheets were manually cut with scissors to fit in a 6 or a 12 well 
plate for cell culture 
Following 48 hours of incubation, cells were stained with Coomassie. The 
fibres were moved to a fresh plate, and both fibres and the TCP were 
examined with light microscopy. It was observed that a number of cells 
accumulated on the edges of the fibre sheet and lose fibre end (Figure 4. 
3). Inferior cell attachment was observed at the centre of the fibre sheets. 
More viable cells were found on the surface of the plate compared to the 
fibre sheets. 
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Figure 4. 3: Coomassie blue staining of cells cultured on 
unsuspended fibres.  
Both SH-SY5Y and U-87MG cells were cultured on PAN and PJ 
unsuspended nanofibre sheets. The cells were incubated for 48 hours and 
stained using Coomassie blue stain. A high number of cells were found 
attached to the edges (white arrows) plate and loose fibre (black arrows). 
The images were obtained using a light microscope. 
4.3.2.2 Suspended random nanofibres scaffolds 
As explained in section 2.2.1.1 random nanofibre scaffold designs were 
engineered on a 600 X 300mm polyester sheet with an array of 1cm 
circles cut throughout the sheet. Both PAN and PJ fibres were electrospun 
onto the sheet which was further secured by another identical top sheet. 
Each scaffold was cut to fit into a 12 well plate and sterilised with 70% 
ethanol as described in section 2.2.3.4. The fibres were transferred to a 
12 well plate after sterilisation.  
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Figure 4. 4: Coomassie blue staining of cells cultured on random 
nanofibre scaffolds.  
Both SH-SY5Y and U-87MG cells were cultured on PAN and PJ fibres 
electrospun on a random fibre design. The cells were incubated for 48 
hours and stained using Coomassie blue stain. A high number of cells 
were found attached to the fibre than the plate. The images were 
obtained using a light microscope.   
Both SH-SY5Y and U-87MG cells were maintained in T25 flasks prior to 
seeding onto random nanofibre scaffolds. Cells were seeded at 50,000 
cells/well and incubated at 37°C in a humidified atmosphere for 48 hours. 
Following incubation, the fibres were transferred to a fresh plate, and 
both the original plate and the fibres were stained for total protein with 
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Coomassie blue for visualisation (Figure 4. 4). When observed under light 
microscopy, it was evident that a large number of cells were found 
attached to fibres compared to the plate and the fibres remained 
completely intact.      
4.3.2.3 Aligned nanofibre scaffolds  
Preliminary cell attachment investigation was performed on the aligned 
nanofibre design. Both PAN and PJ fibres were used to make aligned fibres 
using the design explained in section 2.2.1.2. Both SH-SY5Y and U-87MG 
cells were investigated for cell attachment on aligned fibres. Cells were 
seeded at 50,000cells/well in each well and incubated at 37°C in a 
humidified atmosphere for 48 hours. Following incubation, the fibres were 
transferred into a fresh plate, and both the original plate and the fibres 
in the fresh plate was stained with Coomassie blue (Figure 4. 5). When 
compared with the random fibre design and plate, both SH-SY5Y and U-
87MG cells exhibited attachment and growth that allied with the fibre 
design pattern. The cells grew along the fibre in a uniform direction with 
cells aligned with the fibre direction.  
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Figure 4. 5: Coomassie blue staining of cells cultured on aligned 
nanofibre scaffolds.  
Both SH-SY5Y and U-87 MG cells were cultured on the aligned fibres. The 
cells were incubated for 48 hours and stained using Coomassie blue stain. 
The orientation of the cells seeded on the aligned fibre was very different 
from random fibre or the plate. The aligned fibres provided guidance for 
the cells to grow along the fibre. 
4.3.3 Cytoskeletal staining and SEM analysis 
Investigating morphological characteristics of cells cultured on fibres was 
essential. To achieve this, cells were dehydrated as described in 2.2.9.3 
and examined in high magnification using an SEM (Figure 4. 7) and also 
stained for a cytoskeletal protein; α-tubulin as described in section 
2.2.9.2. Immunofluorescently stained fibres were mounted on a glass 
slide with anti-fade mountant vectorshield containing DAPI and imaged 
with immunofluorescence microscopy (Figure 4. 6).       
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Figure 4. 6: Cytoskeletal protein stain to show cell attachment on 
nanofibre.  
The cells were cultured for 48 hours, fixed and stained for α-tubulin. The 
images were obtained using an Olympus immunofluorescence microscope. 
Red fluorescence - α-tubulin, cytoskeletal stain, blue fluorescence - DAPI 
nuclei stain and green fluorescence - autofluorescence from the fibre. 
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Figure 4. 7: SEM imaging showing cell attachment on nanofibre. 
The cells were cultured for 48 hours, fixed and dehydrated for SEM 
imaging. The cells were found wrapped and grown within the fibres. The 
images were obtained using the Phenom desktop SEM.    
4.3.4 Cell attachment and growth 
In order, to investigate the level of cell attachment, growth and survival 
of both neuronal and glial cells on both PAN and PJ fibres, an assay that 
measured cell metabolic activity/proliferation was used. It was vital to 
understand the longevity of both cell types on the fibres.  The experiment 
was set up as explained in section 2.2.7, and the ability of the cells to 
survive on fibres compared to the plate was studied by analysing cell 
metabolic activity/viability using the MTT reduction assay on both fibres 
and plate. Cells were cultured for 11 days on both plastic and fibres with 
viability assessed every 48 hours.  
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Figure 4. 8: SH-SY5Y proliferation on PAN, PJ fibres and plate. 
Panel (A) represents cell cultured on PAN compared to the plate and (B) 
represents PJ compared to the plate. Obtained values were converted to 
percentage setting control (day1) values to 100% (not shown). Results 
are expressed at the mean ratio ± SEM n=6 *P<0.005 against plate vs 
fibre determined by two-tailed Student-T test and Two-Way ANOVA with 
Sidak’s multiple comparisons tests.       
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Figure 4. 9: U-87 MG proliferation on PAN, PJ fibres and plate. 
Panel (A) represents cells cultured on PAN compared to the plate and (B) 
represents PJ compared to the plate. Cells on plate expressed a gradual 
increase in cell number and viability later started decreasing after day 7 
in both cases. Obtained values were converted to percentage setting 
control (day1) values to 100% (not shown). Results are expressed at the 
mean ratio ± SEM n=6 *P<0.005 against plate vs fibre determined by 
two-tailed Student-T test and Two-Way ANOVA with Sidak’s multiple 
comparisons tests.    
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The results show that SH-SY5Y cells were able to proliferate and survive 
longer on PAN fibre compared to PJ fibres while the rate of proliferation 
was reduced on fibres in comparison to culture plastic (Figure 4. 8).SH-
SY5Y showed a gradual increase in cell growth and survived throughout 
the 11days on PAN fibre but expressed a slower growth rate on PJ with a 
decrease in cell viability after day 7. Cells on plate expressed a gradual 
increase in cell number and viability later started decreasing after day 7 
in both cases.  In contrast, U-87 MG cells were able to proliferate and 
survive longer on PJ fibre (Figure 4. 9) compared to PAN fibre. U-87MG 
showed a steady survival until day 3 and gradually started to decline 
when cultured on PAN fibres but PJ high rate of proliferation was observed 
with continuous survival throughout 11days. Similarly, the rate of 
proliferation was reduced on the PJ fibre compared to TCP. It was noticed 
that cells grown on TCP entered the log phase from day 3 and remained 
in the stationary phase for day 5 and 7, and subsequently began to die 
from day 7. A similar profile was observed for both SH-SY5Y cells cultured 
on PJ and U-87MG on PAN. SH-SY5Y on PAN and U-87MG on PJ showed 
a steady increase and continued to proliferate for 11 days.     
4.3.5 Investigation of U-87MG growth in DMEM 
To create a co-culture model to investigate Toxins, the investigation of 
growth characteristics of both cell lines in the same media was necessary. 
As the recommended culture media was different for SH-SY5Y and U-87 
MG, it was essential to identify if both cells could be cultured with one 
media. U-87MG was cultured in both media (EMEM and DMEM/F12) 
separately, and changes in cell morphology were monitored with light 
microscopy.  
CHAPTER IV        IMMORTALISED CELL LINE SCAFFOLD MODEL 
146 
 
      
Figure 4. 10: U-87 MG cultured in DMEM media.  
Figure A and B represents a light microscope image of U-87MG cultured 
in EMEM and DMEM respectively. C represents the expression 
Neurofilament expressed by SY-SY5Y, GFAP expressed by U-87 MG 
cultured in both media and Albumin from the FBS present in the media. 
Figure D shows the doubling time of u-87MG cells when cultured in both 
EMEM and DMEM. Obtained values were converted to percentage setting 
control (day1) values to 100% (not shown). Results are expressed at the 
mean ratio ± SEM n=3 *P<0.005 against plate vs fibre determined by 
two-tailed Student-T test and Two-Way ANOVA with Sidak’s multiple 
comparisons tests.          
GFAP expression (an astrocytic protein marker) was assessed in cell 
cultured in DMEM or EMEM media. Protein cell lysates were prepared from 
cultured cells grown in respective media quantified using mini Lowry’s 
method as described in section 2.2.10.1.3. Protein (30 µg) was separated 
using SDS-PAGE, transferred to nitrocellulose and probed for GFAP as 
described in section 2.2.10.2. When observed under the light 
microscopes U-87 MG cells cultured in both EMEM and DMEM expressed 
similar morphology (figure 4.10 A and B) and doubling time (Figure 4.10 
D). The western blot analysis confirmed the expression of GFAP for cells 
cultured in both media (Figure 4.10 C). These tests confirmed that U-87 
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MG could be cultured in DMEM with no gross changes in properties of the 
cell line. Future experiments in the project were conducted using 
DMEM/F12 based media for both SH-SY5Y and U-87 MG cells.  
4.3.6 Cell differentiation 
To investigate cell differentiation of the two neural cell types, SH-SY5Y 
and U-87MG were grown in the presence of different differentiating 
agents for 5 days. For SH-SY5Y, cells were grown in serum-free media 
supplemented with retinoic acid (1 µM) or B27 supplement (1 % (v/v)). 
U-87MG cells were grown in serum-free medium supplemented with 
dbcAMP (0.3 mM) or B27 Supplement (1 % (v/v)). After 5 days of growth, 
the SH-SY5Y cells were examined for axon outgrowth and neurofilament-
H protein expression representing characteristics of a maturing neuronal 
phenotype.  U-87 MG cells were examined for stellate-like structures and 
GFAP protein expression representing characteristics of a maturing 
astrocyte phenotype.  Cells cultured on both plate and fibres were fixed, 
and the morphological changes were examined with light microscopy. 
Expression of neurofilament and GFAP was analysed with 
immunofluorescence confocal microscopy. The level of protein expression 
was analysed for cells differentiated on both plate and fibre using western 
blotting and densitometry analysis.     
4.3.6.1 Immunofluorescence staining of differentiation markers 
SH-SY5Y and U-87MG were cultured on both PAN and PJ fibres in the 
presence of differentiating agents for 5 days. The scaffolds were fixed 
using 90%methanol/TBS and stained for protein differentiation markers 
βIII tubulin (SH-SY5Y) and GFAP (U-87MG). Immunofluorescence images 
obtained from differentiating cells showed that neuronal SH-SY5Y cells 
were able to extend axons on PAN fibres which stained positive for βIII 
tubulin; a mature neuronal marker. Both RA and B27 supplementation 
showed similar results with extended βIII tubulin-positive axons 
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compared to the non-treated control (Figure 4.11). However, on PJ fibre 
SH-SY5Y cells struggled to grow and differentiate.  
 
Figure 4. 11: Immunofluorescence imaging of Differentiated SH-
SY5Y on PAN fibre.  
SH-SY5Y cells were cultured on PAN for 48 hours and differentiated using 
RA and B27 Supplement for 5 days. Cells were fixed then stained for βIII 
tubulin and imaged using a Leica confocal microscope. Neurite outgrowth 
was observed throughout the fibres, and high expression of βIII tubulin 
was observed.  Red- βIII tubulin, blue- DAPI Nuclei stain, green- 
autofluorescence from nanofibres. The arrows indicate the axonal 
elongation in the differentiated sample.  
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Figure 4. 12: Immunofluorescence imaging of Differentiated SH-
SY5Y on PJ fibre.   
SH-SY5Y cells were cultured on PJ for 48 hours and differentiated using 
RA and B27 Supplement for 5 days. Cells were fixed then stained for βIII 
tubulin and imaged using a Leica confocal microscope. Very poor neurite 
outgrowth and low expression of βIII tubulin were observed.  Red- βIII 
tubulin, blue- DAPI Nuclei stain, green- autofluorescence from nanofibres.  
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Figure 4. 13: Immunofluorescence imaging of Differentiated U-87 
MG on PAN fibre.  
Cells were fixed then stained for GFAP and imaged using a Leica confocal 
microscope. Feeble expression of GFAP was observed along with many 
debris due to dead cells. Red- GFAP, blue- DAPI Nuclei stain, green- 
autofluorescence from nanofibres.  
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Figure 4. 14: Immunofluorescence imaging of Differentiated U-87 
MG on PJ fibre. 
Cells were fixed then stained for GFAP and imaged using a Leica confocal 
microscope.  Differentiated cells appeared to be clustered and showed 
high expression of GFAP when treated with dbcAMP and B27.  Red- GFAP, 
blue- DAPI Nuclei stain, green- autofluorescence from nanofibres. The 
images were obtained at multiple magnifications from multiple samples 
and different locations of each scaffold. 
In contrast, glial U-87MG cells cultured on PJ fibre (figure 4.14) showed 
improved cell growth and differentiation as highlighted by GFAP positive 
staining of cellular extensions. U-87MG cells struggled to grow and 
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differentiate in PAN fibre (figure 4.13). Several cells with stable 
expression of GFAP were observed in U-87MG exposed to both dbcAMP 
and B27 supplement compared to the undifferentiated control.        
4.3.6.2 Protein expression analysis 
The expression of the protein was quantified using western blot analysis. 
Both SH-SY5Y and U-87MG cell were cultured on both fibres and plate 
then differentiated for 5 days. A pool of cells from an entire 12 well plate 
was used to extract protein from each treatment as described in section 
2.2.10.1.1, 2.2.10.1.2 for plate and fibre respectively. Protein extracts 
were quantified using mini Lowry’s protein quantification, and extracts 
(20µg) separated using 10% (w/v) SDS-PAGE gel electrophoresis. 
Separated proteins were transferred to a nitrocellulose membrane, and 
SH-SY5Y samples immunoprobed for phosphorylated neurofilament 
heavy chain (axon and neuronal maturity marker), βIII tubulin (mature 
neuronal marker) and synaptophysin (synaptic and neuronal network 
maturity marker) while GFAP expression (mature astrocyte marker) was 
evaluated for U-87MG. 
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Figure 4. 15: Phosphorylated neurofilament-H (SMI 34) protein 
expression in differentiated SH-SY5Y cell on a plate, PAN and PJ 
fibre.  
(A) Blot image obtained at 210sec exposure time and (B) Densitometry 
analysis of bands was performed using Advanced Image Data Analyser 
(AIDA) software (Fuji), and values obtained were normalised against 
loading control. Results are expressed as the mean percentage ± SEM 
n=3 *P<0.05 between plate vs fibres, fibre vs fibre and treatment vs 
control were determined by Two-Way ANOVA Tukey multiple comparison 
tests.      
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Figure 4. 16: βIII tubulin protein expression in differentiated SH-
SY5Y cell on a plate, PAN and PJ fibre.  
(A) Blot image obtained at 150sec exposure time and (B) Densitometry 
analysis of bands was performed using Advanced Image Data Analyser 
(AIDA) software (Fuji), and values obtained were normalised against 
loading control. Results are expressed as the mean percentage ± SEM 
n=3 *P<0.05 between plate vs fibres, fibre vs fibre and treatment vs 
control were determined by Two-Way ANOVA Tukey multiple comparison 
tests.      
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Figure 4. 17: Synaptophysin protein expression in differentiated 
SH-SY5Y cell on a plate, PAN and PJ fibre.  
(A) Blot image obtained at 60sec exposure time and (B) Densitometry 
analysis of bands was performed using Advanced Image Data Analyser 
(AIDA) software (Fuji), and values obtained were normalised against 
loading control. Results are expressed as the mean percentage ± SEM 
n=3 *P<0.05 between plate vs fibres, fibre vs fibre and treatment vs 
control were determined by Two-Way ANOVA Tukey multiple comparison 
tests.      
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Figure 4. 18: GFAP protein expression in differentiated U-87MG 
cell on a plate, PAN and PJ fibre.  
(A) Blot image obtained at 90sec exposure time and (B) Densitometry 
analysis of bands was performed using Advanced Image Data Analyser 
(AIDA) software (Fuji), and values obtained were normalised against 
loading control. Results are expressed as the mean percentage ± SEM 
n=3 *P<0.05 between plate vs fibres, fibre vs fibre and treatment vs 
control were determined by Two-Way ANOVA Tukey multiple comparison 
tests.      
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Results obtained from the western blot analysis indicated that expression 
of neurofilament-H (200 kDa), βIII tubulin (50 kDa) and synaptophysin 
(34k Da) significantly increased when cells were grown on PAN compared 
to cells cultured on the standard TCP. Weak expression or no expression 
of these proteins was observed from cells differentiated on PJ fibres.  U-
87MG cell extracts exhibited high expression of GFAP (50 kDa) on PJ fibre 
compared to TCP while low expression of GFAP was observed in 
undifferentiated (control) and feeble GFAP expression was seen for U-87 
MG cells cultured on PAN fibre. However, both SH-SY5Y and U-87MG 
showed higher levels of differentiation markers when induced to 
differentiate with B27 supplementation compared to retinoic acid on PAN 
and PJ fibres respectively. Higher expression of the protein was also seen 
in a cell on the plate when differentiating with B27 supplement.    
4.3.7 Toxicology analysis on SH-SY5Y and U-87MG on both TCP 
and 3D nanofibres  
In order to evaluate the efficacy of the nanofibre model, toxins capable 
of affecting the cells by causing mitochondrial dysfunction, glutathione 
depletion and impaired proteasome-mediated degradation were used. 
SH-SY5Y and U-87MG cells cultured on a plate, PAN and PJ fibres were 
exposed to different toxins for 72 hours. The effects of these toxins were 
compared between the cells grown on fibres and cells cultured on a plate 
surface. The effect of the treatments on cells cultured on both nanofibre 
and plate were examined by analysing cell metabolic activity and viability 
using MTT and CellTiter-Glo® 3D assay respectively. The results indicated 
that the cells exposed to treatments on nanofibres were more sensitive 
compared to the plate and showed increased susceptibility to cell death. 
At a lower concentration of treatments, it was also observed that the cells 
grown on fibre showed increased resistance expressing the slower rate of 
cell death against the effect of toxins. As shown in figure 4.19 for SH-
SY5Y cells on PAN fibres mitochondrial impairment is more sensitive on 
the fibre than the plate. However, proteasome impairment and 
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glutathione depletion between the substrates were significantly different 
with better cell viability compared to mitochondrial impairment. A 
significant difference was observed between the treatment and control of 
both plate and fibres. The toxins have caused a reduction in cell viability 
on both plate and fibres which was also further validated with CellTiter 
Glo® 3D viability assay. SH-SY5Y cells on PJ fibre showed extreme 
damage when exposed to toxins as our previous investigations suggested 
that PJ is not capable of supporting SH-SY5Y cell growth and this may 
have caused further damage causing increased cell death.    
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Figure 4. 19: CellTiter-Glo® 3D viability assay showing the effect 
of Toxins on SH-SY5Y cultured on Plate, PAN and PJ fibre.  
Figure A  represents comparison between plate and PAN fibre and Figure 
B shows comparison between plate and PJ fibre. Results are expressed at 
the mean ratio ± SEM n=6 for MTT and n=3 for CellTiter *P<0.005 
against plate vs fibre and control vs treatment for plate and fibre was 
determined by Two-Way ANOVA with Sidak’s multiple comparisons tests.   
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Figure 4. 20: CellTiter-Glo® 3D viability assay showing the effect 
of Toxins on U-87 MG cultured on Plate, PAN and PJ fibre.  
Figure A  represents comparison between plate and PAN fibre and Figure 
B shows comparison between plate and PJ fibre. Results are expressed at 
the mean ratio ± SEM n=6 for MTT and N=3 for CellTiter *P<0.005 
against plate vs fibre and control vs treatment for plate and fibre was 
determined by Two-Way ANOVA with Sidak’s multiple comparisons tests.   
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U-87 MG cells cultured on PAN showed a similar effect as SH-SY5Y on PJ. 
Our study has shown that PJ is the favourable material to support U-87 
MG cell growth and the inhabitable surface may have caused extensive 
cell death. However, U-87MG on PJ fibres showed higher sensitivity to 
toxins at higher concentrations and a slower rate of cell death on lower 
concentrations. The treatments were highly significant compared to the 
untreated control on both plate and fibres.       
4.3.8 Effect of the glial extracellular matrix on neurones 
Cells from the glial cell family are known to support neuronal growth, 
protection and survival. To understand the effect of glial cell’s ECM can 
have on neuronal cells we cultured glial cells on a substratum prior to 
stripping the cells and culturing neuronal cells on the stripped surface 
with no additional differentiating agents. A detailed description of the 
methodology has been described in section 2.2.8. The neuronal cells were 
cultured under standard conditions with cell culture media containing 1 % 
(v/v) serum for 14 days. The cells were monitored and imaged under a 
light microscope for every 48 hours. At the end of 14 days, the cells were 
fixed and stained for βIII tubulin for immunofluorescence imaging.  
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Figure 4. 21 SH-SY5Y cells cultured on U-87MG ECM feeder layer. 
SH-SY5Y cells were cultured for 14 days and was imaged under a light 
microscope every 48 hours. The image represents untreated surface 
(control) and glial stripped surface at 48 hours, 72 hours, 120 hours and 
day 14. At day 14 the cells were methanol fixed and stained for βIII 
tubulin (red) and DAPI (blue). The white arrow on the 
immunofluorescence image point the neurite extension expressing βIII 
tubulin with support for glial ECM. No neurite elongation was observed on 
untreated surface.    
 
Within 48 hours the cells cultured on the stripped feeder layer showed 
faster cell proliferation with some neurites extending compared to the 
control. At the end of day 14, the SH-SY5Y cells showed greater 
morphological maturity with long axonal-like projections evident 
throughout the plate (Figure 4.21). The control plate with no glial stripped 
feeder layer expressed a slower growth rate and very few neurite 
extensions.  The axonal extensions were confirmed by staining for βIII 
tubulin and imaged under an immunofluorescence microscope. 
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4.3.9 Development of a 3D co-culture model 
The 3D co-culture system was set up as described in section 2.2.12.  The 
fibres and the 2D surface was arranged as shown in figure 4.22. The cells 
were cultured and differentiated individually with B27 supplement for 5 
days. Three different possibilities for a co-culture was experimented to 
see the influence of the nanofibre and astrocytes on Neuronal cells. SH-
SY5Y cell was cultured on PAN and U-87MG was cultured on PJ. The cells 
were also exposed to low levels of toxins and viability was measured 
every 72 hours using CellTiter-Glo® 3D.   
 
Figure 4. 22: Schematic representation of the experimental setup 
designed to create a co-culture system. 
4.3.9.1 Establishment of co-culture with neuronal cells on the 2D 
surface and glial cell on PJ fibre 
In this experimental set up a two different surface was investigated. The 
SH-SY5Y cells were cultured and differentiated on TCP and the glial cells 
on PJ fibres. After 5 days of differentiation fibre grown glial cells were 
transferred to TCP containing neurones and incubated with growth 
medium in the presence of different Toxins. As shown earlier in section 
4.3.4, cells cultured on TCP survive fewer days compared to cells cultured 
on fibres. Therefore, this co-culture experiment was only performed for 
7 days, and an endpoint viability measurement was taken after the 7th 
day. The viability data showed that both cells cultured on plate and fibre 
was damaged due to the effect of toxin and expressed poor cell viability 
compared to untreated control.  SH-SY5Y cells cultured on plate shower 
lower cell viability compared to the U-87MG cultured on PJ fibre (Figure 
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4.23 A). Though the SH-SY5Y cells expressed poor cell viability, the cells 
showed better resistance to the toxin in the presence of astrocytes.   
 
Figure 4. 23 Co-culture cell viability of SH-SY5Y and U-87 MG 
showing SH-SY5Y cells cultured on TCP and U-87MG on PJ fibre. . Both 
cells were differentiated and exposed to toxins Results are expressed at 
the mean ratio ± SEM n=3 *P<0.005 against plate vs fibre and control 
vs treatment was determined two-tailed Student-T test and Two-Way 
ANOVA with Sidak’s Multiple Comparison tests. 
4.3.9.2 Co-culture with glial cells on the 2D surface and neuronal 
cell on PAN fibre 
In this experimental set, we assessed how astrocytes could influence the 
growth of neuronal cells cultured on fibres when exposed to toxins. The 
SH-SY5Y cells were cultured on PAN fibre, and the U-87MG cells were 
cultured on a TCP. Similar to the previous experiment, both cells were 
induced to differentiate with B27 supplement and was performed the 
same as the previous experiment in section 4.3.9.1. 
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Figure 4. 24: Co-culture cell viability of SH-SY5Y and U-87 MG.  
SH-SY5Y cells cultured on PAN fibre and U-87 MG on TCP. Both cells were 
differentiated and exposed to toxins Results are expressed at the mean 
ratio ± SEM n=3 *P<0.005 against plate vs fibre and control vs treatment 
was determined two-tailed Student-T test and Two-Way ANOVA with 
Sidak’s Multiple Comparison tests. 
Similar to the previous experimental set up (section 4.3.9.1), both SH-
SY5Y and U-87MG cells showed significantly poor cell viability due to the 
toxin exposure compared to the control (figure 4.23 B). Presence of 
astrocytes may not have influenced the survival of neurons, but neurons 
on PAN showed slower cell death compared to neurons on a plate in the 
presence of astrocytes. Astrocytes cultured on the plate was more 
susceptible to toxins and expressed low cell viability.    
4.3.9.3 Establishment of a 3D nanofibre based co-culture model 
with differentiated neuronal and glial cells.  
In this experimental set up of co-culture, both neuronal can glial cells 
were cultured on PAN and PJ fibres, respectively. This experiment 
assessed the ability of 3D scaffold and astrocytes to act together in 
supporting neuronal cell survival.  Both cells were differentiated using 
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B27 for five days then arranged to form the co-culture as shown in figure 
4.22 A. The neuronal cells were placed in the bottom the glial cells on the 
top separated with a hollow spacer and exposed to low levels of Toxins.  
As both cells were cultured on fibre, the experiment was continued for 20 
days, and the viability of the cells was measured using CellTiter-Glo® 3D 
ever every 3 days as described in section 2.2.11. Our results showed that 
(figure 4.24), in general, neurones cultured on PAN fibre exhibited 
prolonged survival in the presence of toxins when cultured as a co-culture 
along with astrocytes. Similar effects were also observed in astrocytes 
cultured on PJ fibre. Both cells type showed prolonged survival for nine 
days and very gradual cell death after day 11. No significant difference 
was observed between the treatment and control up to day 11 on both 
SH-SY5Y (Figure 4.24 A) and U-87 MG (Figure 4.25 B). After 11 days 
both cell viability started to decline and expressed a significant difference 
between treatment and control. When differentiated SH SY5Y (Figure 
4.24 C) and U-87MG (Figure 4.24 D) cells were cultured separately on 
nanofibre scaffolds and exposed to toxins for 72 hours, both cell types 
showed a loss of survival representing heightened sensitivity to the toxins. 
Compared to the individual culture longer survival and higher resistance 
to the toxins were observed in the co-culture of neuronal and astrocytes.  
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Figure 4. 25 Effect of toxins on differentiated SH-SY5Y cultured 
on PAN and U-87MG cultured on PJ in a co-culture model.  
Graph A shows differentiated neuronal and graph B astrocytes viability in 
co-culture exposed to toxins. C and D shows individual cultures 
differentiated for 5days and exposed to toxins for 72 hours. Results are 
expressed at the mean ratio + SEM n=3 *P<0.005 against control vs 
treatment for each measurement was determined by Two-Way ANOVA 
with Sidak’s multiple comparisons test. 
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4.4 Discussion 
The principal aim of this study was to create a nanofibre scaffold that was 
capable of attachment, growth visualisation of cells and able to perform 
functional biological measurements.  In the previous chapter, we 
demonstrated that we could manufacture different models of nanofibre 
scaffolds that were suitable for different invitro cell type models.   
Biomaterial scaffolds can support and provide a suitable habitat for the 
cells to attach, proliferate and differentiate (Chan, B. and Leong 2008). 
In this study, PAN, a synthetic resin, was chosen for synthesising 
nanofibre scaffolds based on their beneficial structural properties 
including strength and toughness. Jeffamine® is a synthetic compound 
containing terminal amine groups on polyethene oxide polymer. In this 
chapter human SH-SY5Y neuroblastoma and human U-87MG 
glioblastoma cell lines were used to investigate the ability of the synthetic 
nanofibre scaffolds to facilitate biological functions including cell adhesion, 
proliferation & differentiation. Initially, the fibres were electrospun on full-
length polyester sheets which were cut into shapes to fit in well plates. 
When cells were cultured on these sheets of fibres, it was noticed that 
the cell migrated to the edges of the fibre and many cells were found 
attached to the loose fibre (figure 4.3) this led to an idea of fully 
suspended nanofibre scaffolds. A study has shown that polyester and 
polypropylene can be negatively charged, thus causing the cells to be 
repelled at loose ends of the fibre mats (Yovcheva, Avramova, Mekishev, 
et al. 2007). When cultured on suspended scaffolds, a number of cells 
were found attached to the centre of the scaffold in comparison to the 
plate (figure 4.4). The cell distributions and cell attachment were 
confirmed by Coomassie blue staining and immunofluorescence analysis.     
Several studies have demonstrated that aligned fibre can promote cell 
alignment and guidance.  Aligned fibre has been used in several studies 
that involve muscle regeneration, cell migration and fibre alignment for 
ligaments in rodent models (Ahmed and Brown 1999; Aviss, Gough and 
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Downes 2010; Shang, Yang, Cheng, et al. 2010). The major drawback of 
several studies was that it lacked the structure to hold the fibre intact 
throughout the study, and they were pseudo-3D scaffolds. The model 
developed in this study is fully suspended real 3D model that is multiple 
orientations in a single scaffold. We have demonstrated that the neuronal 
and glial cells are capable of attaching and growing on the aligned fibre 
model. Our immunofluorescence images have shown that the aligned 
fibres support a corresponding cell pattern attachment and growth 
organising cells along the direction of the fibres. The direction of cell 
growth on aligned vs random fibre was assessed with images using Fast 
Fourier Transform (FFT) analysis. This was performed by another team 
member and has been reported in his work.   
This study was primarily focused only on random fibres. The results show 
that PAN and PJ nanofibres are suitable biomaterials to produce random 
nanofibre constructs that support neuronal and glial cells, respectively. 
The biomaterial preference for each cell type was evident in each cell 
type’s ability to attach and grow throughout 11 days of culture on 
nanofibre scaffolds. In both cases, cell growth and survival were 
maintained for longer on nanofibre scaffolds compared to conventional 
tissue culture plastic. Several studies have reported the benefits and 
enhancement of cell metabolism when cultured on the 3-dimensional 
nanofibrillar surface due to its 3D structure and larger surface area-
volume ratio compared to a TCP (Farzaneh, Pournasr, Ebrahimi, et al. 
2010; Mahairaki, Lim, Christopherson, et al. 2010). The preferential 
attachment and growth of glial cells to PJ rather than PAN highlight 
potential differences in the ECM which promotes the adhesion and 
proliferation of cells (Frantz, Stewart and Weaver 2010; Hinz 2015).  The 
composition of nanomaterials influences cell growth & survival due to 
topographic and biochemical cues induced by their unique physical and 
chemical properties (Chueng, Yang, Zhang, et al. 2016).   When growing 
co-cultures, it is potentially more desirable to culture cells onto a multi 
3D surface that is capable of mimicking the native ECM. The improved 
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growth and survival of both cell types could also be attributed to the 
physical properties of the nanofibre. Nanofibres were spun to produce a 
fully suspended 3D nanofibre structure allowing a greater surface area 
access to nutrients when cells were cultured on these scaffolds compared 
to pseudo-3D structures. Similarly, the flow rate was optimised to 
1mL/hour for a maximum of 2 hours, since electrospinning larger 
volumes resulted in highly dense scaffolds. Dense fibres may help in 
holding cells trapped but not support cell attachment and growth, also 
impedes the visual monitoring of cells. 
Currently, no comparative information is available for neuronal and glial 
cells cultured on nanofibres electrospun using PAN and PJ. Initial 
experiments confirm that both glial and neuronal cells are capable of 
attaching to PAN and PJ fibres and were able to proliferate. Results from 
Coomassie blue staining (figure 4.4) immunofluorescence (figure 4.6) 
and SEM imaging confirmed this (figure 4.7). The proliferation assay 
experiment suggested that SH-SY5Y cell express improved survival and 
proliferation on PAN than PJ fibre, while U-87MG cells were found 
attached to both fibre types. Furthermore, increased cell number and 
survival was seen on PJ than PAN for U-87MG cells. The prolonged 
survival of each cell on different fibre type was confirmed by culturing the 
cells for 11 days and investigating the cell metabolic activity. Data (Figure 
4.8 and 4.9) obtained from both fibre types and plate showed that the 
cells were able to survive longer in fibre than the plate. This may be due 
to the larger surface area; a suitable scaffold material and the cells were 
able to utilise nutrients entirely from the media. SH-SY5Y cells showed 
prolonged survival on PAN and U-87MG on PJ fibre. The ability of these 
cells to adapt to specific surfaces opens up a wide range of possibilities 
including targeted cell growth, creating cell channelling and surface-
specific 3D neurodegenerative disease models. 
It was essential to understand the ability of both SH-SY5Y and U-87MG 
cells to differentiate on fibres. After identifying and confirming suitable 
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nanofibre, both cell types were exposed to the differentiating inducing 
agents, RA for SH-SY5Y and dbcAMP for U-87MG (Tiryaki, Ayres, Ahmed, 
et al. 2015; Korecka, van Kesteren, Blaas, et al. 2013; Fedoroff, McAuley, 
Houkle, et al. 1984). The B27 supplement is a commercially available 
product that is commonly used for the survival and maintenance of 
primary neurons (Roth, Zhang, Chiu, et al. 2010; Kovalevich and 
Langford 2013) and was used in this study as an alternative 
differentiating agent.  Our results showed that both cell lines were 
capable of differentiating on fibre. SH-SY5Y cells showed extended axonal 
growth on PAN fibre (Figure 4.11), and U-87MG cells expressed higher 
levels of GFAP, but the differentiated cells appeared to form into clusters 
(Figure 4.14). Limited cell growth and cell differentiation were observed 
when SH-SY5Y and U-87MG were cultured on PJ and PAN fibre 
respectively.  Expression of phosphorylated neurofilament H (NF-H; 
SMI34) (figure 4.15), βIII tubulin (figure 4.16) and synaptophysin (figure 
4.17) for SH-SY5Y cells and high levels of GFAP (figure 4.18) expression 
for U-87MG cells were also confirmed using western blot analysis. Indeed, 
western blot analysis clearly showed increased neurofilament SMI 34 
levels representing a neuronal marker of maturity (Gray, Rice, 
Nightingale, et al. 2013), βIII tubulin; a mature neuronal marker (Choi, 
S. H., Kim, Hebisch, et al. 2014), and synaptophysin; a synaptic and 
neuronal synaptic marker (Lee, T. T., Chana, Gorry, et al. 2015) all 
showed increased levels when SH-SY5Y cells were grown on PAN fibre 
compared to tissue culture plates and PJ fibre. Elevated levels of GFAP, a 
standard marker for astrocytes (Tong, J., Ang, Williams, et al. 2015), was 
evident in U87-MG cells grown on PJ fibre. Furthermore, these levels were 
elevated in response to either dbcAMP or B27 supplementation.  
Once confirmation was obtained showing of both cell type was capable of 
nanofibre growth and differentiation, we examined the response of both 
SH-SY5Y and U-87MG to toxins cultured both on plate and fibre. 
Rotenone and MPTP are commonly used to induce complex 1 inhibition 
(Innamorato, Jazwa, Rojo, et al. 2010; Tanner, Kamel, Ross, et al. 2011), 
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MG 132 mimics proteasome inhibition (Chan, N. C., Salazar, Pham, et al. 
2011) and Buthionine-Sulfoximine (BSO) promotes glutamylcysteine 
synthetase inhibition (Smeyne and Smeyne 2013). We, therefore, used 
rotenone, MPTP, MG132 and BSO to create sub-lethal conditions in SH-
SY5Y and U-87MG cells cultured on both TCP and PAN / PJ fibres. Our 
results showed that the cells on fibre exhibited higher sensitivities to the 
different toxins compared to cells grown on conventional TCP. Cells 
cultured on both fibres showed a similar effect, but cells SH-SY5Y cultured 
on PJ and U-87MG on PAN showed more significant loss of cell viability 
due to the toxins.  This may be due to the increased cell surface area in 
contact with the toxins on fibre compared to cells cultured on a flat 2D 
culture plate (Figure 4.19 and 4.20).  
Several studies have also shown that glial cells are one of the essential 
integral functional element supporting neurons for responding to 
neuronal activity regulating synaptic transmission, plasticity and neuronal 
protection (Hillen, Burbach and Hol 2018). To examine the effect glial 
cells can have on a neuronal cell population we cultured neuronal cells on 
a plate with glial cell stripped ECM as a feeder layer. Our results show 
much matured axonal projection and neuronal growth after 14 days of 
culturing. The cells were cultured in 1% serum condition without any 
differentiating agents. When compared to the control the cells cultured 
on the feeder layer showed very long axonal projection and network 
connections. The matured axonal growth was confirmed with βIII tubulin 
staining on an immunofluorescence microscope (Figure 4.21). Due to the 
limitation in time, this experiment was not performed on nanofibres, but 
this method could make inhabitable neuronal surfaces like PJ to become 
a neuron-supporting surface and can provide more natural ways for 
axonal elongations. 
From understanding the effect of glial ECM on the neuron, we designed a 
3D co-culture model that can bring both differentiated neuron and 
astrocytes to a proximity to provide neurotrophic factors and support 
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biochemically against low levels of neural toxins. Several studies have 
shown that astrocytes play a significant role in providing neuro 
protections and a vital role in the CNS (Takuma, Baba and Matsuda 2004; 
Barreto, E White, Ouyang, et al. 2011; Cabezas, El-Bachá, González, et 
al. 2012). Our results suggest that when either of the cells was cultured 
on a tissue culture plastic, the cells showed very poor cell viability. The 
endpoint viability for SH-SY5Y cultured on a plate and U-87MG on PJ or 
vice versa (figure 4.23 and 4.24) showed more significant damage due 
to the toxins. Whereas when both cells were cultured on their favourable 
scaffolds, the results indicated that neuronal cells exhibit improved 
survival rates when culture with astrocytes. Neuronal cells showed 
prolonged survival against the toxins for nine days with a gradual loss of 
viability only seen from the 11th day was observed. A similar effect was 
seen in the astrocyte cell population too (Figure 4.25). The chronic co-
culture model has demonstrated the prolonged survival of cells, and two 
different types of cell can be cultured on a different surface to recreate 
realistic chronic models.  With the presence of astrocytes and nanofibre, 
the neuronal cells were able to express resistance to the lower 
concentrations of toxins. Astrocytes provide the neurotrophic factor 
(Lindahl, Saarma and Lindholm 2017) and the nanofibre provides robust 
structural support leading to prolonged cell survival. Several studies have 
also shown that glial cell line-derived neurotrophic factors can support 
neuronal cell line growth and very useful to study neurodegenerative 
diseases (Nishiguchi, Tokugawa, Yamamoto, et al. 2003; Shishkina, 
Mishchenko, Mitroshina, et al. 2018).  A similar effect of toxins on the 
undifferentiated cell was also seen when differentiated SH-SY5Y and U-
87MG cells were exposed to toxins individually (figure 4.24). Both cell 
type were sensitive to the inhibitor and showed a higher rate of cell death. 
They are thus showing that both astrocyte and nanofibres played a dual 
role in improved cell survival in the chronic 3D co-culture model. The 3D 
co-culture system is not just limited to just two layers. The model can 
hold multiple layers capable of harbouring different brain cell types in 
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each layer at different proximities thus creating an in vivo like in vitro 
brain cell populations.  The system can open up to several studies that 
involve investigating more than one cell thus creating more realistic 
grounds to test drugs and several other protective agents reducing 
animal trails.    
4.5 Conclusion   
In summary, this chapter demonstrated that both PAN and PJ electrospun 
nanofibres are capable of harbouring SH-SY5Y and U-87MG cells. More 
specifically we have clearly shown that SH-SY5Y cell preferably grows on 
PAN fibre and U-87MG prefers PJ fibre. The chapter has also 
demonstrated that U-87MG can be cultured in the same cell culture 
medium that is used for SH-SY5Y and both cells can be differentiated with 
multiple differentiating agents on nanofibres. Our western blot analysis 
showed elevated expression of the neuronal associated protein on PAN 
and high expression of GFAP for U-87MG cells on PJ. We have also 
demonstrated that toxins that are commonly used in several neural cell 
degeneration related studies can be used to investigate cells cultured on 
nanofibres too. Cells exposed to toxins individually showed greater 
sensitivity whereas in our 3D co-culture model cells cultured on nanofibre 
expressed prolong cell survival compared to cells on plate. Using 3D 
nanofibre scaffolds to investigate neural cell degeneration could lead to a 
breakthrough in understanding the importance of providing a natural 
habitat for the cells and the ability of nanofibres to support the survival 
of different cell types. Taken further, multiple treatments could be 
investigated and scale up the manufacture of suspended nanofibre 
scaffolds in well TCP would improve high content screening models used 
in drug discovery and to identify possible biomarkers linked to loss of 
neuronal cells in neurodegenerative disease.
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Chapter 5: Stem & primary cells scaffold model 
5.1 Introduction 
5.1.1 Neural Stem cells 
Over the last two decades, neural stem cells (NSCs) have become the 
main focus of interest in developing therapeutic strategies for several 
CNS disorders (Oh, J., Jung, Lee, et al. 2018). With a well-understood 
nature of degeneration, and disease like Amyotrophic lateral sclerosis, 
Parkinson's disease, Alzheimer's disease, and Huntington's disease  has 
been perhaps the most widely researched condition for the use of neural 
stem cells (Björklund and Lindvall 2000). Other neurological diseases like 
Huntington's and Alzheimer's diseases also represent potential targets for 
such therapies (Rossi and Cattaneo 2002). Neural stem cells have mostly 
been derived from adult, fetal or embryonic rodent sources limiting the 
capacity to grow these cells while maintaining stable phenotype with the 
limited passage number. Similarly, human-derived neural stem cells 
(hNSC) have several drawbacks that include the limited donor availability, 
slow rate of cell proliferation and difficulties of long term expansion 
(Kaneko, Kako and Sawamoto 2011). The ability of hNSCs to differentiate 
to multiple neuronal cells types makes them a powerful tool for both 
research and treatment in neurological disease. Many studies have shown 
that it is possible to differentiate rodent stem cells and transplant them 
into various animal models (Conti, Reitano and Cattaneo 2006). However, 
only a few earlier studies using human embryonic or foetal stem cells and 
demonstrate truly functional differentiation into neurons (Donato, Miljan, 
Hines, et al. 2007). Optimised culture conditions for immortalisation with 
myc transcriptional factor can improve the life span and availability of 
hNSCs. Two such stable stem cell-like cell lines are the ReNcell CX and 
ReNcell VM cell lines. ReNcell CX cells were derived from the cortical 
region of a human fetal brain and immortalised using c-myc, whereas 
ReNcell VM cells were derived from ventral mesencephalon region of the 
human fetal brain and immortalised by retroviral transduction with the v-
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myc oncogene. Cultured ReNcell line shows the ability to multiply 
continually and exhibit properties of hNSCs. For example, studies have 
shown the expression of NESTIN in an undifferentiated state, and upon 
withdrawal of growth factors from the medium the cells differentiate to a 
mixture of neuronal and glial cell types (Hovakimyan, Müller, Wree, et al. 
2012). A study conducted using the ReNcell VM cell line created a 3D 
culture model of Alzheimer’s disease (AD) with mutations in the genes 
encoding β-amyloid precursor protein, and presenilin 1, which was able 
to recapitulate the hallmarks of AD pathology (Kim, Y. H., Choi, D'avanzo, 
et al. 2015; Choi, Se Hoon, Kim, Quinti, et al. 2016). Even though 
ReNcells have great potential, several practical limitations are using these 
cells for clinical investigation and applications, as they have a high risk of 
uncontrolled growth leading tumour like progressions (Donato, Miljan, 
Hines, et al. 2007; Oh, J., Jung, Lee, et al. 2018).  
5.1.2 Primary cell cultures 
In bioscience research, cell culture studies are a valuable asset for in vitro 
and in vivo experiments. Cell culture techniques allow for more controlled 
manipulation and development of cellular functions and processes. For 
many decades, cell culture studies have been based on established cell 
lines have led to several scientific advancements; however, it has become 
increasingly necessary to interpret data from such cell lines with caution. 
Multiple studies have also pointed out the misleading, misidentified and 
contaminated cell lines, which has led to increased concerns and a great 
interest in the use of primary cell culture (Allston-Roberts, Barallon, 
Bauer, et al. 2010; Lorsch, Collins and Lippincott-Schwartz 2014). Many 
research studies are performed on cell lines due to several factors, such 
as they are readily available, have high proliferation capability; they are 
relatively easy to culture and transfect.  Cell lines are often cultured and 
maintained over decades, forcing them to adapt to the 2D culture 
environment resulting in altered morphology and genetic drift making 
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them different both genetically and phenotypically to their tissue of origin 
(Alge, Hauck, Priglinger, et al. 2006; Pan, C., Kumar, Bohl, et al. 2009).   
In primary cell culture, cells are isolated directly from tissue and 
established to grow in vitro. Cells isolated from a tissue have a finite 
lifespan depending on the cell type. Most primary cell cultures cannot be 
expanded whereas few may have minimal expansion capacity. Primary 
cells hold the morphology of a normal cell and will maintain many of the 
essential properties and markers that are usually observed well in vivo 
(Pan, C., Kumar, Bohl, et al. 2009). Despite these multiple advantages, 
the primary cell culture is very challenging, and most cell types require 
particular conditioned culture media. Practices like culturing primary cells 
on to more physiologically relevant substrates or materials can 
significantly improve cell attachment, growth and purity. Primary cell 
culture systems can be an excellent model for studies in cancer research, 
virology, drug screening, toxicity, vaccine production and tissue 
engineering. The main advantage of using primary cell culture is that the 
cells are non-transformed and non-immortalised. Therefore, they are 
capable of mimicking a living model yielding more physiologically relevant 
results. In the case of functional activities and experiments, primary cells 
have a very distinctive receptor profile, express unique enzymes and 
other signalling pathways that work in a manner not found in non-primary 
cells (Uysal, Sevimli, Sevimli, et al. 2018).  Primary cultures replicate 
more closely what happens in vivo, where cells like neurons stop dividing 
and undergo differentiation to take on their individual functions. Similarly, 
when primary cells are cultured in a culture dish, they tend to follow a 
similar trajectory (Lab Manager Feb 9th 2016).  
Recently interest has risen in using primary cells in 3D cell culture models, 
as they can produce more biologically representative systems showing 
similar properties as an in vivo multicellular environments (Edmondson, 
Broglie, Adcock, et al. 2014). For example, a study on primary hepatocyte 
cultures showed that when cultured as a monolayer on plastic the cells 
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stayed undifferentiated and died within a few days, whereas they 
survived for almost three weeks and exhibited differentiation when 
cultured in a 3D culture of collagen gel matrix (Gómez‐Lechón, Jover, 
Donato, et al. 1998). Primary cells cultured in 3D cell culture models are 
showing better success in attempts to engineer physiologically relevant 
cells and tissue models (Justice, Badr and Felder 2009). A significant 
difference is observed between cells cultured in a tissue culture dish 
versus a 3D culture system, regarding the access to soluble factors and 
the distribution and types of cell to cell interaction (Hoffman 1993; 
Schmeichel and Bissell 2003; Yamada, Pankov and Cukierman 2003). 
Many studies have encountered more of a spherical distribution of cells 
on a 3D compared to a 2D culture system, and in the case of cells like a 
primary neuron, it allows them to develop outgrowths in all directions in 
a 3D culture. One study has shown increased cell viability of neurons 
harvested from an embryonic brain when cultured in 3D compared to a 
monolayer culture (Fawcett, Barker and Dunnett 1995). Multiple studies 
have reported longer neurite outgrowth, longer survival and improved 
neuronal cell differentiation in 3D compared to 2D cultures (Bellamkonda, 
Ranieri, Bouche, et al. 1995; Blackshaw, Arkison, Cameron, et al. 1997; 
Pardo and Honegger 2000). Many other studies have mentioned similar 
data for multiple primary cell types in 3D culture models (O'Connor, 
Stenger, Shaffer, et al. 2000; Peretz, Talpalar, Vago, et al. 2007). 
Primary cell culture research is a critical tool for the future of scientific 
breakthrough and therapies and combining it with 3D culture; it will 
become a powerful approach for the achievement of significant advances. 
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5.2 Content of this chapter  
In this chapter, we have mainly focused on two different types of cell. 
These are 1) neural stem cells as modelled by the ReNcell CX human 
neural progenitor cells line capable of differentiating into neurons and 
glial cells, 2) primary neurons and glial cells extracted from an embryonic 
day 18 rat brain hippocampus. The main aim of the work shown in this 
chapter was to demonstrate our in-house developed random nanofibre 
model was capable of supporting the growth the two different cell types 
and had the potential for being used as a suitable model for investigating 
neurodegenerative and other diseases. The chapter has demonstrated 
the ability of both cells types to be attached, adapt, proliferate and grow 
on PAN and PJ fibres. Cell attachment and proliferation was investigated 
using immunofluorescence microscopy and viability assay. We have also 
shown some preliminary experiments to investigate the effect of 
parkinsonism-inducing agents on stem cells. Both stem cell and primary 
cells were exposed to four different toxins capable of causing different 
biochemical changes were used. Rotenone and MPTP to induce complex 
1 inhibition, MG132 inducing proteasome inhibition and BSO a 
glutamylcysteine synthetase inhibitor to reduce glutathione levels for a 
short period, and we studied the possibility for the neurons to recover 
with the help of glial cells and nanofibres using a co-culture model. Our 
preliminary experiment of the primary hippocampal cell 3D co-culture 
model has demonstrated that it can be a suitable model for screening 
neuroprotective agents and drugs suitable for neuron and related glial 
disorders. 
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5.3 Results   
5.3.1 ReNcells CX human neural progenitor cell line 
5.3.1.1 Culturing and subculturing 
The cells were cultured and maintained in a T25 flask and harvested 
based on experimental requirements. Prior to culturing, the flasks and 
TCP were coated with laminin (20 µg/ml) as described in section 2.2.4.2.1. 
The complete medium for culturing ReNcell CX is made using 500 ml 
Knockout Dulbecco’s modified Eagle’s medium (DMEM)/F-12, which was 
supplemented with 10µg human recombinant FGFb, 10 µg human 
recombinant EGF, 10 ml StemPro neural supplement, 5 ml of sterile-
filtered L-glutamine, 5 ml of sterile-filtered 10000 U/ml penicillin and 100 
μg/ml streptomycin. The complete medium was stored at 4 ºC and 
warmed to 37 ºC before use. The cells were obtained from the liquid 
nitrogen storage and thawed and plated by following steps mentioned in 
section 2.2.4.2.3. Upon reaching 80% confluency, the medium was 
removed, and the flask was rinsed with PBS. Cells were detached by 
adding 1-3 ml of accutase and incubation at 37oC for 3-5 minutes, after 
which the accutase activity was neutralised by adding a complete medium. 
Cell detachment was confirmed using a light microscope, and cells that 
had not detached were further detached by either tapping gently on the 
sides of the flask or by squirting medium using a pipette over the region.  
The detached cells were then transferred into a tube and pelleted by 
centrifugation at 300 x g for 5 minutes. The resultant pellet was re-
suspended in growth medium, and the required number of cells (250,000 
cells in T25 flasks and 1,000,000 cells in T75 flasks) was transferred to a 
sterile tissue culture flask containing pre-warmed growth medium. 
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Figure 5. 1: ReNcell CX cell attachment on laminin-coated and 
uncoated light microscope image.   
(A) Represents cells cultured on the laminin-coated surface and (B) 
shows cells forming spheroidal clusters with no laminin coating.   
The images were obtained after the cells were cultured of 120 hours 
under regular conditions.  Cells cultured on a laminin-coated surface 
adhered to the surface, proliferated and formed a monolayer, whereas 
the cells cultured in the uncoated flasks were still viable but stayed 
floating in the medium forming spheres and clusters.     
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5.3.1.2 Culturing on nanofibre scaffolds 
ReNcell culture was performed on both PAN and PJ fibres. Both types of 
fibre scaffold were sterilised with 70 % v/v ethanol, as explained in 
section 2.2.5. Random fibres were used to investigate cell attachment, 
for which the fibres were soaked in 20 µg/ml laminin overnight before cell 
seeding. Cells were seeded at a density of 50,000 cells/well in each well 
with nanofibre scaffolds and incubated at 37°C in a humidified 
atmosphere of 95% air and 5% CO2 for 48 hours.  
 
Figure 5. 2: ReNcell culture on PAN and PJ random fibres.  
The cells were incubated for 48 hours and stained using Coomassie blue 
stain (A and B). The cells were also dehydrated and examined by SEM (C 
and D).  A higher number of cells was found attached to the PJ fibre than 
to PAN fibres. The image is a representative of n=6 repeats    
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Two days later, the cells were stained with Coomassie blue for 
approximately 10 minutes. The fibres were moved to a new TCP, and 
both fibres and the TCP were examined using a light microscope. After 
examining multiple samples, a good number of cells were found attached 
to both PAN and PJ fibres, with more cells found on PJ compared to PAN.  
The cells on the fibres were also dehydrated as explained in section 
2.2.9.3 and examined by SEM. The cells were found attached on both 
PAN and PJ; the cells were found wrapped around and growing within the 
fibres 
5.3.1.3 ReNcell CX attachment and growth 
Similar to the studies on SH-SY5Y and U-87 MG cell lines, we investigated 
the ability of ReNcell CX cells to attach to, grow and survive in both PAN 
and PJ fibres. The experiment was set up as explained in section 2.2.7, 
and the ability of the cells to survive on fibres compared to the TCP was 
studied by analysing cell growth and viability by measuring their 
metabolic activity using MTT reduction assays on both fibres and TCP. 
Cells were cultured for 15 days on both plastic and fibres with metabolic 
activity assessed every 48 hours.  The data obtained suggested that the 
cells cultured on both PAN and PJ had a similar growth rate and a steady 
increase in the metabolic activity was observed. Upon reaching 100% 
confluency, the cells grown on the TCP slowly started detaching and dying 
after 7 days in culture. ReNcell CX cells cultured on PAN also expressed 
a steady increase in cell number similar to that observed in the TCP. The 
MTT analysis demonstrated that there was no significant difference in a 
cell in cell growth until day 7 for cells cultured on PAN and TCP. MTT 
reduction after day 7 remained constant until day 15 for the cell on PAN. 
In contrast cells culture on PJ fibre showed a very high rate of increase 
in MTT reduction compared to the cells cultured on TCP increases in MTT 
reduction continued upto day 15.    
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Figure 5. 3: ReNcell CX MTT metabolic assay on PAN, PJ and TCP. 
Panel (A) represents cells cultured on PAN compared to TCP and (B) 
represents growth on PJ compared to TCP. ReNcell CX showed a gradual 
increase in cell growth and survived throughout the 15 days on both PAN 
and PJ fibres.  Results are expressed at the mean ratio ± SEM n=3 
*P<0.005 against TCP vs fibre determined by two-tailed Student-T test 
and Two-Way ANOVA with Sidak’s multiple comparisons tests.  
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5.3.1.4 Cell differentiation 
As described in section 2.2.4.2.6 ReNcell CX cells were induced to 
differentiate by maintaining the cells in a mitogen-free medium.  The cells 
were cultured for 24 hours, after which the medium was replaced with 
differentiation medium for 5 days.  The ReNcell CX cells are capable of 
differentiating into neurons and glial cells, which was confirmed with 
immunofluorescence staining. Undifferentiated control was stained for 
mouse anti-nestin antibody, which recognises a type VI intermediate 
filament (IF) protein encoded by the NES gene expressed in progenitor 
stem cells. When differentiated, the neurons were stained with mouse 
anti-βIII tubulin antibody, which recognises a mature neuronal marker. 
Astrocytes were stained using rabbit anti-glial fibrillary acidic protein 
(GFAP), which recognises an intermediate filament protein expressed 
highly in this class of glial cells. Anti-mouse Alexa fluor 568 (red) and 
anti-rabbit Alexa Fluor 647 (magenta) were used as secondary antibodies. 
The immunofluorescence images showed that undifferentiated cells 
exhibited high expression of nestin and that they were spread across the 
fibres on both PAN and PJ fibre scaffolds. The highest expression for both 
βIII tubulin and GFAP was observed on cells cultured on PJ compared to 
PAN. A low number of cells was observed on PAN fibre, thus resulting in 
reduced expression of βIII tubulin and GFAP. ReNcell CX cells were 
therefore capable of differentiating on both PAN and PJ fibres      
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Figure 5. 4: Immunofluorescence image of undifferentiated and 
differentiated ReNcells on PAN and PJ fibres.  
Panels A and B represent undifferentiated cells expressing nestin. Panels 
C and D represent neurons expressing βIII tubulin. Panels E and F 
represent glial cells expressing GFAP.    
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5.3.1.5 Effects of toxins on ReNcells CX 
Similar to the SH-SY5Y and U-87MG cells ReNcells was also exposed to 
toxins that can cause similar neural cell degeneration pathophysiology. 
ReNcell CX cells (50,000 cells per well) were cultured on PAN, PJ and TCP. 
After 24 hours, the cells were switched to differentiation medium for 72 
hours, which was then replaced with differentiation medium containing 
rotenone (0.5 µM), MPTP (2.5 µM), MG132 (10 µM) and BSO (2 mM). 
After a further 72 hours, the effect of the treatments on cells cultured on 
both nanofibre and TCP were examined by analysing their effect on cell 
viability using the CellTiter-Glo® 3D assay.    
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Figure 5. 5: Effect of toxins on ReNcell CX cells.  
Cells were cultured, differentiated and exposed to low concentrations of 
rotenone, MPTP MG132 and BSO on PAN, PJ and the TCP for 72 hours 
and cell viability was measured using CellTiter-Glo® 3D assay. The results 
are expressed at the mean ratio ± SEM n=3 *P<0.005 against TCP vs 
fibre and control vs treatment for TCP and fibre was determined by Two-
Way ANOVA with Sidak’s multiple comparisons tests 
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The CellTiter-Glo® 3D assay data showed that cells cultured on both TCP 
and fibre responded similarly when exposed to the toxins compared to 
the untreated control on both TCP and fibre. However, after 72 hours of 
exposure, cells cultured on the TCP showed about a more significant 
reduction in cell viability compared to both PAN and PJ fibres. The cells 
cultured on PAN showed a significant reduction in cell viability for 
rotenone, MPTP and BSO compared to the TCP whereas when treated 
MG132 cells on PAN expressed similar cells viability as the cells on the 
TCP (Figure 5.5 A). In contrast, cells cultured on PJ showed better 
resistance to the treatment. Significantly higher cell viability was 
observed on PJ for all treatments compared to the TCP (Figure 5.5 B).   
5.3.2 Primary neurons and glial cells 
5.3.2.1 Culturing of primary cells on TCP and fibres  
Hippocampal tissue from an E18 rat was used to extract neurons and glial 
cells. The tissue sample was prepared, and the cells were dissociated as 
explained in sections 2.2.4.3.1 and 2.2.4.3.2. Unlike neuroblastoma, 
glioblastoma and ReNcell CX, primary cells were extracted and seeded 
directly on to the nanofibres. Before cell seeding on nanofibres, the 
scaffolds were immersed in PLL for 1-4 hours at 37°C or 4°C for overnight. 
Cells were cultured on both PAN and PJ fibres alongside PLL coated 
coverslips as a corresponding control. The cells obtained from the tissue 
comprised of a mixed population of neurons and glial cells. Two types of 
cell culture media were used to promote neuron and astrocyte growth. 
The cells were cultured in NbActive1 to promote the growth of neurons 
only, and NbAstro medium was used for glial cells, which promotes the 
growth of astrocytes.  The cells were cultured for over 2 weeks with media 
changes every four days to remove any dead cells. 
5.3.2.2 Primary cell metabolic activity  
After the cells were dissociated from the primary tissue sample, 50,000 
cells/well were seeded on PLL coated PAN, PJ and coverslip and then 
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incubated at 37 oC in a humidified atmosphere of 95% air and 5% CO2. 
To monitor the level of proliferation and prolonged survival, each cell 
types was cultured on each fibre type for 21 days alongside control cells 
cultured on 2D tissue culture plastic surface (control) with media changes 
every 72 hours. All samples were tested for cell metabolism using MTT 
reduction assays as explained in section 2.2.6.3.  From the data obtained, 
(Figure 5.6) it can be seen that primary neurons cultured on the TCP and 
PAN fibre showed a constant level of MTT reduction. A significant decrease 
in MTT reduction was observed just for the cells grown on the TCP on 
days 16 and 20 (Figure 5.6 A). In contrast, the cells cultured on PJ fibre 
scaffolds showed a decrease in MTT reduction with a significant difference 
being observed between the cells cultured on TCP and PJ fibre (Figure 5.6 
B).  
Data obtained from culturing primary glial cells on TCP showed that the 
cells had a steady level of MTT reduction for 12 days and showed a slight 
progressive decrease after that. However, cells cultured on PAN showed 
a gradual increase in cell metabolic activity throughout the 20 day 
incubation period and cells on the TCP decrease in cell viability after day 
12 (Figure 5.7 A). A significant difference was observed between the cells 
on the PAN and TCP through the experiment. A significant difference in 
the MTT data was seen day 8-20 when compared with day 4 (Figure 5.7 
A). Whereas, the cells cultured on PJ showed a very high proliferation 
rate and continued proliferating for 21 days when the MTT data was 
analysed between each time points. A highly significant difference in the 
data was observed when day 4 was compared with day 8-12 (Figure 5.7 
B). The cells expressed steady cell viability throughout 21 days with a 
significant difference when compared to the TCP.  
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Figure 5. 6: MTT metabolic assay of primary hippocampal neurons 
cultured on PAN, PJ fibre compared to TCP.  
The cells were maintained in culture for 21 days, and the metabolic 
activity was measured every 72 hours using MTT reduction assay.  
Results are expressed at the mean ratio ± SEM n=3 *P<0.005 against 
TCP vs fibre and between the time points was determined by Two-Way 
ANOVA with Sidak’s multiple comparisons tests.       
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Figure 5. 7: Primary hippocampal glial cell viability assay on PAN, 
PJ fibre compared to the TCP.  
The cells were maintained in culture for 21 days, and the cell viability was 
measured every 72 hours using MTT reduction assay.  Results are 
expressed at the mean ratio ± SEM n=3 *P<0.005 against TCP vs fibre 
and between the time points was determined by Two-Way ANOVA with 
Sidak’s multiple comparisons tests.       
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5.3.2.3 Immunofluorescence 
Primary neurons were cultured only on PAN, and glial cells were cultured 
only on PJ fibres due to the limited number of tissue samples available. 
A total of 50,000 cells per well were seeded onto each fibre type and 
incubated with appropriate media at 37°C in a humidified atmosphere of 
95% air and 5% CO2 for 21 days. After 21 days, the cells growing on 
scaffolds were fixed using 90% v/v methanol in TBS and then stained for 
immunofluorescence imaging as described in section 2.2.9.2. The 
primary neurons were incubated with rabbit anti-synaptophysin 
antibodies to show synaptic activity across the fibres and monoclonal 
mouse anti-βIII tubulin antibody to show mature axonal elongation. Glial 
cells were incubated with rabbit anti-GFAP only to detect astrocytes. 
Alexa Fluor 532 anti-rabbit Ig was used for detection of synaptophysin, 
whereas anti-mouse Ig and anti-rabbit Ig Alexa Fluor 568 was used for 
detection of primary antibodies bound to βIII tubulin and GFAP, 
respectively.   Scaffolds were placed on glass slides with anti-fade 
mountant vectorshield containing DAPI to stain nuclei. When observed 
with the aid of a confocal microscope, neuronal cells (figure 5.7) showed 
mature network connections between multiple cells. Axonal projections 
(red) were observed throughout the fibres (green) in all directions, and 
a large number of synapses (yellow) were observed throughout the 
sample (Figure 5.8). The nanofibres were able to support and act as a 
track to guide axons to connect with neighbouring cells, creating complex 
systematic network connections. Primary glial cells (figure 5.9) were 
stained only for GFAP, which is a standard marker that is strongly 
expressed in astrocytes. A large number of astrocytes (red) was observed. 
Other glial family cells were also observed within the fibre scaffold which 
only showed nuclei stain (blue) with no GFAP expression. These cells may 
have been oligodendrocytes, microglial or ependymal cells.              
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Figure 5. 8: Immunofluorescence image of primary hippocampal 
neurons cultured on PAN scaffolds.  
Cells were cultured for 21 days and were stained for βIII tubulin (red), 
synaptophysin (yellow) and nuclei (blue). Green represents the 
autofluorescence from the fibres.   
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Figure 5. 9: Immunofluorescence image of primary glial cells from 
hippocampal tissue.  
The cells were cultured on PJ scaffolds for 21 days in NbAstro medium, 
before being fixed and stained for GFAP (red) and nuclei (blue). Green 
represents the autofluorescence from the fibres.  Cells that do not 
express GFAP showed only the nuclei stain.  
5.3.2.4 3D co-culture model  
This experiment aimed to investigate the recovery of primary neuronal 
cells on nanofibre scaffolds, after being exposed to low concentrations of 
toxins in the absence and presence of nanofibre scaffolds containing 
primary glial cells. The 3D co-culture system was set up as described in 
section 2.2.12. The co-culture model can be investigated with three 
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different experimental set. Due to the limitations in the availability of 
tissue samples the co-culture model was investigated only with multi fibre 
layered model. Primary neurons were cultured on PAN, and primary glial 
cells were cultured on PJ fibres. The cells were dissociated from the 
hippocampal tissue sample and were seeded on to the fibres with the 
appropriate culture medium to promote either neuronal or glial cell 
growth. After 7 days in culture, the primary neuronal cells were exposed 
to rotenone (0.5 µM), MG132 (10 µM) and BSO (2 mM) incubated for 3 
days, at concentrations causing sub-lethal damage to the cells is caused 
in subsequent incubation periods. After that, the scaffolds were arranged, 
as shown in figure 2.11A. The primary neurons exposed to the toxins as 
layer 1 and PJ fibre containing primary glial cells as layer 2, both layers 
being separated with a hollow spacer. The co-culture was maintained in 
medium containing a 50:50 (v/v) mix of NbActive1 and NbAstro culture 
for 15 days. Cell viability was measured every 48 hours for each layer 
individually, and the medium was replaced at the same time for 
remaining wells.  Along with the co-culture, simultaneously a separate 
set of neuronal cells cultured on PAN was treated with toxins for 3 days 
and replaced with fresh culture medium and cultured individually. The 
individual culture was also maintained, and viability was measured every 
48 hours for 20 days.  
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Figure 5. 10: Primary neurons and glial cell co-culture model. 
Neurons were cultured on PAN and treated with toxins for 36 hours. 
Following the treatment affected neuronal cells were cultured as a co-
culture with healthy glial cells on PJ fibre. Every 48 hours, the scaffolds 
were separated and investigated for cell viability using CellTiter-Glo® 3D 
assay. Data shown in graph A the obtained values were converted to 
percentage keeping control at 100% and day 1 was set to 0% to 
demonstrate post-treatment neuronal recovery, and for graph B raw data 
was plotted to show post-treatment cell proliferation. No statistical 
analysis was performed as n=1 
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The entire experiment was only performed once, and our preliminary 
findings suggested that the neuronal cells were affected by the toxins and 
continued to lose viability even after 7 days into co-culture with fresh 
medium. After the 7th day, the rate of cell death was reduced, and the 
metabolic activity of the cells was stable for the rest of the experiment. 
Low response to MG132 was observed, and about 50% of cell death was 
observed when treated with rotenone and BSO. By contrast, the primary 
glial cells exhibited long term survival and proliferation throughout the 
experiment and a slower rate of proliferation after day 7. When the 
primary neurons were exposed to the toxin and cultured individually 
without the glial cells, the obtained CellTiter-Glo® 3D data showed a much 
more significant decrease in viability (Figure 5.11). After 3 days of 
exposure, almost 70% of cells were viable, and a continuous decline in 
cell viability was observed throughout 20 days. By the end of the 20th 
day, viability was reduced to only 10% to 20% of control values for all 
three treatments. 
 
Figure 5. 11: Primary neuron cultured on PAN and treated with 
toxins.  
Neurons were cultured on PAN and treated with toxins for 36 hours and 
then cultured in fresh medium for 20 days. Every 48 hours, each scaffold 
was tested for cell viability using CellsTiter-Glo ® 3D viability assay.  The 
obtained values were converted to percentage keeping control at 100% 
and day 1 was set to 0% to demonstrate post-treatment neuronal 
recovery. No statistical analysis was performed as n=1 
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5.4 Discussion  
This chapter mainly focused on demonstrating that random PAN and PJ 
nanofibre scaffolds that were manufactured in-house can be suitable to 
conduct studies that involve other cell types like neural progenitor and 
primary cells obtained from a tissue sample. Data presented in the two 
previous chapters have demonstrated that in-house manufactured PAN 
and PJ nanofibre scaffolds support the attachment and growth of 
immortalised neurons and glial cells. In the previous chapter, we 
performed a series of experiments to understand the ability to the two 
immortalised cell types proliferate, differentiate and react to toxins on 
nanofibre scaffolds. This results chapter has also followed similar 
experimental approaches to see if PAN and PJ fibre can be a suitable 
material for stem cells and primary cell cultures. The study was 
performed using ReNcell CX, a neural progenitor cell line capable of 
differentiating into a mixture of neurons and glial cells, and primary 
neurons and glial cells from E18 rat hippocampal tissue.   
The investigation started with analysing if the ReNcell were capable of 
attaching to the nanofibre. ReNcell cultures require laminin to attach to 
a surface; therefore, all of the material and surfaces were coated with 
laminin before culturing the cells. From the Coomassie blue staining 
(Figure 5.2 A and B), we were able to identify that ReNcells were capable 
of attaching to both PAN and PJ fibre scaffolds. Further evaluation was 
made using the SEM imaging (Figure 5.2 C and D). From the SEM analysis, 
we noticed that on PAN fibre the cells were found attached and holding 
on to the intersection of two fibre strands whereas on PJ fibre the cells 
were more growth within the fibre and also was found wrapped around 
the fibre. On PJ it looks more like the cells have accepted the scaffold as 
a part of the cell body and used the nanofibres as a support to grow within 
the mat. A large number of cells were found attached to laminin-coated 
PCL than tissue culture plastic or uncoated surface /and PJ fibre scaffolds, 
we investigated their proliferation and survival on both PAN and PJ for 15 
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days (Figure 5.3). The attachment and proliferation analysis 
demonstrated that both PAN and PJ was a suitable substrate to support 
ReNcell CX growth. However, cell cultured on PJ fibres demonstrated a 
higher rate for proliferation compared to PAN and TCP. The cells cultured 
on PJ showed a gradual increase in cell viability for 15 days whereas cells 
on PAN fibre expressed a slower rate of cell proliferation similar to TCP 
until day 7 and then a gradual increase up to day 15. However, few 
studies have reported that cells cultured on TCP exhibit a higher rate of 
proliferation and higher survival compared to a 3D culture (Laco, Grant 
and Black 2013; Kijeńska, Prabhakaran, Swieszkowski, et al. 2014). In 
contrast to those studies, the cells cultured on both PAN and PJ showed 
better survival compared to the cells on TCP. The proliferation assay was 
only investigated on undifferentiated ReNcells; further investigation on 
differentiated cells may show the extended survival of neurons and glial 
based on the choice of material surface.    
After we have shown that the ReNcell CX cells are capable of attaching 
and proliferating on PAN and PJ, we investigated if they were capable of 
differentiating to neurons and glial cells on both PAN and PJ.  The 
influence of the various nanofibre surfaces on ReNcell CX cell morphology 
and distribution was investigated through immunofluorescence staining 
(Figure 5.4). Several studies have shown that many factors can induce 
differentiation of a neural progenitor cell (Reubinoff, Itsykson, Turetsky, 
et al. 2001; Dhara and Stice 2008). In this study, we differentiated 
ReNcell by withdrawing the mitogens from the cell culture medium. In 
our previous results chapter on SH-SY5Y and U-87MG we were able to 
demonstrate that neuronal (SH-SY5Y) cells preferred the PAN surface and 
glial (U-87MG) cells preferred the PJ surface. A similar effect was also 
expected in ReNcells when differentiated on PAN and PJ; but instead, 
ReNcell CX cells were capable of differentiating into neurons and glial cells 
on both PAN and PJ nanofibre scaffolds. Neurons were stained for βIII 
tubulin, and glial cells were stained for GFAP. From the 
immunofluorescence imaging, it was evident that the ReNcell CX was 
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capable of differentiating in neurons and glial cells. The imaging also 
revealed that vast population of the cell was found accumulated in 
different regions of PJ fibre (Figure 5.4D) whereas cells attached to PAN 
(figure 5.4 C) was spread across the entire regions. Short extensions of 
neurite outgrowth were observed expressing βIII tubulin a matured 
neuronal marker (figure 5.4 C and D). 
Similarly, GFAP expressing glial cells were found in large clusters on PJ 
fibre (figure 5.4 F) and a tiny group of cells found in multiple regions on 
PAN fibres (Figure 5.4 E). Undifferentiated ReNcell CX was examined with 
nestin protein a standard marker used for ReNcell CX (Lendahl, 
Zimmerman and McKay 1990; Donato, Miljan, Hines, et al. 2007). The 
undifferentiated ReNcell CX displays an immature neural morphology 
(Figure 5.4 A and B). A study on ReNcell CX has reported that on TCP the 
cells tend to form a small polygonal shape with few processes that 
develop into a tight cobble-stone pattern when confluent (Donato, Miljan, 
Hines, et al. 2007). Similarly, clusters of undifferentiated cells were 
observed in several regions on both PAN and PJ fibres.     
ReNcell cell lines have been used to investigate neurodegenerative 
diseases in several studies (Schüle, Pera and Langston 2009; 
Gnanasegaran, Govindasamy, Musa, et al. 2016). A study published a 
decade ago has demonstrated the potential of ReNcell VX cells as a model 
and showed the association of neurodegeneration with the PINK1 gene. 
The study used transfected siRNA to target PINK1 gene, and the results 
indicated that age-dependent neurodegeneration was observed with the 
reduced long-term viability of the neurons, demonstrating that the effect 
was triggered through a mitochondrial apoptosis pathway (Wood-
Kaczmar, Gandhi, Yao, et al. 2008).  ReNcell cell lines have their 
limitations, being an immortalised cell type, but may still provide a 
promising model for studying neurodegenerative conditions (Schüle, Pera 
and Langston 2009).  Unlike other models and studies, we investigated 
toxins on ReNcell CX cells that were cultured on 3D nanofibre scaffolds, 
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which are capable of providing a robust environment for the cells to 
respond against the toxins. The differentiated cells were exposed to 
toxins for 72 hours, and the data showed that the cells on TCPs had lower 
viability than those on fibres (figure 5.5 A and B). Cells cultured on PJ 
showed higher viability compared to PAN. In section 5.3.1.3 we have 
shown that a higher metabolic activity and cell viability was observed on 
PJ compared to PAN. One possible explanation for this is that, since both 
cell types were found on fibres, glial cells within the nanofibre scaffolds 
may have released neurotrophic factors and neuroprotective agents that 
protected neurons against the effects of the toxins. To validate this 
phenomenon, further investigation will need to be carried out.  
The main source of primary cultures is from either adult or embryonic 
animal tissue, which is then cultured either as an explant culture, 
suspension or as monolayer and maintained in vitro. As these cells have 
undergone very few doublings, they are more representative of the main 
functional component of the tissue from which they were obtained 
compared to established cell lines, thus representing a more 
physiologically relevant model (Alge, Hauck, Priglinger, et al. 2006; Pan, 
C., Kumar, Bohl, et al. 2009). In the current study, we have used primary 
cultures of neurons and glial cells derived from E18 embryonic rat 
hippocampus. The brain was removed and dissected to appropriate tissue 
by a company named BrianBits, UK. The hippocampal tissue was 
processed in-house to obtain neurons and glial cells. Preliminary studies 
showed that the primary cultures were capable of surviving on both PAN 
and PJ fibres compared to the TCP (Figure5.6 and 5.7). The primary 
neurons are not capable of dividing, and the MTT assay showed that 
primary neurons cultured on PAN expressed a constant metabolic activity 
for 21 days whereas a decrease in cell metabolism was observed from 
day 16 on TCP. However, on the viability of neuronal cells cultured on PJ 
fibre was gradually decreasing. At day 20 almost 50% reduction in cell 
metabolic activity was observed from the MTT data when compared to 
the first measurement (figure 5.6 B). The Primary glial cell was capable 
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of dividing and from the MTT analysis (Figure 5.7) it was evident that glial 
cells were able to survive and express the increase in cell metabolism up 
to 21 days in culture on both PAN and PJ. The MTT analysis showed a 
significant increase and long-term metabolic activity on the fibres 
compared to the TCP. The cells on TCP expressed an increase in metabolic 
response until day 12 and gradual decrease after that until day 21.     
Cell attachment and differentiation were further confirmed by 
immunofluorescence imaging.  Neurons were stained for βIII tubulin, and 
synaptophysin and glial cells were stained for GFAP. When observed 
under a confocal microscope the neurons exhibited branches of neurite 
extensions in contact with neighbouring cells along with evidence of 
synapse formation (figure 5.8). The cells were presumably using the 
nanofibres as robust support to extend long axons all over the fibre. The 
glial cells showed a strong expression of GFAP and star-shaped structured 
forming a monolayer on the top surface of the fibre, typical of astrocytes 
(figure 5.9). However, not all cells were positive for GFAP expression; 
these could be other glial cell types. The cell culture medium supplied by 
BrainBits for the glial cells was mainly to promote the growth of 
astrocytes. It was evident that both neurons and glial cells were 
physically and biochemically capable of growing and differentiating on 
PAN and PJ fibres, respectively.  
A primary aim of the study was to develop a 3D co-culture model to 
evaluate and neural cell degeneration. The primary neuronal cell cultures 
grown on PAN scaffolds were exposed to low concentrations of toxins 
prior to being co-cultured with the glial cell PJ scaffolds in toxin-free 
conditions to monitor the viability of the neuronal cells. The cell viability 
data obtained for the neuronal cell scaffolds showed almost 80% of the 
neuronal viability was lost due to the toxin exposure (Figure 5.10 A). The 
trend suggested that neurons were dying up to day 7, after which they 
stabilised up to day 20. A similar effect was seen for all three of the toxins 
used, among which rotenone caused the most damage. The glial cell data 
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suggested that these cells remained viable throughout the experiment 
with a minimal reduction in cell viability compared to the control (figure 
5.10 B). However, when the primary neurons were exposed to toxins and 
subsequently cultured in the absence of glial cells, they exhibited much 
more significant decreases in cell viability than those in co-
cultures(Figure 5.11). Due to the financial and time limitations, the 
experiment was performed only once and, therefore, to prove the 
hypothesis of primary neuronal survival in the presence of glial cell 
scaffolds will require further investigation.  
5.5 Conclusion 
In summary, this chapter has demonstrated that ReNcell CX cells and 
primary cultures of cells derived from E18 rat brain tissue can be cultured 
on both PAN and PJ nanofibres. We have shown with some preliminary 
experiments that ReNcells are capable of growing on both PAN and PJ but 
with a higher proliferation rate and survival on PJ compared to PAN. Both 
PAN and PJ fibre have also shown that they are capable of promoting 
ReNcell CX cell differentiation to neurons and glial cells. In general, 
primary cells are complicated to handle and culture. They tend to die due 
to microbial contamination during the culture period easily. However, in 
our study model, we were able to manufacture nanofibre scaffolds that 
were maintained sterile and were also capable of supporting primary 
neuron and glial cell survival.  Both cell types exposed to toxins and 
demonstrated that it could be a suitable model for investigating neural 
cell degeneration. Our findings may have shown realistic information 
compared to other studies performed on 2D tissue culture plastics. 
Unfortunately, the chronic co-culture model for primary cell study was 
investigated only once. Nevertheless, our preliminary findings have 
suggested that the co-culture model is up-and-coming and may be a very 
suitable candidate for performing chronic studies and high throughput 
screening of neuroprotective agents and therapeutic drugs for 
neurodegenerative disease. 
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Chapter 6: Main Discussion 
6.1 Introduction  
Neuronal and glial cells have been the main focus for investigating 
neurodegenerative diseases for several decades (Vila, Jackson-Lewis, 
Guégan, et al. 2001; Teismann, Tieu, Cohen, et al. 2003; Oh, S. E., Park, 
He, et al. 2018). Tissue engineering is an ever-expanding field, and a 
promising strategy for cell therapy. It lies in fixing damaged organs, 
tissues in vivo and also by generating engineered tissue constructs by in 
vitro techniques for subsequent transplantation. For several decades 
many studies have shown that biomaterials can play a role in the 
development of functional cells and tissues for the replacement of lost or 
affected cells and tissues (Kim, B., Baez and Atala 2000; Khan and 
Tanaka 2018). These replacements are commonly created with 
combinations for living cells, biomaterial scaffoldings and signalling 
molecules (Kim, I., Seo, Moon, et al. 2008). Studies have shown when 
engrafted cells are delivered on a biomaterial scaffold based system 
benefits have been recorded regarding cell replacement, tissue repair and 
in vitro studies. This may be because well-designed scaffolds are capable 
of providing structural support and the free flow of essential factors that 
can enhance the survival and function of the cells (Skop, Calderon, Cho, 
et al. 2014). When biomaterials are structured to provide an artificial ECM 
or more natural like habitat for cells, it can elevate the natural biological 
and mechanical functions of the native ECM of the cells.  
Research into 3D cell culture has grown in the last few years.  A keyword 
search in PubMed for 3D cell cultures shows 8872 articles published until 
February 2019, with the first ever paper on 3D culture published in 1968. 
The exponential increase publications show the importance and interest 
among researchers on 3D cell culture techniques. When cells are cultured 
on a 3D scaffold, they exhibit features that are much closer to in vivo 
conditions (Vinci, Gowan, Boxall, et al. 2012). The 3D culture models 
have proven to be realistic for translating the study findings for in vivo 
CHAPTER VI                                                             MAIN DISCUSSION 
207 
 
applications. 3D cell culture studies cover a wide range of topics and have 
proven to be very suitable for several investigations and studies. Studies 
such as differentiation studies, drug discovery and pharmacological 
applications, tumour models, genetic studies, protein expression 
application, understanding cell physiology, investigating  cell proliferation 
and cell cycle studies, cell cytoskeleton studies, apoptosis, cell adhesion 
and cell signalling, cell morphology, tissue engineering studies, and co-
culture behavioural study have benefited from 3D models. With several 
advantages of 3D cell cultured, in vitro studies are now closer in 
mimicking a human in vivo tissue.  A follow-on benefit will be the 
reduction and replacement of some animal model studies for research 
and product safety testing. They offer a robust superstructure that can 
be utilised to understand complex cell interactions that are not possible 
with 2D cell culture techniques. 3D cultures are more relevant cell models 
that are capable of better interaction between different cell types 
promoting integration flow or sometimes used as a barrier tissue. A 
critical step is a design and the choice of biomaterial used. The 
biomaterial scaffold must be capable of supporting and controlling the 
structural and functional integrity of the cell. It must be biocompatible 
and promote cell survival. In general, it should promote cell adhesion, 
proliferation, migration and differentiation, but in the case of a barrier, 
scaffold can restrict migration of cells. Constructing a suitable biomaterial 
scaffold requires properties like a sizeable surface-area-to-volume ratio 
making it suitable for a large number of cells, a high degree of porosity, 
interconnected structures, membrane thickness and individual filament 
diameters. Several techniques have been used to achieve these cues by 
using different types of natural and synthetic material to form 
biocompatible scaffold membranes. 
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6.2 Electrospinning biomaterials scaffolds for in vitro cell culture 
and tissue engineering. 
Polymer-based nanofibres can be produced by the method of 
electrospinning and benefits like fibre composition, adjustable fibre 
diameter, orientation, degradation, physical and mechanical properties, 
and surface modification can be tailored to specific application making it 
a very suitable process to produce scaffolds  for cell therapy, tissue 
engineering and 3D cell culture studies (Dahlin, Kasper and Mikos 2011; 
Thenmozhi, Dharmaraj, Kadirvelu, et al. 2017). A significant number of 
research projects have been carried out on 3D cell culture methods on 
electrospun nanofibres using a wide range of natural, synthetic and 
blended polymers. Nanofibre scaffolds have been produced in different 
forms and by using many methods but most published work reports that 
spun fibres are deposited on and in contact with a solid carrier substrate 
thus making it a pseudo3D or the materials produced are not easily 
handled in a culture system. In this study, we have designed a 
production-ready process to create fully suspended correct 3D nanofibre 
scaffolds. The design allows the delicate nanofibre membrane to be 
manipulated during cell culture and tissue engineering. The design is very 
suitable for 6, 12 and 24 well TCP and can be incorporated to hold 
nanofibres made using suitable polymers.  
Suspended 3D scaffold with three orientations was engineered in this 
study, with each type providing different structural cues for different cell 
types.  The random fibre well plate insert (section 2.2.1.1) consisted of 
random electrospun nanofibre membranes laid across circular apertures 
and then held in place or sandwiched between an identical substrate with 
laser cut circular apertures.  The technique has been perfected to create 
reproducible scaffolds which can be inserted individually into well plates. 
The aligned fibre scaffold (section 2.2.1.2) uses a unique and patent-
pending method to manufacture aligned suspended fibre membranes. 
Collector drums rotating at high-speed is the principal method to 
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manufacture aligned nanofibres.  This approach requires very high 
surface speeds of the collector drum, rotor and modification of the 
existing electrospinning system (Yu, Shao, Xu, et al. 2017). Our method 
only requires a laser cut sheet with a design that produces regions of 
aligned and random nanofibre membrane in a single scaffold insert. The 
design comprises of two rectangular apertures which form pathways for 
electrostatic discharge and an elliptical aperture which does not have an 
efficient pathway for electrostatic discharge and the aligned fibres are 
formed in this region. During electrospinning, an electrostatic field which 
develops between two rectangular regions forces a charged fibre over 
one region to travel and stretch to form an aligned fibre and reaches the 
opposite region which is instantaneously at a lower potential. Based on 
similar principle we have also developed a radial fibre design (section 
2.2.1.3) that comprises of an inner circle and outer circle forming radial 
fibred between the two. Each scaffold model can be used for various 
studies like neurodegenerative study, spinal cord study, retinal 
investigation, wound healing research, orthopaedic research, etc. This 
study was focused on investigating the ability of random suspended 
nanofibre 3D scaffolds to support the growth of neuronal and glial cells 
to establish an improved in vitro model.   
Currently, there are wide range of natural, synthetic and blended 
polymers that have been used for manufacturing electrospun nanofibres 
for various application and studies by different research groups (Zagho 
and Elzatahry 2016),(Electrospin Tech polymer data). In this study, we 
have primarily chosen to work with PAN and PJ polymers Jeffamine® ED-
2003 was used as an additive to modify PAN forming PJ. Limited 
comparative information is available on cell-based techniques using PAN 
and PJ fibres. In general, PAN is a carbon-rich polymer that has been 
widely used in many different applications, and a few studies have shown 
it to be a suitable material of in vitro cell culture studies. Both PAN and 
PJ are readily dissolvable in DMF when heated at 50°C overnight with 
constant stirring.  When PAN is completely dissolved, it appears in pale 
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yellow and adding 5wt% Jeffamine ® with an absorbance of 40%±2% 
and 75%±2% measured at 540nm respectively. Each batch of polymers 
was prepared and stored at 4°C and heated to room temperature before 
use. The Rheometer measurements revealed that 10wt% PAN expressed 
a viscosity of 7E-1 ± 1 Pa.s  with a calculated breakup time of 3E-1 ±0.5 
seconds of PJ at  7E-1± 1 Pa.s with a calculated breakup time of 2E-1± 
0.5 seconds. Adding 5wt% of jefammine has not altered the extensional 
viscosity of PAN. The scaffolds made using a blunt-end needle system 
and a rotating collector in a controlled humidity, and temperature 
chamber maintained at 65% and 21°C respectively. The polymers were 
capable of free-flow when pumped at 1ml/hour rate, and the fibres were 
obtained at 21kv for PAN and 18kv for PJ. When an electrical potential of 
the surface is increased to a sufficient value, the electrical forces act in 
opposition to and dominate the surface tension of the fluid causing the 
jet of the fluid to eject (Reneker and Yarin 2008).  Another critical factor 
is the flow rate during the spinning. Each polymer requires an optimised 
flow rate based on the polymer properties and the type of fibre required. 
In this study, both PAN and PJ were spun at 1ml/hour flow rate 
throughout the study. Fibre diameter and the architecture of the 
nanofibre surface can influence the growth of cells. Nanofibres were 
achieved with an average fibre diameter ranging between 500-600nm. 
Our water contact angle study showed that PAN is hydrophobic, and PJ is 
hydrophilic. Several studies have confirmed the hydrophobicity properties 
of PAN as hydrophobic and Jeffamine® as hydrophilic (Kobayashi, Nagai, 
Wang, et al. 1996; Krakovský, Pleštil and Almásy 2006; Alarifi, Alharbi, 
Khan, et al. 2015). The average membrane thickness used for this study 
was 33.5µm and 30µm for PAN and PJ respectively. Increase in the total 
volume of deposition will lead to an increase in the thickness of the 
membrane. Sterilisation is an essential part of this study. Several 
techniques are currently available to sterilise nanofibres. Conventional 
techniques used are gamma treatment, autoclave, dry heat, vacuum, 
plasma treatment, ethanol, UV and electron beam treatments (Yixiang, 
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Yong, Liao, et al. 2008; Duszyer, Koral Koc, Hockenberger, et al. 2013; 
Dai, Ronholm, Tian, et al. 2016; Rediguieri, Sassonia, Dua, et al. 2016). 
In this study, the fibres were tested with 70% ethanol, UV treatment and 
antibiotic treatment. From further investigating on all three methods of 
sterilisation, the study was performed using a combination of multiple 
sterilisation procedures. The study has demonstrated an SOP for 
sterilisation without causing structural, physical or chemical property 
damage and developing a contaminant-free nanofibre scaffold suitable 
for cell-based techniques.  
6.3 3D scaffolds vs 2D TCP on immortalised cells 
Cell culture techniques are a vital tool in today’s biological research and 
immortalised cells have been the main root of this technique for decades.  
Culturing these cells on a 2D TCP has been the standard practice for some 
time now, but a flat and stable surface can never represent or accurately 
model the in vivo nature of human tissue. Many studies have shown that 
cells cultured in 3D have demonstrated high physiological relevance and 
improvement in biological response like high cell number, morphology, 
the rate of proliferation, differentiation and viability.  Studies have also 
shown that cells cultured in 3D responds better to stimuli, drug 
metabolism, and protein synthesis concerning high relevance to an in 
vivo system (Antoni, Burckel, Josset, et al. 2015). Physiological relevance 
is a crucial factor for study-related drug discovery, drug testing and cell-
based assays.  
In this study, we have used two commercially available human cells lines 
SH-SY5Y neuroblastoma and U-87 MG glioblastoma on both PAN and PJ 
nanofibre scaffolds. The study was mainly focused on random nanofibre 
scaffolds of PAN and PJ. Initially, we started with manufacturing 
nanofibres on a flat surface forming an unsuspended membrane which 
was more of a pseudo3D scaffold. Cells exposed to those material were 
found more attached to the edges of the fibre and on losing fibre ends. It 
was also impossible to maintain the fibres to be intact in lengthy culture 
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procedures and this led to engineering and manufacturing a fully 
suspended random scaffold. When the cell was introduced to a full 
suspended scaffold, most of the cells were found wholly attached 
throughout the fibre scaffolds, and the fibres were maintained intact 
throughout the procedure. The cell attachment was confirmed by 
Coomassie blue staining and immunofluorescence analysis. The results 
show that PAN and PJ nanofibres are suitable biomaterials to produce 
random nanofibre constructs that support neuronal and glial cells, 
respectively. Our investigation of cell proliferation for 11 days showed 
that PAN was the preferred surface for neuroblastoma and PJ preferred 
surface of the glioblastoma, but in both cases, cell growth and survival 
were maintained for longer on nanofibre scaffolds compared to 
conventional TCP. Several studies have shown that cells cultured on the 
3D structure are capable of surviving a more extended period compared 
to 2D TCP as the cells die due to cell confluency (Antoni, Burckel, Josset, 
et al. 2015). Comparatively both 3D has double the total surface area 
compared to a 2D surface. A flat region on a 2D 12 well TCP has a growth 
region of 3.8 cm2 (2D X and Y axis) with a total well diameter of 22.1mm 
whereas the both scaffolds used in this study is 10mm in diameter and 
30micron in thickness providing a total growth surface region of 6.3cm2   
The reason behind SH-SY5Y preferring the hydrophobic carbon-rich 
surface and U-87MG preferring a hydrophilic carbon and amine surface is 
still unknown. Hypothetically we think the neuronal cell is more prone to 
migration and extension. Therefore, a hydrophobic surface can support a 
lighter and flexible cell attachment but may also easily allow the cell body 
and neurites to roll over the surface for cell-cell contact making it easy 
for creating complex network connections. Whereas glial cells naturally 
are supporting cell in the brain and they tend to link firmly to adjacent 
neuronal cells and provide support and protection.  The glial cell may 
require a hydrophilic surface that may have a better influence on the ECM 
leading to a firm attachment to the surface. This hypothesis does require 
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further investigation and explanation to validate the theory behind the 
mystery of surface preference by each cell type.  
After identifying the suitable nanofibre, both cell types were exposed to 
differentiation inducer RA for SH-SY5Y and dbcAMP for U-87MG (Tiryaki, 
Ayres, Ahmed, et al. 2015; Korecka, van Kesteren, Blaas, et al. 2013; 
Fedoroff, McAuley, Houkle, et al. 1984). The B27 supplement is a 
commercially available product that is commonly used for the survival of 
primary neurons and differentiation (Roth, Zhang, Chiu, et al. 2010; 
Kovalevich and Langford 2013) and was used in this study as an 
alternative differentiating agent. When examined for possible 
differentiation markers SH-SY5Y cells cultured on PAN showed elevated 
levels of SMI 34 phosphorylated neurofilament, βIII tubulin and 
synaptophysin and U-87MG showed high levels of GFAP compared to the 
cells on the plate. The data from confocal imaging and western blot 
analysis showed that PAN and PJ fibres are capable of supporting SH-
SY5Y and U-87MG cell differentiation. Our results on exposure to toxins 
showed that the cells on fibre exhibited higher sensitivities to the different 
toxins compared to cells grown on conventional TCP. Cells cultured on 
both fibres showed a similar effect cell cultured on fibres for more 
susceptible to toxin than the cell on the plate. However, cells SH-SY5Y 
cultured on PJ and U-87MG on PAN showed greater damage and a 
significant decrease in cell viability due to the toxins and also may be due 
to the non-preferable surface.  The increased susceptibility may be due 
to the increased cell surface in contact with the toxins on fibre compared 
to cells cultured on a flat culture plate. The ECM plays a central role in 
the proliferation, differentiation and function of the cells. Glial cells are 
the primary supporting cells for the neuron in the brain (Takuma, Baba 
and Matsuda 2004; Barreto, E White, Ouyang, et al. 2011; Cabezas, El-
Bachá, González, et al. 2012). Our preliminary investigation on glial ECM 
on 2D surface revealed the differentiation capabilities of neurons when 
cultured on glia ECM. The neuronal cells were capable of producing 
matured axonal elongation with the growth factors from the glial ECM. 
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The matured axonal growth was confirmed with βIII tubulin staining on 
an immunofluorescence microscope. Due to the limitation in time, this 
experiment was not performed on nanofibres, but this method could 
make inhabitable neuronal surfaces like PJ to become a neuron-
supporting surface and can provide more natural ways for axonal 
elongations. 
Several studies have shown the role of glial cell and the better 
development of neurons when cultured as a co-culture. Co-culturing of 
cells is a commonly used method to understand the response of one type 
of cell to the presence of another.  Neurons and glial cells coexist in nature, 
and several models are used to co-culture these cells (Berre‐Scoul, 
Chevalier, Oleynikova, et al. 2017). Most co-culture models are 2D based 
systems where both types of cells are either cultured together in the same 
dish or one type cultured on the base surface, and others introduced 
cultures on a glass coverslip or transwell inserts (Skaper and Facci 2018). 
Either of these methods has various limitations or disadvantages like it is 
a 2D surface, damage caused by the movement of the coverslip, improper 
supply of growth factors, challenging to handle, uncontrollable cell habitat.  
We investigated our co-culture system with neurons and astrocytes 
exposed to toxins, and our results indicate that neurons exposed to toxins 
had a better chance of survival when cultured as a co-culture along with 
astrocytes on a scaffold-based model. The chronic co-culture model has 
demonstrated the prolonged survival of cells, and two different types of 
cell can be cultured on different scaffolds to recreate more realistic 
chronic models of studying neural cell degeneration.  With the presence 
of astrocytes and nanofibre, the neuronal cells were able to express 
resistance to the lower concentrations of toxins. Astrocytes provide the 
neurotrophic factor (Lindahl, Saarma and Lindholm 2017), and the 
nanofibre provides robust structural support leading to prolonged cell 
survival. Several studies have also shown that glial cell line-derived 
neurotrophic factors can support neuronal cell line growth and this is 
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proving to be very useful in studying neurodegenerative diseases 
(Nishiguchi, Tokugawa, Yamamoto, et al. 2003; Shishkina, Mishchenko, 
Mitroshina, et al. 2018).  A similar effect of toxins on the undifferentiated 
cell was also seen when differentiated SH-SY5Y and U-87MG cells were 
exposed to toxins individually (figure 4.27). Both cell type was sensitive 
to the inhibitor and showed a higher rate of cell death. They show that 
both astrocyte and nanofibres play a dual role in longer survival of the 
cells in the chronic 3D co-culture model.    
Our co-culture model can be designed with any choice of electrospinnable 
polymer and can be made to fit precisely into a well plate. The model can 
consist of a two-layered co-culture system or can also be a multilayered 
system. For example, a scaffold with the neuronal cell can be cultured to 
form one layer and can be sandwiched between different types of glial 
cells on different layers. In this system, each layer of the scaffold can be 
placed at very close proximity or can be at a measured specific distance. 
The system also provides an advantage of measuring the cell viability of 
individual cell type from each scaffold layer.  Cells showing lower viability 
can be replaced with scaffolds containing healthier cells. Each layer of 
cells can be easily arranged or separated based on experimental needs. 
The system opens up a wide range of opportunities to researchers and 
can be used as a very close model to replicate an in vivo system.  
6.4 Investigation of stem cell and primary cell on PAN and PJ 
nanofibre scaffolds 
Stem cell technology and primary cell-based techniques have pioneered 
the method 3D scaffold-based tissue engineering studies. Carbon-based 
nanomaterials have revolutionised stem cell and primary cell research 
(Stout and Webster 2012; Baldrighi, Trusel, Tonini, et al. 2016). 
Developing scaffolds with nanoscale features which mimics the habitat of 
cells in tissue is one of the significant challenges in the field of tissue 
engineering, and electrospinning of nanofibre membranes has shown 
great potential in overcoming this challenge (Vasita and Katti 2006). 
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Combination of cell therapy and polymer-based nanofibres material have 
overcome several obstacles in tissue engineering and regenerative 
medicines leading to the development of treatment for several medical 
conditions. As a part of the investigation in this study, we tested the high 
carbon-rich based PAN and carbon-amine rich PJ nanofibres on stem cell-
like neural progenitor cells and primary neuron and glial cells. 
As the first part of the investigation first, we tested if the chosen material 
can support the attachment of ReNcell CX and primary neurons and 
primary glial cells. As a result of our proliferation study, we were 
convinced that both ReNcell and the primary cells were capable of 
attaching and proliferating on both PAN and PJ fibre with only minor 
setbacks. ReNcell showed better survival and proliferation on PJ 
compared to PAN, primary neurons better survival on PAN and primary 
glial showed high survival rate on both PAN and PJ fibres. In both cases, 
long term survival of the cell on the plate was very questionable 
compared to fibres. Next, we investigated the ability of these cells to 
differentiate. ReNcell could differentiate into neurons, and glial cells 
whereas primary neurons do not divide but the cells are capable of 
differentiating and producing extend neurite outgrowths, and primary 
astrocyte growth was promoted from the glial cells.  Immunofluorescence 
imaging revealed the ability of these cells to differentiate on PAN and PJ 
fibres. Neurons were stained for βIII tubulin, and glial cells were stained 
for GFAP.  The high expression on both proteins was expressed for 
cultures on PAN and PJ fibres. We investigated the expression of nestin 
protein, which is a standard marker for undifferentiated ReNcell CX 
(Donato, Miljan, Hines, et al. 2007). In the case of differentiated ReNcells, 
though neuron and glial cells were found on both PAN and PJ, a high 
number of cells were found on PJ compared to PAN therefore low 
expression on βIII tubulin, and GFAP was observed on cells cultured on 
PAN. When stained primary cells were observed under a confocal 
microscope, the neurons were found growing as a single cell with 
branches of neurite extensions in contact with neighbouring cells along 
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with some strong synaptic activity. The 3D nanofibre act as a support for 
the extension of neurite outgrowth in all direction enabling the cells to 
create a complex network connection with surrounding cells in its natural 
form. The glial cells showed a strong expression of GFAP and star-shaped 
structured forming a monolayer mostly on the top surface of the fibre. 
Many cells were found with no GFAP expression, and they might have 
been other glial family of cells.     
As per the plan in the study, the cells were investigated with toxins. The 
differentiated ReNcells were exposed to toxins for 72 hours, and the data 
showed that the cells on the plate had a lower viability percentage 
compared to the fibres. Cell cultured on PJ showed higher viability 
compared to PAN. Introducing healthy ReNcells as co-culture on a 
different scaffold may have revealed if the damaged cells could recover. 
Similarly, when we investigated the recovery of primary neurons from 
the damage caused by the toxins with the co-culture support of healthy 
glial cells. The neuronal cells were exposed to toxins for 48 hours and co-
cultured with glial cells for 15 days in fully healthy conditions. From a 
preliminary experimental data, the neurons were dying up to day 7, and 
after day 7, the cells stopped dying and continued to survive up to day 
20, and the glial cell was observed as healthy and viable through the 
experiment. Moreover, when exposed individually the primary neurons 
showed very poor viability, and the cells continued to die since day one 
after the exposure. Due to time constraints and financial support, the co-
culture model for ReNcells was not investigated, and the co-culture on 
Primary neurons and glial cells were only performed once. Further 
experimental repeats are required to understand and validate the survival 
of primary neurons in the presence of glial cells. Providing an adaptable 
structure to mimic the native ECM is one of the most significant 
challenges of 3D based scaffold models.  Among all available methods, 
electrospun nanofibres have shown the most promising results in several 
studies and therapies. 
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7.0 Conclusion and future work 
7.1 Conclusion  
This thesis has presented data gathered as part of a PhD project 
“Development of a novel 3D nanofibre co-culture model for 
characterisation of neural cell degeneration”. The investigations shown in 
this thesis covers an extensive topic on neurodegenerative disease that 
happens in the human brain. There are number of discovered 
degenerative disease like amyotrophic lateral sclerosis, Parkinson's 
disease, Alzheimer's disease, and Huntington's disease. All these diseases 
share few common factors but still has its uniqueness in the 
pathophysiology. The model shown and investigated in this study was 
mainly focused on two significant representatives the neuronal and glial 
cells. These two types of cells are primarily affected in all 
neurodegenerative diseases. The slightest change in their regular 
function and metabolism leads to complications that can become one of 
the neurodegenerative diseases. Due the limited resource, knowledge 
and time in this study we have only focused on a small group cell types 
and materials. The primary focus of the research was to develop a 
nanofibre scaffold model that may mimic a 3D habitat allowing us to test 
and understand the behaviour of the two cell types under various 
conditions. The neural degeneration studies performed in this study 
shows a broad spectrum of scope for a researcher to choose and tailor it 
to maybe a specific type of neurodegenerative disorder. The novel co-
culture model has also demonstrated that ability to investigate the two-
primary type of cells by providing a suitable habitat with benefits of an in 
vivo like in vitro environment. The co-culture method has shown the 
possibilities to investigate several disorders that involve more than one 
type of cell. The entire study may have revealed a vast topic of neural 
cell degeneration but with all the findings and the information provided 
in this study researchers will be able to pick and choose suitable method 
or a model for much targeted research towards a specific 
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neurodegenerative disease or any other disease that can benefit in 
studying on a fully suspended 3D nanofibre scaffold model.               
The study was mainly based on nanofibres made using Polyacrylonitrile 
(PAN) (Mw 150,000) and Jeffamine® ED-2003 as an additive (PJ). In this 
study, we developed three different engineered designs that may be 
suitable for a research which uses in vitro models. For example, studies 
which target the development of drugs to treat the disease of the brain 
and retina, spinal cord damage, and, chronic wounds. In addition, 3D 
nanofibre scaffolds show potential as acellular scaffolds for soft and hard 
tissue repair an as a platform for implanting cells as part of a cell-based 
or regenerative therapy. With the in-house built electrospinning system, 
using PAN and PJ polymers, we developed a reproducible process to 
fabricate fully suspended and ultrathin nanofibre fibre scaffolds which 
were secured between two support substrates which then allowed for 
easy handling and chronic studies. The SOP for sterilising nanofibre 
scaffolds demonstrated that the scaffolds could be sterilised with no 
physical damage or changes to its function and properties. Our various 
cell-based investigations have shown that both PAN and PJ fibres are 
capable of supporting cell attachment, proliferation, survival and 
differentiation. 
The cell-based techniques in this study were performed using three 
different cell types that are commonly used in neurodegenerative related 
research. The study was conducted using  
1. Immortalised cell line human SY-SY5Y neuroblastoma cells and Human 
U-87 MG glioblastoma cells. 
2. Human ReNcell CX neural progenitor cell, and 
3. Primary neurons and astrocytes dissociated from an embryonic day 18 
rat hippocampus. 
Primary investigation on all the three cell types was to investigate if cells 
are capable of attaching and proliferating on PAN and PJ nanofibres. Our 
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proliferation assay, which cultured each cell type for more than seven 
days showed a selective response based on the two kinds of nanofibres 
used and also expressed a more extended period of survival on fibres 
than TCP. We differentiated the cell types on both PAN and PJ fibres and 
showed the expression of several differentiation markers for both neurons 
and glial cells. Toxins were used to recreate neural cell degeneration 
pathophysiology for all cell types. An increased response to the toxins 
from the cells was observed for those grown on PAN and PJ fibres. The 
immortalised cells appeared more sensitive when exposed individually, 
and the ReNcell have expressed a minor resistance to the treatment.  
Our state-of-the-art multi-stacking co-culture method using scaffolds has 
shown astonishing preliminary data on the immortalised cells and for the 
primary cells. High resistance to the inhibitors was observed when the 
immortalised neurons and astrocytes were cultured as a co-culture on the 
scaffolds and comparatively when one of the cells was cultured on a 2D 
based surface reduced cell viability was noticed. The recovery study 
performed as a co-culture on primary neurons also revealed that when 
the primary neurons were exposed to the inhibitors for a short time and 
co-cultured with healthy glial cells, the neurons were able to have 
prolonged survival. However, when tested without the presence of the 
astrocytes, the primary neurons exposed to the inhibitors showed 
reduced cell viability even though the inhibitors were removed from the 
culture and replaced with nutrient-rich media. This preliminary 
experiment has been demonstrated that the presence of glial cells and 
glial-derived neurotrophic factors from the glial cells are essential 
components for neuronal cell survival. Also, with the help of a robust 3D 
scaffold the in vitro structure resembles the natural in vivo tissue. The 
multi-layered co-culture system presents opportunities to create a wide 
range of in vitro human models using multiple layers of multiple cell types 
which are better suited to screening for potential drug candidates to 
improve the chance of drugs having successful clinical trials. This would 
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help to reduce the reliance on animal testing by the pharmaceutical 
industry.                                
Nanofibres can be made with a range of natural and synthetic materials 
and provides a high surface area with adjustable porosity causing a 
significant effect of cell attachment, proliferation and differentiation.  
Although the study has demonstrated several aspects of PAN and PJ 
nanofibre, both PAN and PJ may not be suitable for all type of cell-based 
investigations. Our nanofibre design is made to accommodate many 
different polymers, and these may be chosen to suit separate therapeutic 
investigations. The work demonstrates for the first time the benefits of 
using suspended, ultrathin 3D nanofibre scaffolds for in vitro models and 
justifies further in-depth research to develop models of other diseased or 
damaged tissue.    
7.2 Future Work 
7.2.1 Polymers and nanofibres  
The study was primarily focused only on nanofibres made using PAN and 
PJ polymers. An extensive range of polymers are available which can be 
electrospun to form nanofibre materials, some polymers are derived from 
animal and plants, while others are synthesised from fossil fuels. One of 
the main advantages of polymer-based nanofibres is that the polymers 
can be blended and several additives can be used to dope to the 
nanofibres to change their functional properties. An area of future work 
will be to manufacture nanofibre using biodegradable, non-degradable 
and medical grade polymers to build the bespoke and preferred micro-
environments for cells which will lead to manufacturing specific human 
tissues.  However, rather than doping the whole fibre it is possible to coat 
the outer surface of each fibre using an electrospraying process to provide 
cells with specific physical and chemical cues. In addition, it has been 
shown that electrospinnable polymers can be blended with proteins and 
growth factors to enhance cell growth and maintenance.  
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In this thesis, only random nanofibre scaffolds where used to progress 
the development of a neurodegenerative model. But the aligned and 
radial fibre synthesis techniques developed during this research are being 
used by other researchers to create new in vitro human tissue models.   
7.2.2 Cells based techniques 
Primarily, the study focused on understanding and controlling the 
morphology of cells on new 3D scaffolds, which involved characterising 
cell attachment, proliferation and differentiation. In future, the work 
could be extended to investigate how cells adapt to different habitats, 
how neuronal elongation can be encouraged or inhibited and whether 
nanofibre surfaces can control cell division.  All of these will benefit from 
the in-depth molecular biological analysis, such as the mass spectrometry 
fingerprint of proteins expressed internally or externally during the 
metabolic process of cells cultured on fibre compared to cells on TCP. 
GFAP was the only glial cell marker investigated in this work. Follow on 
studies would look into the expression of other astrocyte markers like 
EAAT1/GLAST, EAAT2/GLT-1 Glutamine synthetase, S100 beta ALDH1L1.  
Using immortalised glial cells, we demonstrated that the glial cell ECM 
can promote the development of matured neuron and axonal elongation 
without using any other differentiating agents. This experiment was only 
performed on the 2D surface; a plan for a future investigation would 
involve performing the same experiment using nanofibres as the cell 
culture surface and examine if the nanofibres can promote enhanced 
neurite extension and direction compared to cells of TCP.  Using 
techniques like qRT- PCR and mass spectrometry analysis it should be 
possible to identify the key proteins in the glial cell ECM that triggers the 
differentiation mechanism in neuronal cells. 
So far the influence of toxins on cell viability have been assessed using 
the nanofibre model, but further investigations should focus on molecular 
and genetic-based analysis to improve understanding, with many studies 
reporting that several genes are associated with neural cell degeneration 
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pathophysiology. A similar investigation could be carried out using our 
nanofibre model to analyse the expression of these genes and to 
understand the difference in the pathway response of each gene 
expression when cultured on nanofibres and on the plates. The co-culture 
model can be tested in multiple methods. Current techniques only 
focused on two-layer based co-culture system. In future, we will be 
investigating on multiple layered scaffolds to establish in vitro tissue 
which matches the in vivo condition.  
7.2.3 Other nanofibre based studies 
The surface of nanofibres can be modified using a number of known and 
well-established techniques. Several studies have incorporated growth 
factors, antimicrobial agents and proteins within the nanofibre which has 
led to better cell attachment and cell growth. An alternative is to coat the 
surface of the nanofibre with a very thin layer using an electrospray 
technique.  
We have experimented on surface modification of nanofibres for several 
other studies which may also be used in the future for developing an 
improved neurodegenerative diseases model. One such study which was 
performed involved using precision robotics and spraying techniques to 
coat the surface of aligned fibre with hydroxyapatite embedded in a 
perfluoroelastomer polymer, as shown in Figure 7.1. The coated 
nanofibres were challenged with primary human tenocyte and osteoblast 
cells (Figure 7.1 A-F). The results from the study showed high viability 
and bone spike formation of osteoblast on the coated surface (Figure 7.1 
A, B and C) and tenocytes stretched along the uncoated aligned fibre 
structure forming a collagen-rich monolayer as shown in Figure 7.1 D, E 
and F. The cells cultured on the aligned fibres were stained for collagen 
protein (red) and nuclei stain using DAPI (blue) and rich collagen 
deposition was observed in the uncoated region and high yield of 
osteoblast with nuclei stain was seen on the coated area, Figure 7.1 H 
and I.    
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Figure 7. 1: Human Osteoblast and Tenocyte cultured on 
hydroxyapatite-coated aligned nanofibre.  
Figure A-C represents osteoblast cells expressing bone spikes. Figure D-
F shows tenocytes wrapped and growing along the fibres. Image G shows 
EDX analysed for different chemical elements. Figure H and I show 
immunofluorescences imaging expressing collagen and DAPI nuclei stain. 
The Yellow arrow indicates collagen (red) deposition; blue arrow 
represents hydroxyapatite coating (magenta) and white show DAPI stain 
(blue).  
Nanofibres seem to create ideal structures for harbouring cells; 
biodegradable fibres can be used to develop cellular implants to promote 
cell growth and replace damaged or lost cells in several diseases which 
are similar to neurodegenerative diseases. We have also tested the ability 
of neuronal and glial cells to attach and grow on graphene coated surfaces 
and partial graphene coated nanofibres. Several studies have reported 
that neuronal cells have shown better attachment and growth when 
cultured on graphene. Cellular implants which incorporate graphene 
circuits are the main focus of several research groups.  
CHAPTER VII                                      CONCLUSION & FUTURE WORK 
225 
 
 
Figure 7. 2: Neural cells cultured on graphene-coated coverslips. 
(A) Neuronal cells and (B) Glial cells 
 
Figure 7. 3: Neural cells cultured on graphene-coated nanofibres. 
(A) Neuronal cells and (B) Glial cells 
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Our preliminary experiments on the graphene-coated coverslip (Figure 
7.2) and graphene-coated nanofibre (Figure 7.3) demonstrated the 
ability of neural cells to attach and grow on graphene. The cells cultured 
on nanofibre and graphene also showed the formation of an integrated 
network of neural cells and graphene islands along the nanofibres. This 
work may lead to the development of graphene and nanofibre based 
biosensors or flexible implants that can monitor cell activity and induce 
cell response with an electrical impulse.  
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